PERSONAL DETAIL


DATIN PROF. DR. ZAHURIN BINTI MOHAMED

Department of Pharmacology
Faculty of Medicine
 
  +60379675725
  +60379674791
  zahurin@um.edu.my
 Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia
 
ResearcherID Link
  http://www.researcherid.com/rid/C-1112-2010

BIOGRAPHY


I obtained my BSc and PhD in Pharmacology from the University of Dundee (UK), joined the University of Malaya as a tutor in 1979, and was promoted to Professor of Pharmacology in 2000. I was the Head of the Department of Pharmacology for over 18 years from 1994, which ended in August 2014, following my appointment into the university's Board of Directors (BOD). My appointment as member of BOD ended in Dec 2015. My main research currently is in pharmacogenomics (PGx), being the country representative on PGx research for an international group (Global Genomic Medicine Collaborative under the National Institute of Health, USA) and 2 regional groups (including the Southeast Asian Pharmacogenomics Network). PGx is currently one of the fastest growing research area globally and I have supervised over 25 postgraduate students in this field over the years. My laboratory was awarded research funding of over RM3.5 million over a period of 5 years from 2011 to 2015, and our team has published over 105 papers since then. I have been invited to speak on PGx at international and national conferences.  I am also a member of at least 7 committees at the national level, the most significant being the National Committee for Clinical Research (NCCR), chaired by the Director-General of Health, Malaysia. My expertise in Good Clinical Practice (GCP) is recognised, being invited to be a speaker and facilitator at GCP Workshops throughout the country. My expertise also extends to being a consultant for contract research in the form of Bioequivalence (BE) Studies for various generic drug manufacturers since 1999, and to date, we have completed over 32 consultancies.  My Bioequivalence Centre has two accreditations, one under SAMM ISO-IEC 17025/2001, and the other is under Ministry of Health, and is one of only four accredited centres in Malaysia. I was appointed by the Minister of Science, Technology and Innovations, to be a member of the National Bioethics Council (NBC) and presented the Keynote Address at its launch. I have been a Vice-Chairman of NBC. I was also appointed by the Deputy Prime Minister (who was also then the Minister of Education), to be a representive of the University's Senate to the University's Board of Directors, the appointment ended in Dec 2015.  I am also an active member of several NGOs, and frequently and passionately participate in various community and student events.

 


ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • Malaysian Society of Biochemistry and Molecular Biology, Secretary, 1982 to 1988, (National)
  • Sabbatical Leave at University of South Australia, Adelaide., Research Collaboration, 1988 to 1989, (International)
  • Seminar Women and Health 1991. Organised under University Women s Association, Chairman, 1991 to 1991, (National)
  • Sabbatical leave at the Dept of Biochemistry, National Univ. of Malaysia, Research Collaboration, 1993 to 1993, (National)
  • SEMINAR WOMEN AND HEALTH II 1994. ORGANISED UNDER UNIVERSITY WOMEN S ASSOCIATION , Chairman, 1994 to 1994, (National)
  • National Committee on Clinical Research, Committee Member, 1994, (National)
  • NATIONAL COMMITTEE ON CLINICAL RESEARCH, MINISTRY OF HEALTH (JAWATANKUASA PENYELIDIKAN KEBANGSAAN, KEMENTERIAN KESIHATAN MALAYSIA), Panel Member, 1996, (National)
  • Malaysian Society of Pharmacology and Physiology (MSPP), President, 1996 to 2000, (National)
  • IXTH SOUTHEAST ASIAN DRUG METABOLISM WORKSHOP. ORGANISED UNDER THE MALAYSIAN SOCIETY OF PHARMACOLOGISTS AND PHYSIOLOGISTS, Chairman, 1998 to 1998, (International)
  • United Nations University Symposium on Endocrine Disrupting Chemicals , Honorary Secretary, 2000 to 2000, (International)
  • NATIONAL COMMITTEE FOR GOOD LABORATORY PRACTICE, MINISTRY OF HEALTH, Committee Member, 2000, (National)
  • MEDICAL CENTRE RESEARCH COMMITTEE, FACULTY OF MEDICINE, Committee Member, 2001, (National)
  • EXECUTIVE COMMITTEE OF THE MALAYSIAN SOCIETY OF PHARMACOLOGY AND PHYSIOLOGY 2002/2004, Exco Member, 2002 to 2004, (National)
  • JAWATANKUASA KUMPULAN KESEPAKARAN FAKULTI PERUBATAN BAGI PENILAIAN KENAIKAN PANGKAT KE JAWATAN PROFESOR MADYA/PROFESOR BAGI UKM, Committee Member, 2002, (National)
  • ANIMAL ETHICS COMMITTEE OF THE FACULTY OF MEDICINE [ JAWATANKUASA KECIL ETIKA PENJAGAAN DAN PENGGUNAAN HAIWAN, FAKULTI PERUBATAN], Committee Member, 2002 to 2004, (National)
  • NATIONAL COMMITTEE ON BIOEQUIVALENCE STUDIES, Committee Member, 2002, (National)
  • National Committee for Malaysian Guidelines on Good Clinical Practice, Panel, 2002, (National)
  • 16TH SCIENTIFIC MEETING OF MSSP, Organising Committee, 2004, (National)
  • MALAYSIAN SOCIETY OF PHARMACOLOGY AND PHYSIOLOGY, President, 2004, (National)
  • MEDICAL ETHICS COMMITTEE OF THE UNIVERSITY OF MALAYA MEDICAL CENTRE [JAWATANKUASA ETIKA PERUBATAN], Committee Member, 2004 to 2013, (National)
  • HEALTH AWARENESS NETWORK INITIATIVES, Honorary Secretary, 2005, (National)
  • PERSATUAN KANSER NETWORK (KANWORK), Committee For Finance, 2005, (National)
  • EXPERT COMMITTEE FOR THE PROMOTION TO PROFESSOR AND ASSOCIATE PROFESSOR [AHLI JAWATANKUASA KESEPAKARAN BAGI PELANTIKAN/KENAIKAN PANGKAT KE JAWATAN PROFESOR/PROFESOR MADYA], Committee Member, 2005, (National)
  • JAWATANKUASA PENYELIDIKAN JANGKAPENDEK (PJP) DAN FUNDAMENTAL (PPF), UNIVERSITI MALAYA, Committee Member, 2005, (National)
  • AHLI PANEL PENILAIAN KURSUS PTK BAGI SKIM PERKHIDMATAN PENSYARAH TAHAP KECEKAPAN 3 DAN 4, UNIVERSITI MALAYA, Panel Member, 2006, (National)
  • JAWATANKUASA TEKNIKAL (LATIHAN) PERUBATAN TRADISIONAL DAN KOMPLEMENTARI, KEMENTERIAN KESIHATAN MALAYSIA, Committee Member, 2006, (National)
  • Asian Network of Pharmacogenomics Research, Exco Member, 2008, (International)
  • National Protem Committee on Bioethics (under Ministry of Science, Technology and Innovations), Panel Member, 2010, (National)
  • INTERNATIONAL ASSOCIATION OF BIOETHICS, Member, 2010, (International)
  • National Bioethics Council, Council Member / National Delegate, 2011, (National)
  • Malaysian Association for the Study of Obesity (MASO), Member, 2011, (National)
  • Monash University External Member of Staff Selection Committee for Academic Appointments, Panel Member, 2011, (National)
  • South-East Asian Pharmacogenomics Network, International Board Member, 2012, (International)
  • Expert Panel Member for Pre-Investigational New Drug Application (IND), Ministry of Health Malaysia, Panel Member, 2012, (National)
  • Committee Member for Assessment of Exploratory Research Grant Scheme (ERGS) 2012, Ministry of Higher Education Malaysia , Committee Member, 2012, (National)
  • Panel Penilai Geran Penyelidikan Di Bawah Kluster Health & Translational Medicine (HTM) 2012, Panel Member, 2012 to 2012, (University)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Head, University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine, 01/01/2016 to 25/09/2016
  • Head, University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine, 01/01/2015 to 31/03/2015
  • Head of Department, Pharmacology, Faculty of Medicine, 01/07/2014 to 31/07/2014
  • Head, University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine, 02/01/2014 to 31/12/2014
  • Head of Department, Pharmacology, Faculty of Medicine, 01/09/2012 to 30/06/2014
  • Head of Department, Pharmacology, Faculty of Medicine, 01/07/2012 to 31/08/2012
  • Head of Department, Pharmacology, Faculty of Medicine, 09/07/2011 to 30/06/2012
  • Head of Department, Pharmacology, Faculty of Medicine, 01/07/2011 to 08/07/2011
  • Head of Department, Pharmacology, Faculty of Medicine, 01/11/2009 to 30/06/2011
  • Member of Board of Director of University of Malaya Specialist Centre (UMSC), University Malaya, 12/10/2015 to 12/10/2018 (Representing the Board of Directors of the University of Malaya)
  • Member of Appeal Panel against Disciplinary Action, University of Malaya Category D, representing UM's Board of Directors (Ahli Jawatankuasa Rayuan Tatatertib Universiti Malaya D), University Malaya, 02/04/2015 to 02/04/2018
  • Board member of UM Jana Dana Sdn Bhd, representing UM's Board of Directors (Ahli Lembaga Pengarah UM Jana Dana Sdn Bhd), University Malaya, 02/04/2015 to 02/04/2018
  • Panel member of the Audit Committee of the University of Malaya, representing UM's Board of Directors (Ahli Jawatankuasa Audit Universiti Malaya), University Malaya, 02/04/2015 to 02/04/2018
  • Member of the Steering Committee for Development of Health Metropolis University of Malaya (UMHM), representing UM's Board of Directors (Ahli Jawatankuasa bagi Projek Pembangunan Metropolis Perubatan Universiti Malaya), University Malaya, 02/04/2015 to 02/04/2018
  • Panel for Appeal against Student Disciplinary Action, representing UM's Board of Directors (Pengganti Wakil Lembaga ke Jawatankuasa Rayuan Tatatertib Pelajar) , University Malaya, 02/04/2015 to 02/04/2018
  • Member of Panel for Disciplinary Action for University of Malaya D, representing UM's Board of Directors (Ahli Jawatankuasa Tatatertib Universiti Malaya D), , University Malaya, 02/04/2015 to 02/04/2018
  • Committee Member for Assessment of Research Funds under the Institute of Management and Monitoring of Research (Ahli Jawatankuasa penilaian bagi permohonan geran penyelidikan di bawah tadbir urus IPPP Peringkat UM), University Malaya, 01/01/2015 to 31/12/2016
  • Vice-Chairman of the National Bioethics Council, National, 02/06/2014 to 01/07/2015 (The election of the Vice Chairman was made at the June meeting of the National Bioethics Council and carried out among the council members)
  • Member of Committee for Planning of Human Resource for Faculty of medicine (Ahli Jawatankuasa Perancangan Sumber Manusia bagi Fakulti Perubatan), Faculty, 02/06/2014 to 30/06/2015
  • Panel of Interviewers for Student Entry into University of Malaya, University Malaya, 14/03/2014 to 14/03/2015
  • Council member for the Chair for the Protection of Finance for Aged Citizens (Ahli majlis Kursi Perlindungan Kewangan Warga Tua), University Malaya, 14/02/2014 to 14/02/2017 (This appointment was made by virtue of being in the University's Board of Directors)
  • Member of the Committee for Promotion of Professors representing UM's Board of Directors (Ahli Jawatankuasa Pemilih bagi maksud pelantikan ke suatu Kursi dan Kenaikan Pangkat ke Jawatankuasa Profesor Kanan dan Profesor Gred Khas, University Malaya, 14/02/2014 to 14/02/2017
  • Member of Board of Directors of UM Capital Berhad (UMCB), representing UM's Board of Directors (Ahli Lembaga Pengarah UM Capital Berhad), University Malaya, 14/02/2014 to 14/02/2017
  • Member of Board of Directors of UM Capital Berhad (UMCB), representing UM's Board of Directors (Ahli Lembaga Pengarah UM Capital Berhad), University Malaya, 14/02/2014 to 14/02/2017 (This appointment was made by virtue of being the University's Board of Directors)
  • Appointed by the Minister of Education, to represent Senate at the University of Malaya's Board of Directors. , University Malaya, 01/02/2014 to 01/02/2017
  • Head of Research Centre for the University of Malaya Bioequivalence and Testing Centre (UBAT), University Malaya, 02/01/2014 to 31/12/2015
  • Head Coordinator, Faculty, 01/01/2014 to 31/12/2014
  • Member of the National Committee for Clinical Research, chaired by the Director-General of Health, Ministry of Health, Malaysia, National, 01/01/2014 to 31/12/2015 (Has been an active member of this committee since 1994)
  • Country Representative and Member of the Steering Committee for SEAPharm (Pharmacogenomic Research Network South-East Asia, International, 01/01/2014 to 31/12/2014 (This will be formalised at a Round Table Meeting at the Symposium for Genetic and Genome Guided Personalized Medicine in Asia: Overview and Applications in Bangkok 2-3 Feb 2012)
  • Council Member of the National Bioethics Council - extension of term., National, 31/12/2013 to 31/12/2015
  • Head of Section, University Malaya, 31/12/2013 to 31/01/2014 (University of Malaya Bioequivalence and Testing Centre (UBAT))
  • Assessor of the Fundamental Research Grant Scheme (FRGS) at the UM level, University Malaya, 20/09/2013 to 20/09/2013
  • Member of the Medical Centre Research Committee (MCRC), University Malaya, 19/07/2013 to 19/07/2013 (from the time it was established till when it was disbanded to be taken over by other research committees)
  • Senate Representative for Interview of Candidates for University of Malaya's Vice Chancellor from Nov 2013, National, 10/07/2013 to 10/07/2013
  • Assessor for the Exploratory Research Grant Scheme, under the Ministry of Higher Learning, National, 02/04/2013 to 05/04/2013
  • Committee Member of the Ethics Committee, representing the Department of Pharmacology, University Malaya, 02/01/2013 to 02/01/2013 (Alternate member with Head of Department of Pharmacy)
  • Panel member of the Health and Translational Research Cluster, University Malaya, 01/01/2013 to 31/12/2014
  • Panel Reviewer/Committee member for Fundamental Research Grant Scheme (FRGS) and Exploratory Research Grant Scheme at UM level, University Malaya, 01/01/2013 to 31/12/2014
  • Senate Member of the University of Malaya, University Malaya, 17/12/2012 to 16/12/2015
  • Senate Representative for UM Staff Application for Conferences, University Malaya, 17/12/2012 to 15/12/2015
  • Medical Ethics Committee Member, University Malaya, 10/10/2012 to 02/01/2013
  • Panel Reviewer for the Health and Translational Medicine Cluster, University Malaya, 02/01/2012 to 31/12/2012
  • Council Member of the National Bioethics Council (Majlis Bioetika Negara), National, 13/10/2011 to 31/12/2014 (The formation of the National Bioethics Council was approved by Cabinet on 9th July 2010. My role in the Council is a 'personal to holder' expert for Pharmacogenomics and Bioethics)
  • Committee Member for Assessment of Exploratory Research Grant (Health and Clinical Science). Ministry of Higher Education. , National, 27/05/2011 (Appointment is by the Ketua Pengarah, Jabatan Pengajian Tinggi, Ministry of Higher Education.)
  • Panel Member for the Assessment of ERGS Grant 2011 in the field of Medical Science and Clinical. , National, 27/05/2011 (Appointment was made by Ketua Pengarah, Jabatan Pengajian Tinggi Malaysia, Dato' prof Dr Rujhan Mustafa)
  • Member of the University of Malaya Medical Centre Ethics Committee. , Faculty, 17/01/2011 (I have been alternate member of this committee with the Head of the Pharmacy Department since I was the Head of Pharmacology in 1994)
  • National Committee for the revision of the Third Edition of Malaysian Guidelines for Good Clinical Practice. Representing the academicians. The Third Edition was out in January 2011., National, 01/11/2010 to 17/01/2011
  • Panel Penilai Pakar untuk Penilaian Pembiayaan Dana Kementerian Sains, Teknologi dan Inovasi. 27 Julai 2010 27 Julai 2012., National, 27/07/2010 to 27/07/2012
  • Panel Temuduga Program Ijazah Luar Negara (PILN) 2009 and 2010. Jabatan Perkhidmatan Awam., National, 25/12/2009
  • Panel of auditors for Research Centres of the University of Malaya. , University Malaya, 01/04/2009
  • Chairman of Judging Committee for PECIPTA, an Inter-University Compettition for Inventions and Innovations organised jointly between UM and Ministry of Higher Education , National, 02/02/2009 to 31/10/2009
  • Panel of Assessors for National Science Foundation Award, Ministry of Science, Technology and Innovations (MOSTI) for 2009 and 2010. , National, 05/01/2009 to 31/12/2014
  • Country Representative and member of the Steering Committee for the Asian Network of Pharmacogenomics Research (ANPR), International, 07/07/2008 to 31/12/2014 (I was fortunate enough to be present at the ANPR meeting that was held in Inje University, Busan, South Korea in 2009.)
  • Head of the Pharmacogenomics Laboratory, Faculty of Medicine. The number of postgraduate students registered in the lab currently is 21., Faculty, 03/12/2007
  • Committee for Postgraduate Studies of the Faculty of Medicine. Representing the Para-Clinical Departments. , Faculty, 02/01/2007 to 31/10/2008
  • Panel Member of Penilaian Tahap Kecekapan (PTK) Bagi Skim Perkhidmatan Pensyarah Gred 45/51 Tahap Kecekapan (TK) 3 & 4 ., University Malaya, 09/01/2006
  • Member of the Medical Centre Research Committee (MCRC), University Malaya, 01/11/2005 to 19/07/2013 (I have been a member of MCRC since its inception till July 2013 when the role of MCRC has been taken over by another committee which is department-based.)
  • National Committee for Good Laboratory Practice chaired by Professor Dato' Navaratnam. Ministry of Health, Malaysia., National, 13/12/2004 to 31/12/2014
  • National Committee Establishment of Standard and Criteria for the Programmes in Traditional and Complementary Medicine, Ministry of Health Malaysia Traditional and Complementary Medicine, Ministry of Health, Malaysia , National, 01/01/2004 to 31/12/2008
  • National Bioequivalence Committee. Chaired by the Director of the National Pharmaceutical Control Bureau, Ministry of Health. Committee member since its inception in 2004., National, 01/01/2004 to 31/12/2014
  • University of Malaya Committee for the Assessment of Vote F and Fundamental Vote (representing the science-based research). [Jawatankuasa Penyelidikan Jangka Pendek dan Penyelidikan Fundamental Universiti Malaya] , University Malaya, 07/01/2002 to 31/12/2008
  • Committee Member of the Animal Ethics Committee of the Faculty of Medicine [ Jawatankuasa Kecil Etika Penjagaan dan Penggunaan Haiwan, Fakulti Perubatan] , University Malaya, 01/01/2002 to 30/12/2005
  • Advisory Committee for Clinical Investigation Centre, University of Malaya Medical Centre , Faculty, 03/01/2000 to 31/12/2007
  • Founding member and Member of the Board of SUCXeS (Shimadzu-University of Malaya Centre for Xenobiotic Services), Faculty of Medicine, University of Malaya , University Malaya, 05/07/1999
  • Head of the University of Malaya Bioequivalence and Testing Centre (UBAT), University Malaya, 01/06/1999 to 31/12/2015 (Founding Member of UBAT)
  • Principal Investigator of the University of Malaya Bioequivalence and Testing Centre, Faculty of Medicine, University of Malaya (UBAT). Contract research in the form of Bioequivalence Studies have been carried out since 1999 but UBAT has only recently been named so., University Malaya, 01/04/1999 (This centre is in the process of applying for ISI 17025)
  • National Committee for setting the Malaysian Guidelines to conduct drug-related clinical trials in Malaysia for the Ministry of Health (Guidelines published in June 2000. Currently undergoing revision) , National, 01/03/1999
  • Academic Advisor to MBBS II students for several years including 2008/09, 2009/10, 2010/11, 2011/12, 2012/13, Faculty, 05/12/1994 to 31/12/2014 (Have been volunteering for this off and on for many years.)
  • National Committee on Clinical Research, chaired by the Director General of Health. Appointment was by the Ministry of Health, Malaysia. Committee Member since January 1996 till now, National, 01/04/1994 to 31/12/2014 (This is a powerful, high-level committee that decides on all aspects of clinical research done in Malaysia.)
  • Head of Department of Pharmacology since 1994 till present except for short periods, University Malaya, 01/02/1994 to 30/06/2014
  • President of the University Womens Association for the University of Malaya, University Malaya, 12/12/1988 to 18/12/1990 (President of the University Womens Association)
  • College Master, University Malaya, 05/12/1988 to 07/12/1992 (Master of Third Residential College)
  • College Secretary, University Malaya, 01/01/1986 to 30/12/1988 (Third Residential College, University of Malaya)
  • Honorary Secretary of the Malaysian Biochemical Society, National, 12/05/1985 to 24/08/1987
  • President of the Malaysian Society of Pharmacology and Physiology, National, 02/01/1984 to 21/01/1986

AREAS OF EXPERTISE
(Area).


  • Clinical Pharmacology (Pharmacokinetics; Drug Metabolism)
  • Molecular Pharmacology (Pharmacogenomics; Pharmacogenetics)
  • Medical Pharmacology (Bioequivalence Studies)


RECENT SELECTED PUBLICATIONS
(Publication).


Book

2011
  • Malaysian Guidelines to Good Clinical Practice. Third Edition. Published by the Ministry of Health, Malaysia. January 2011. 

2003
  • Sample Preparation for GCMS Analysis of Biomedical Samples. Xenobiotic Analysis Series Vol 7. Mustafa Ali Mohd and Zahurin Mohamed. 2003. ISBN No. 983-2085-50- 0 
  • Mustafa Ali Mohd and Zahurin Mohamed \"Sample Preparation for GCMS Analysis of Biomedical Samples. Xenobiotic Analysis Series Vol 7. \", 2003, ISBN No. 983-2085-50-0, 

2001
  • Basics of column and solvent selection in HPLC Analysis. Xenobiotic Analysis Series Vol 5. Mustafa Ali Mohd and Z Mohamed. 2001. Penerbitan Salafi, 
  • Semi Micro HPLC and LCMS. Xenobiotic Analysis Series Vol 6. Mustafa Ali Mohd and Z. Mohamed. 2001. Penerbitan Salafi. 
  • Troubleshooting HPLC Systems. Xenobiotic Analysis Series Vol 2. Mustafa Ali Mohd and Z. Mohamed. 2001, Penerbitan Salafi. 
  • Drugs of Abuse. Xenobiotic Analysis Series Vol 4. Mustafa Ali Mohd, Hussain Habil and Z.Mohamed. 2001, University of Malaya Press. 

2000
  • Lee Toong Chow, Yuen Kah Hay, Yahaya Hassan, Fudziah Dato Ariffin, Zahurin Bt Mohamed, Aishah Latiff, Aishah Adam \"Ministry of Healths \"Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies\", 2000, 
  • Abdul Rani Abdullah, Kulenthran Arumugam, Melissa Chan, Mustafa Ali Mohd, Rokiah Pendek, Ruby Hussain, Samsinah Hussain & Z.Mohamed. "Endocrine-Disrupting Chemicals. Xenobiotic Analysis Series Vol 3. ", 2000, SUCXeS 
  • Mustafa Ali Mohd, Hussain Habil and Z.Mohamed. Drugs of Abuse. Xenobiotic Analysis Series Vol 2. 2000. 

1999
  • Ramli Abd Ghani, Zahurin Bt Mohamed, Nazrin Ahmad Azli, Ho Tze Ming and Faridah Aryani Md Yusoff \"Ministry of Healths \"Guidelines for Application to Conduct Drug-Related Clinical Trials in Malaysia\", 1999, 
  • Mustafa Ali Mohd, Yuki Hashi and Z.Mohamed. Volatile Organic Compounds. Xenobiotic Analysis Series Vol 1. 1999 

1994
  • REVIEW OF MEDICAL PHYSIOLOGY by W.F.Ganong. (KAJIAN SEMULA FISIOLOGI PERUBATAN). Translated by Mustafa Ali Mohd, Zurina Ismail & Zahurin Mohamed. Awarded second price for best translated science book for 1996. 1994 (Translation published by Dewan Bahasa dan Pustaka). Dewan Bahasa dan Pustaka. , 

1991
  • FUNDAMENTALS OF FIXED PROSTODONTICS by H.T. Shillingburg, S.Hobo & L.D. Whitsett. (ASAS PROSTODONTIKS TETAP). Translated by Mustafa Ali mohd, Noor Hayaty Kassim & Zahurin Mohamed. 1991 (Translation published by Dewan Bahasa dan Pustaka) 

1990
  • LIVING NUTRITION (PEMAKANAN UNTUK HIDUP) by F.J. Store & M. McWilliams. Translated by Mustafa Ali Mohd, Zahurin Mohamed. Zurina Ismail & Tika Haji Mohamed. 1990, John Wiley & Sons (Translation published by Dewan Bahasa dan Pustaka, 

1989
  • BASIC MICROBIOLOGY WITH APPLICATIONS by T.D.Brock, K.M.Brock and D.M.Ward. Published by (ASAS MIKROBIOLOGI DAN PENGGUNANNYA)Translated by Zahurin Mohamed, Mustafa Ali Mohd, Tik Haji Mohamed & Zurina Ismail. 1989, Prentice-Hall, New Jersey (Translation published by Dewan Bahasa dan Pustaka) 
Article in Academic Journals

2019
  • Abdulmannan H. Fateh, Zahurin Mohamed, Zamri Chik, Mohammed Abdullah Alshawsh. Prenatal developmental toxicity evaluation of Verbena officinalis during gestation period in female Sprague-Dawley rats. February 2019. Chemico-Biological Interactions 304. DOI: 10.1016/j.cbi.2019.02.016 (ISI-Indexed)
  • Atefehalsadat Seyedan, Zahurin Mohamed, Mustafa Ahmed AL-Shagga, Mohammed Abdullah Alshawsh. Cynometra cauliflora Linn. Attenuates metabolic abnormalities in high-fat diet-induced obese mice (2019) March 2019. Journal of Ethnopharmacology 236 DOI: 10.1016/j.jep.2019.03.00 (ISI-Indexed)
  • Abdulmannan H.Fateh, ZahurinMohamed, Zamri Chik, Abdulsamad Alsalahi Siti Rosmani Md Zain, Mohammed A.Alshawsh (2019). Mutagenicity and genotoxicity effects of Verbena officinalis leaves extract in Sprague-Dawley Rats.. Journal of ethnopharmacology. Volume 235, 10 May 2019, Pages 88-99. (ISI-Indexed)
  • Sanaz KooshaSanaz Koosha, Zahurin Mohamed, Ajantha Sinniah, Mohammed Abdullah Alshawsh. Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer (2019). March 2019. Scientific Reports 9(1):5148. DOI: 10.1038/s41598-019-41685-1 (ISI-Indexed)

2018
  • Alsalahi, A., Alshawsh, M. A.*, Chik, Z., & Mohamed, Z. (2018). Effect of Catha edulis (khat) on pancreatic functions in streptozotocin-induced diabetes in male Sprague-Dawley rats. Experimental Animals, 2018; 67 (4) 517-526. doi:10.1538/expanim.18-0057 (ISI-Indexed)
  • Zain, M. A., Zainal, N. Z., Kanagasundram, S. and Mohamed, Z. (2018) “Genetic association study of PDLIM5 and HTR2A variants in Malaysian subjects diagnosed with bipolar disorder; a genetic modelling approach”, Neuroscience Research Notes, 1(1), pp. 11-20. doi: 10.31117/neuroscirn.v1i1.9. (Non-ISI/Non-SCOPUS)
  • Prevalence of HLA-DQ Alleles and Haplotypes in Patients with Hepatitis B Infection. American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS). (2018) Volume 43, No 1, pp 159-168. ISSN (Online) 2313-4402 (ISI-Indexed)
  • Ranjithkumar C, Pandy V*, Mohamed Z (2018). Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal. European Journal of Pharmacology, 818, 10-16. https://doi.org/10.1016/j.ejphar.2017.10.025. (ISI-Indexed)
  • Zaharan NL, Muhamad NH, Jalaludin MY, Su TT, Mohamed Z, Mohamed MNA, Majid HA (2018) Non-synonymous single nucleotide polymorphisms and physical activity interactions on adiposity parameters in Malaysian adolescents. Frontiers in Endocrinology. 9:209. doi: 10.3389/fendo.2018.00209. eCollection 2018 (ISI-Indexed)
  • BEHNAZ RIAZALHOSSEINI, ZAHURIN MOHAMED, YAMUNAH DEVI APALASAMY, NOOR SHAFILA SHAFIE and ROSMAWATI MOHAMED (2018) Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population. BIOMEDICAL REPORTS. (2018) DOI: 10.3892/br.2018.1126 (ISI-Indexed)
  • Elham Amini, Mojtaba Golpich, abdoreza soleimani farjam,, Raymond bin Azman Ali,, Zahurin Mohamed. Brain Lipopolysaccharide Preconditioning-Induced Gene Reprogramming Mediates a Tolerance State in Electroconvulsive Shock Model of Epilepsy. May 2018. Frontiers in Pharmacology 9:416. DOI: 10.3389/fphar.2018.00416 (ISI-Indexed)
  • Chong, Huey Yi; Lim, Yi Heng; Prawjaeng, Juthamas; et al.Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population (2018) Pharmacogenetics and Genomics Volume: 28 Issue: 2 Pages: 56-67 Published: FEB 2018. DOI: 10.1097/FPC.0000000000000319 (ISI-Indexed)
  • Mojtaba Golpich, Elham Amini, Zahurin Mohamed, Abolhassan Ahmadiani. Reprogramming in inflammatory response to neuronal damage induced by the brain LPS preconditioning: Possible implications in rat model of Parkinson’s disease. January 2018. Parkinsonism & Related Disorders 46:e3. DOI: 10.1016/j.parkreldis.2017.11.011 (ISI-Indexed)
  • Sajad Jamalpour, Shamsul Mohd Zain, Maryam Mosavat, Zahurin Mohamed, Siti Zawiah Omar. A case-control study and meta-analysis confirm glucokinase regulatory gene rs780094 is a risk factor for gestational diabetes mellitus (2018). January 2018. Gene 650(15 April 2018):34–40. DOI: 10.1016/j.gene.2018.01.091 (ISI-Indexed)
  • Mohd Aizat Mohd Zain, Vijayapandi Pandy, Abu Bakar Abdul Majeed, Zahurin Mohamed. Chronic restraint stress impairs sociability but not social recognition and spatial memory in C57BL/6J mice. November 2018. Experimental Animals 68(1). DOI: 10.1538/expanim.18-0078. LicenseCC BY-NC-ND 4.0 (ISI-Indexed)
  • Zain MA, Rouhollahi E, Pandy V*, Mani V, Majeed ABA, Wong WF, Mohamed Z (2018). Phencyclidine dose optimisation for induction of spatial learning and memory deficits related to schizophrenia in C57BL/6 mice. Exp. Anim. 67(4), 421–429. (ISI-Indexed)
  • Zin, Siti Rosmani Md; Mohamed, Zahurin; Alshawsh, Mohammed ; Wong, Won; Kassim, Normadiah. Mutagenicity evaluation of Anastatica hierochuntica L. aqueous extract in vitro and in vivo. Experimental Biology and Medicine Volume: 243 Issue: 4 Pages: 375-385 Published: FEB 2018. DOI: 10.1177/1535370217748574 (ISI-Indexed)

2017
  • Pandy V*, Narasingam M, Vijeepallam K, Mohan S, Mani V, and Mohamed Z (2017). Ethyl acetate fractionate of methanolic extract of noni (Morinda citrifolia Linn.) unripe fruit exhibits a biphasic effect on dopaminergic system in mice. Experimental Animals 66(3), 283-291. (ISI-Indexed)
  • Ten, L. C., Chin, Y. M., Tai, M. C., Chin, E. F. M., Lim, Y. Y., Suthandiram, S., ... & Gan, G. G. (2017). SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression. Scientific Reports, 7. (ISI-Indexed)
  • Zin, S. R. M., Kassim, N. M., Alshawsh, M. A., Hashim, N. E., & Mohamed, Z. (2017). Biological activities of Anastatica hierochuntica L.: A systematic review. Biomedicine & Pharmacotherapy, 91, 611-620. (ISI-Indexed)
  • Sim MS, Soga T, Pandy V, Wu YS, Parhar IS, Mohamed Z. (2017) MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis., 32(6):1767-1783. (Impact factor: 2.297) (ISI-Indexed)
  • Rahmadhani, R., Zaharan, N. L., Mohamed, Z., Moy, F. M., & Jalaludin, M. Y. (2017). The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country. PLoS One, 12(6), e0178695. doi: 10.1371/journal.pone.0178695 (ISI-Indexed)
  • Narasingam M, Vijeepallam K, Mohamed Z, Pandy V* (2017). Anxiolytic- and antidepressant-like activities of a methanolic extract of Morinda citrifolia Linn. (noni) fruit in mice: Involvement of benzodiazepine-GABAAergic, serotonergic and adrenergic systems. Biomedicine & Pharmacotherapy 96, 944-952. (ISI-Indexed)
  • Ranjithkumar C, Pandy V*, Mohamed Z. (2017). Pharmacology and Toxicology of α- and β- Asarone: A Review of Preclinical Evidence. Phytomedicine 32, 41-58 (ISI-Indexed)
  • Sim M S, Soga T, Pandy V, Wu Y S, Parhar I S, and Mohamed Z (2017). MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metabolic Brain Disease, 1-17. doi:10.1007/s11011-017-0061-x (ISI-Indexed)
  • Wai Mun Kong, Zamri Chik, Zahurin Mohamed, Mohammed A Alshawsh: Physicochemical Characterization of Mitragyna speciosa Alkaloid Extract and Mitragynine Using In Vitro High Throughput Assays. Combinatorial chemistry & high throughput screening 10/2017; 20, DOI:10.2174/1386207320666171026121820 (ISI-Indexed)
  • Prevathe Poniah, Shamsul Mohd Zain, Azad Hassan Abdul Razack, Shanggar Kuppusamy, Shankar Karuppayah, Hooi Sian Eng, Zahurin Mohamed: Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic Oncology 05/2017;, DOI:10.1016/j.urolonc.2017.04.017 (ISI-Indexed)
  • Huey Yi Chong, Yi Heng Lim, Juthamas Prawjaeng, Tassaneeyakul Wichittra, Zahurin Mohamed and Nathorn Chaiyakunapruk. Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. Pharmacogenetics and Genomics, Nov 2017, DOI10.1097/FPC.0000000000000319 (ISI-Indexed)
  • Behnaz Riazalhosseini, Rosmawati Mohamed, Devi Apalasamy, Mbongo Langmia, Zahurin Mohamed: Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. Revista da Sociedade Brasileira de Medicina Tropical 04/2017; 50(2):161-166., DOI:10.1590/0037-8682-0416-2016 (ISI-Indexed)
  • Mirazul Islam, Zahurin Mohamed, Yassen Assenov: Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML. International Journal of Genomics 06/2017; 2017(Article ID 2913648):13., DOI:10.1155/2017/2913648 (ISI-Indexed)
  • Evaluation of pharmacokinetics and Blood-Brain Barrier permeability of mitragynine using in vivo microdialysis technique. Wai Mun Kong, Zahurin Mohamed, Mohammed AL Shawsh, Zamri Chik.Journal of Pharmaceutical and Biomedical Analysis. Volume 143 (43-47), 2017 (ISI-Indexed)
  • Chong HY, Mohamed Z, Tan LL, Wu DB, Shabaruddin FH, Dahlui M, Apalasamy YD, Snyder SR, Williams MS, Hao J, Cavallari LH & Chaiyakunapruk N (2017) Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia. British Journal of Dermatology 177(4):1102-1112 doi: 10.1111/bjd.15498 (ISI-Indexed)

2016
  • D. A. Loh, F. M. Moy, N. L. Zaharan, M. Y. Jalaludin and Z. Mohamed. 2016. Sugar-sweetened beverage intake and its associations with cardiometabolic risks among adolescents. Pediatric Obesity. doi:10.1111/ijpo.12108 (ISI-Indexed)
  • Abdulsamad Alsalahi, Mohammed A. Alshawsh*, Rosmawati Mohamed, Naelah A. Alyousefi, Mustafa Ahmed Alshagga, Abdrabuh N Shwter, Ali Al-Maqtari, Radwan H. Ahmed and Zahurin Mohamed*. Conflicting Reports on the Role of the Glycemic Effect of Catha edulis (Khat): A Systematic Review and Meta- analysis. Journal of Ethnopharmacology (2016); Impact Factor 2.9999. (ISI/SCOPUS Indexed Publication)
  • Sanaz Koosha, Mohammed A. Alshawsh, Looi Chung Yeng, Atefehalsadat Seyedan and Zahurin Mohamed. An Association Map on the Effect of Flavonoids on the Signaling Pathways in Colorectal Cancer. International Journal of Medical Sciences 2016. (ISI/SCOPUS Indexed Publication)
  • Lim CH, Zainal NZ, Kanagasundram S, Zain SM, Mohamed Z. Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 2016; 171(6):867-74. (ISI-Indexed)
  • Chellian Ranjith Kumar, Vijayapandi Pandy, Zahurin Mohamed: Biphasic Effects of α-Asarone on Immobility in the Tail Suspension Test: Evidence for the Involvement of the Noradrenergic and Serotonergic Systems in Its Antidepressant-Like Activity. Frontiers in Pharmacology 03/2016; 7(20120537)., DOI:10.3389/fphar.2016.00072 (ISI-Indexed)
  • Mustafa Ahmed Alshagga, Mohammed Abdullah Alshawsh, Atefehalsadat Seyedan, Abdulsamad Alsalahi, Yan Pan, Suresh Kumar Mohankumar, Abdolgodose Alkebsi, Saba Kassim, Zahurin Mohamed: Khat (Catha edulis) and Obesity: A Scoping Review of Animal and Human Studies. Annals of Nutrition and Metabolism 11/2016; 69(3-4):200-211., DOI:10.1159/000452895 (ISI-Indexed)
  • Mojtaba Golpich, Elham Amini, Zahurin Mohamed, Raymond Azman Ali, Norlinah Mohamed Ibrahim, Abolhassan Ahmadiani: Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neuroscience & Therapeutics 11/2016; 23(11):1-18., DOI:10.1111/cns.12655 (ISI-Indexed)
  • Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. Subramaniam KS, Omar IS, Kwong SC, Mohamed Z, Woo YL, Mat Adenan NA, Chung I. Am J Cancer Res. 2016 Jan 15;6(2):200-13. eCollection 2016 (ISI-Indexed)
  • Atefehalsadat Seyedan, Mohammed Abdullah Alshawsh, Mustafa Ahmed Alshagga, Zahurin Mohamed: Antiobesity and Lipid Lowering Effects of Orthosiphon stamineus in High-Fat Diet-Induced Obese Mice. Planta Medica 12/2016;, DOI:10.1055/s-0042-121754 (ISI-Indexed)
  • Immaculate M. Langmia, Yamunah D. Apalasamy, Siti O. Zawiah, Zahurin Mohamed: Impact of IL1B gene polymorphisms and interleukin 1B levels on susceptibility to spontaneous preterm birth. Pharmacogenetics and Genomics 09/2016;, DOI:10.1097/FPC.0000000000000243 (ISI-Indexed)
  • Elnaz Bakhtiyari, Mohammad Mahdi Ahmadian-Attari, Peyman Salehi, Behzad Khallaghi, Leila Dargahi, Zahurin Mohamed, Mohammad Kamalinejad, Abolhassan Ahmadiani: Non-polyphenolic compounds of a specific kind of dried grape (Maviz) inhibit memory impairments induced by beta-amyloid peptide. Nutritional Neuroscience 05/2016;, DOI:10.1080/1028415X.2016.1183986 (ISI-Indexed)
  • Ling JC, Mohamed MN, Jalaludin MY, Rampal S, Zaharan NL, Mohamed Z (2016).Determinants of High Fasting Insulin and Insulin Resistance Among Overweight/Obese Adolescents. Sci Rep 6:36270. (ISI-Indexed)
  • R.M. Guad, N.L. Zaharan, Z. Chik, Z. Mohamed, B.S. Haerian, K.P. Ng, W.A.H. Wan Md Adnan. Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. TRANSPLANTATION PROCEEDINGS 48(1):81-87 FEBRUARY 2016. Impact Factor: 0.98 DOI: 10.1016/j.transproceed.2016.01.001 (ISI-Indexed)
  • Chellian Ranjith Kumar, Vijayapandi Pandy, Zahurin Mohamed. Biphasic effects of -asarone on immobility in the tail suspension test: Evidence for the involvement of the noradrenergic and serotonergic systems in its antidepressant-like activity. FRONTIERS IN PHARMACOLOGY MARCH 2016. Impact Factor: 3.80 DOI: 10.3389/fphar.2016.00072 (ISI-Indexed)
  • Megala Narasingam, Vijayapandi Pandy*, Zahurin Mohamed. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents. EXPERIMENTAL ANIMALS JANUARY 2016. Impact Factor: 0.97 DOI: 10.1538/expanim.15-0088 (ISI-Indexed)
  • Debbie Ann Loh, Foong Ming Moy, Nur Lisa Zaharan, Muhammad Yazid Jalaludin, Zahurin Mohamed. Sugar- sweetened beverage intake and its associations with cardiometabolic risks among adolescents. PEDIATRIC OBESITY FEBRUARY 2016. Impact Factor: 4.57 DOI: 10.1111/ijpo.12108 (ISI-Indexed)

2015
  • Megala Narasingam, Vijayapandi Pandy, Zahurin Mohamed. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents. Experimental Animals 2015. (ISI-Indexed)
  • Apalasamy YD, Ming MF, Rampal S, Bulgiba A, Mohamed Z. Gender-Dependent Association of a 2- Adrenergic Gene Variant With Obesity Parameters in Malaysian Malays. Asia Pac J Public Health. 2015 Mar;27(2):NP154-65. PMID: 22199155. Impact Factor: 1.11 (ISI-Indexed)
  • Apalasamy YD, Rampal S, Salim A, Moy FM, Su TT, Majid HA, Bulgiba A, Mohamed Z. Polymorphisms of the resistin gene and their association with obesity and resistin levels in Malaysian Malays. Biochem Genet. 2015 Jun;53(4-6):120-31. PMID: 25991560 (ISI-Indexed)
  • Nur Elia Nazree, Ai Chin Loke, Nor Zuraida Zainal, Zahurin Mohamed. 2015. Lack of association between TPH2 gene polymorphisms with major depressive disorder in multiethnic Malaysian population. ASIA- PACIFIC PSYCHIATRY 7 (1), pp. 72-77 DOI: 10.1111/appy.12118 (ISI-Indexed)
  • Konstantinos Mitropoulos, Hayat Al Jaibeji, Diego A Forero, Paul Laissue, Ambroise Wonkam, Catalina Lopez-Correa, Zahurin Mohamed, Wasun Chantratita, Ming Ta Michael Lee, Adrian Llerena, Angela Brand, Bassam R Ali, George P Patrinos. Success stories in genomic medicine from resource-limited countries. Human genomics 06/2015; 9(1):11. DOI:10.1186/s40246- 015-0033-3 � 2.15 Impact Factor (ISI-Indexed)
  • Md. Mirazul Islam and Zahurin Mohamed Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery. BioMed Research International 10/2015; 2015(480). DOI:10.1155/2015/731292 2.71 Impact Factor (ISI-Indexed)
  • Nur Elia Nazree, Zahurin Mohamed, Gavin P. Reynolds, Shamsul Mohd Zain, Ruziana Masiran, Hattaa Sidi, Lu Ann Chong, Ann Yee Hway, Aida Syarinaz Adlan, Nor Zuraida Zainal. Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder Asia-Pacific Psychiatry 09/2015; DOI:10.1111/appy.12210 0.63 Impact Factor (ISI-Indexed)
  • Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Fatemeh Hajiaghaalipour, Salma Baig, Faezeh Tayeby, Maryam Zahedifard, Mahmood Ameen Abdulla, Zahurin Mohamed. Curcuma purpurascens BI. rhizome accelerates rat excisional wound healing; involvement of HSP70/Bax proteins, antioxidant defence and angiogenesis activity.Drug Design Development and Therapy 2015. Oct 27;9:5805-13. doi: 10.2147/DDDT.S88196. eCollection 2015. Impact Factor 3.028. (ISI-Indexed)
  • Atefehalsadat Seyedan, Mohammed A. Alshawsh, Mustafa Ahmed Mahdi Al-Shagga, Sanaz Koosha and Zahurin Mohamed. Medicinal Plants and Their Inhibitory Activities Against Pancreatic Lipase: A Review" by Evidence-Based Complementary and Alternative Medicine. Impact Factor = 1.88 (ISI-Indexed)
  • Prevathe Poniah, Zahurin Mohamed, Yamunah Devi Apalasamy, Shamsul Mohd Zain, Shanggar Kuppusamy, Azad Hassan Abdul Razack. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International Journal of Clinical and Experimental Medicine (IJCEM) 2015. Impact Factor = 1.277 (ISI-Indexed)
  • Zain SM, Mohamed Z, Pirmohamed M, Tan HL, Alshawsh MA, Mahadeva S, Chan WK, Mustapha NR, Mohamed R. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease. Scientific Reports 2015. Impact Factor 5.578. Sci Rep. 2015 Aug 21;5:13306. doi: 10.1038/srep13306. (ISI-Indexed)
  • Shamsul Mohd Zain, Zahurin Mohameda, Muhammad Yazid Jalaludin, Fatin Fauzia, Anahita Hamidia, Nur Lisa Zaharan. Comprehensive evaluation of the neuropeptide-y gene variants in risk of obesity: A case-control study and meta-analysis. Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity: a case-control study and meta- analysis. PHARMACOGENETICS AND GENOMICS AUGUST 2015. Impact Factor: 3.45 DOI: 10.1097/FPC.0000000000000164 (ISI-Indexed)
  • Seyedeh Masoumeh Seyedhoseini Tamijani1, Benyamin Karimi, Elham Amini,Mojtaba Golpich, Leila Dargahi, Raymond Azman Ali, Norlinah Mohamed Ibrahim,ZahurinMohamed, Rasoul Ghasemi, Abolhassan Ahmadiani. Thyroid hormones: possible roles in epilepsy pathology. SEIZURE AUGUST 2015. Impact Factor: 2.06 DOI: 10.1016/j.seizure.2015.07.021 (ISI-Indexed)
  • Rouhollahi E, Moghadamtousi SZ, Al-Henhena N, Kunasegaran T, Hasanpourghadi M, Looi CY, Abd Malek SN, Awang K, Abdulla MA, Mohamed Z.The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats. DRUG DESIGN, DEVELOPMENT AND THERAPY 9:3911-3922 JULY 2015 Impact Factor: 3.03 DOI: 10.2147/DDDT.S84560 (ISI-Indexed)
  • Yamunah Devi Apalasamy and Zahurin Mohamed. Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity. HUMAN GENETICS FEBRUARY 2015. Impact Factor: 4.52 DOI: 10.1007/s00439-015-1533-x (ISI-Indexed)
  • Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Hui Jan Tan, Choong Yi Fong, Sau Wei Wong, Lai Choo Ong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. RORA gene rs12912233 and rs880626 polymorphisms and their interaction with SCN1A rs3812718 in the risk of epilepsy: A case–control study in Malaysia. GENOMICS 105(4) · FEBRUARY 2015. Impact Factor: 2.79 · DOI: 10.1016/j.ygeno.2015.02.001 (ISI-Indexed)
  • D A Loh, F M Moy, N L Zaharan, Z Mohamed. Disparities in health-related quality of life among healthy adolescents in a developing country the impact of gender, ethnicity, socio-economic status and weight status. Child Care Health and Development 04/2015; DOI:10.1111/cch.12252 .Impact Factor: 1.83 (ISI-Indexed)
  • Langmia Immaculate Mbongo, Apalasamy Yamunah Devi, Shamsul Zain, Siti Zawiah Omar, Zahurin Mohamed (2015.Protein Profiling of Women with Spontaneous Preterm Birth. Pharmacology 06/2015; 96(1-2):44-48. DOI:10.1159/000430857 1.58 Impact Factor (ISI-Indexed)
  • Hidayati Mohd Sha ari, Batoul Sadat Haerian, Larry Baum, Hui Jan Tan, Mohd Hanip Rafia, Patrick Kwan, Stacey S. Cherny, Pak Chung Sham, Hongsheng Gui, Azman Ali Raymond, Kheng Seang Lim, Zahurin Mohamed. Association of BDNF Polymorphisms with the Risk of Epilepsy: a Multicenter Study. MOLECULAR NEUROBIOLOGY APRIL 2015. Impact Factor: 5.29 DOI: 10.1007/s12035-015-9150-1 (ISI-Indexed)
  • Loh, D. A., Moy, F. M., Zaharan, N. L., & Mohamed, Z. (2015). Disparities in health-related quality of life among healthy adolescents in a developing country - the impact of gender, ethnicity, socio- economic status and weight status. Child Care Health Dev, 15(10). April 2015. Impact Factor: 1.83 DOI: 10.1111/cch.12252 (ISI-Indexed)
  • Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Mohammadjavad Paydar, Mehran Fadaeinasab, Maryam Zahedifard, Maryam Hajrezaie, Omer Abdalla Ahmed Hamdi, Chung Yeng Looi, Mahmood Ameen Abdulla, Khalijah Awang, Zahurin Mohamed. Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 15(1):15 · FEBRUARY 2015 Impact Factor: 1.88 · DOI: 10.1186/s12906-015-0534-6 (ISI-Indexed)
  • MM Islam, M Aktaruzzaman, Z Mohamed. Comparative sequence-structure analysis of Aves insulin. Bioinformation 11(2): 067-072 (2015) 0.50 Impact Factor. Published February 28, 2015; ISSN 0973-2063 (online) 0973-8894 (print) (ISI-Indexed)
  • Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Mohammadjavad Paydar, Mehran Fadaeinasab, Maryam Zahedifard, Maryam Hajrezaie, Omer Abdalla Ahmed Hamdi, Chung Yeng Looi, Mahmood Ameen Abdulla, Khalijah Awang, Zahurin Mohamed. Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway. BMC Complementary and Alternative Medicine 02/2015; 15(1):15. FEBRUARY 2015 Impact Factor: 1.88 · DOI: 10.1186/s12906-015-0534-6 (ISI-Indexed)
  • Langmia IM, Apalasamy YD, Omar SZ, Mohamed Z. Association of VEGFA gene polymorphisms and VEGFA plasma levels with spontaneous preterm birth. Pharmacogenetics and Genomics 2015 Apr;25(4):199-204 (3.45 Impact Factor) DOI: 10.1097/FPC.0000000000000125 , (ISI-Indexed)
  • Polin Haghvirdizadeh, Zahurin Mohamed, Nor Azizan Abdullah, Pantea Haghvirdizadeh, Monir Sadat Haerian, Batoul Sadat Haerian. KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus. EXPERIMENTAL DIABETES RESEARCH · JANUARY 2015 Impact Factor: 3.54 · DOI: 10.1155/2014/908152 (ISI-Indexed)
  • I M Langmia, Y D Apalasamy, S Z Suki, S Z Omar, Z Mohamed. Genetic association of AKAP10 gene polymorphism with reduced risk of preterm birth JOURNAL OF PERINATOLOGY JUNE 2015. Impact Factor: 2.35 DOI: 10.1038/jp.2015.68. http://www.nature.com/jp/journal/vaop/ncurrent/pdf/j p201568a.pdf (ISI-Indexed)
  • Golpich, M., Amini, E., Hemmati, F., Ibrahim, N. M., Mohamed, Z., Raymond, A. A., Dargahi, L., Ghasemi, R., & Ahmadiani, A. (2015). Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Pharmacological Research. 1-30. DOI:10.1016/j.phrs.2015.03.010 (ISI-Indexed)
  • Immaculate Mbongo Langmia, Yamunah Devi Apalasamy, Siti Zawiah Omar, Zahurin Mohamed. Interleukin 1 receptor type 2 gene polymorphism is associated with reduced risk of preterm birth. The Journal of Maternal-Fetal & Neonatal Medicine 2015. DOI:10.3109/14767058.2015.1125466.Impact Factor = 1.367. (ISI-Indexed)
  • Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Stacey S. Cherny, Jae-Gook Shin, Sung Eun Kim, Bok- Ghee Han, Hui Jun Tan, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta- analysis. MOLECULAR NEUROBIOLOGY OCTOBER 2015. DOI: 10.1007/s12035-015-9457-y. (Impact Factor 5.14) (ISI-Indexed)
  • Immaculate Mbongo Langmia, Yamunah Devi Apalasamy, Siti Zawaih Omar, Zahurin Mohamed. Progesterone Receptor (PGR) gene polymorphism is associated with susceptibility to preterm birth. BMC Medical Genetics 08/2015; 16(1). DOI:10.1186/s12881-015- 0202-1, 2.08 Impact Factor (ISI-Indexed)
  • Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Stacey S. Cherny, Jae-Gook Shin, Sung Eun Kim, Bok- Ghee Han7 & Hui Jun Tan, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta- analysis. Molecular Neurobiology 2015. (Tier 1; Impact Factor = 5.137).DOI: 10.1007/s12035-015-9457- y (ISI-Indexed)
  • Abdul Halim-Fikri Hashim, Ali Etemad, Ahmad Zubaidi Abdul Latif, Amir Feisal Merican, Atif Amin Baig, Azlina Ahmad Annuar, Endom Ismail Iman Salahshourifar, Liza Sharmini Ahmad Tajudin Marini Ramli, Rosnah Binti Zain, Shafini Mohamed Yusoff, Surini Yusoff, Tan Soon Guan, Thong Meow Keong, Hatin Wan-Isa, Wan Zaidah Abdullah, Zahurin Mohamed, Zarina Abdul Latiff, Bin Alwi Zilfalil. The first Malay database toward the ethnic-specific target molecular variation. BMC RESEARCH NOTES 8(1):176 APRIL 2015 with 182 READS DOI: 10.1186/s13104-015-1123-y Source: PubMed (ISI-Indexed)
  • Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L, Ghasemi R, Ahmadiani A. Glycogen synthase kinase-3 beta (GSK- 3 ) signaling: Implications for Parkinson's disease PHARMACOLOGICAL RESEARCH MARCH 2015, Impact Factor: 4.41 . DOI: 10.1016/j.phrs.2015.03.010 (ISI-Indexed)
  • Hwa-li Tan, Rosmawati Mohamed, Zahurin Mohamed, Shamsul Mohd Zain. Phosphatidylethanolamine N- methyltransferase gene rs7946 polymorphism plays a role in risk of non-alcoholic fatty liver disease: Evidence from meta-analysis. Pharmacogenetics and Genomics 2015. Impact Factor 3.48 . DOI: 10.1097/FPC.0000000000000193 (ISI-Indexed)
  • Behnaz Riazalhosseini, Zahurin Mohamed, Yamunah Devi Apalasamy, Rosmawati Mohamed. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B. Pharmacogenetics and Genomics 2015. (Tier 1; Impact Factor = 3.481) DOI: 10.1097/FPC.0000000000000187 (ISI-Indexed)

2014
  • Siti Norsyuhada Roffeei, Gavin P. Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida & Zahurin Mohamed. 2014. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Hum. Psychopharmacol Clin Exp 29: 38 45 (ISI-Indexed)
  • Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Choong Yi Fong, Hui Jan Tan, Sau Wei Wong, Ong Lai Choong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of TIMP4 rs3755724 polymorphism to susceptibility to focal epilepsy in Malaysian Chinese. JOURNAL OF NEUROIMMUNOLOGY 2015, 278; 137- 143 DECEMBER 2014. Impact Factor: 2.79 DOI: 10.1016/j.jneuroim.2014.12.016 (ISI-Indexed)
  • Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Nur Elia Mohd Nazree, Nik Ruzyanei Nik Jaafar, Marhani Midin, Srijit Das, Suriati Mohamed Saini (2014). Female Sexual Dysfunction in Patients with Major Depressive Disorder (MDD) Treated with Selective Serotonin Reuptake Inhibitor (SSRI) and Its Association with Serotonin 2A- 1438 G/A Single Nucleotide Polymorphisms. Journal of Sexual Medicine 2014; 11:1047-1055. DOI:10.1111/jsm.12452. (Impact Factor: 3.51) (ISI-Indexed)
  • Siti Norsyuhada Roffeei, Gavin P Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida, Zahurin Mohamed. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.HUMAN PSYCHOPHARMACOLOGY CLINICAL AND EXPERIMENTAL 29(1):38-45 · JANUARY 2014 Impact Factor: 1.85 · DOI: 10.1002/hup.2366 (ISI-Indexed)
  • Zain SM, Rosmawati M, Cooper D, Razali R, Rampal S, Mahadeva S, Chan WK, Anwar A, Nurul SMR, Anis SF, Cheah PL, Basu RC, Tan HL, Mohamed Z. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non- alcoholic fatty liver disease. PLOS ONE 2014;9 (4):e95604 , PLOS ONE 9(4):E95604 APRIL 2014. Impact Factor: 3.53. DOI: 10.1371/journal.pone.0095604 (ISI-Indexed)
  • Shiau Hui Diong, Nor Shuhadah Mohd Yusoff, Maw Shin Sim, Raja Elina Raja Aziddin, Zamri Chik, Rusdi Abdul Rashid, Norliza Chemi, Zahurin Mohamed (2014). Quantitation of methadone and its metabolite in patients under maintenance treatment. JOURNAL OF ANALYTICAL TOXICOLOGY AUGUST 2014 Impact Factor: 2.63 DOI: 10.1093/jat/bku096 (ISI-Indexed)
  • Chor Hong Lim, Shamsul Mohd Zain, Gavin Reynolds, Siti Norsyuhada Mohd Roffeei, Mohd Aizat Mohd Zain, Sharmilla Kanagasundram; Nor Zuraida Zainal, Zahurin Mohamed. Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY 24 · JUNE 2014, Impact Factor: 4.03 · DOI: 10.1016/j.pnpbp.2014.05.017 (ISI-Indexed)
  • Fatemeh Hemmati, Rasoul Ghasemi, Leila Dargahi, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Abolhassan Ahmadiani. Crosstalk between insulin and toll-like receptors signaling pathways. MOLECULAR NEUROBIOLOGY 50(3) JANUARY 2014 Impact Factor: 5.29 DOI: 10.1007/s12035-013-8631-3 (ISI-Indexed)
  • Rana Omidbakhsh, Banafshe Rajabli, Sanaz Nasoohi, Behzad Khallaghi, Zahurin Mohamed, Murali Naidu, Abolhassan Ahmadiani1, Leila Dargahi(2014). Fingolimod affects gene expression profile associated with LPS- induced memory impairment. EXPERIMENTAL BRAIN RESEARCH · JULY 2014 Impact Factor: 2.17 · DOI: 10.1007/s00221-014-4052-4 (ISI-Indexed)
  • Siti Norsyuhada Roffeei, Zahurin Mohamed, Gavin P Reynolds, Mas Ayu Said, Ahmad Hatim, Elsa Haniffah Mejia Mohamed, Syarinaz Ahmad Aida, Nor Zuraida Zainal. Association of FTO, LEPR and MTHFR polymorphisms with metabolic syndrome in Malaysian schizophrenia patients receiving long- term antipsychotic treatment. Pharmacogenomics 2014; 15(4); 477-485(Tier 1; Impact Factor = 3.857). (ISI-Indexed)
  • Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Nur Elia Mohd. Nazree, Nik Ruzyanei Nik Jaafar, Marhani Midin, Srijit Das, Suriati Mohamed Saini. Female Sexual Dysfunction in Patients with Major Depressive Disorder (MDD) Treated with Selective Serotonin Reuptake Inhibitor (SSRI) and Its Association with Serotonin 2A-1438 G/A Single Nucleotide Polymorphisms. JOURNAL OF SEXUAL MEDICINE 11(4) · FEBRUARY 2014 Impact Factor: 3.15 · DOI: 10.1111/jsm.12452 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. 2013. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays.Genetic associations of the INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays. GENETICS AND MOLECULAR RESEARCH: GMR 13(3):4904-4910 · JULY 2014 Impact Factor: 0.85 · DOI: 10.4238/2014.July.4.4 (ISI-Indexed)
  • Larry Baum, Batoul Sadat Haerian , Ho Keung Ng, Virginia C. N. Wong, Ping Wing Ng, Colin H. T. Lui, Ngai Chuen Sin, Chunbo Zhang, Brian Tomlinson, Gary Wing Kin Wong, Hui Jan Tan, Azman Ali Raymond, Zahurin Mohamed, Patrick Kwan. Case–control association study of polymorphisms in the voltage- gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. HUMAN GENETICS 133(5):651-659 · MAY 2014 Impact Factor: 4.52 · DOI: 10.1007/s00439-013-1405-1 · (ISI-Indexed)
  • Sujatha Suthandiram, Gin-Gin Gan, Shamsul Mohd Zain, Ping-Chong Bee, Lay-Hoong Lian,Kian-Meng Chang, Tee- Chuan Ong & Zahurin Mohamed1. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics (2014) 15(11), 1479 1494 (Tier 1). (ISI-Indexed)
  • Minoo Haerian, Larry Baum, Patrick Kwan, Stacey Cherny, Hui Jan Tan, Raymond bin Azman Ali, Zahurin Mohamed. Association of GABRG2 rs211037 polymorphism with susceptibility to epilepsy in Asians: a multicentre cohort study and meta-analysis. THE FASEB JOURNAL 28:912.8 APRIL 2014. Impact Factor: 5.48 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. 2013. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays.Genetics and Molecular Research.Genet Mol Res 2014 Jul 4;13(3):4904-10. PMID:25062423. (ISI-Indexed)
  • Sujatha Suthandiram, Gin Gin Gan, Shamsul Mohd Zain Ping-Chong Bee, L.H. Lian, K.M. Chang, T.C. Ong, Zahurin Mohamed. Impact of genetic polymorphisms of MTHFR, SLC, and ABC on high-dose methotrexate toxicity and plasma levels in adults with haematological malignancies. EUROPEAN JOURNAL OF CANCER MAY 2014. Impact Factor: 4.82 DOI: 10.1016/j.ejca.2014.03.221 (ISI-Indexed)
  • Mohd A. Zain, Siti N. Roffeei, Nor Z. Zainal, Sharmilla Kanagasundram and Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) SEPTEMBER 2013. Impact Factor: 2.27 DOI: 10.1097/YPG.0000000000000015 (ISI-Indexed)
  • M.S. Sim*, A. Hatim, S.H. Diong, Z. Mohamed. Genetic Polymorphism in DTNBP1 Gene Is Associated With Methamphetamine-Induced Panic Disorder. JOURNAL OF ADDICTION MEDICINE OCTOBER 2014 Impact Factor: 1.71 DOI: 10.1097/ADM.0000000000000075 (ISI-Indexed)
  • Mojtaba Golpich, Behrouz Rahmani, Leila Dragahi, Raymond Azman Ali, Norlinah Mohd Ibrahim, Zahurin Mohamed, Abolhassan Ahmadiani. Preconditioning as a Potential Strategy for the Prevention of Parkinson’s Disease. MOLECULAR NEUROBIOLOGY 51(1) · APRIL 2014 Impact Factor: 5.29 · DOI: 10.1007/s12035-014-8689-6 . Tier 1 (ISI-Indexed)
  • Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Batoul Sadat Haerian, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan and Zahurin Mohamed. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. JOURNAL OF HUMAN GENETICS 59(5) · MARCH 2014. Impact Factor: 2.53 · DOI: 10.1038/jhg.2014.19 (ISI-Indexed)
  • Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan, Zahurin Mohamed. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. TUMOR BIOLOGY NOVEMBER 2014 Impact Factor: 3.61 DOI: 10.1007/s13277-014-2785- 0 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Sanjay Rampal, Agus Salim, Moy Foong Ming, Awang Bulgiba, Zahurin Mohamed. 2014 .Association of ADIPOQ gene with obesity and adiponectin levels in Malaysian Malays. MOLECULAR BIOLOGY REPORTS 41(5) · JANUARY 2014 Impact Factor: 1.96 · DOI: 10.1007/s11033-014-3147-0 (ISI-Indexed)
  • Elham Amini, Golpich Mojtaba, Rasoul Ghasemi, Zahurin Mohamed, Norlinah Ibrahim Azman Ali Raymond (2014). A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts. MOLECULAR NEUROBIOLOGY · SEPTEMBER 2014 Impact Factor: 5.29 · DOI: 10.1007/s12035-014-8876-5 (ISI-Indexed)
  • Vijayapandi Pandy, Megala Narasingam, Thubasni Kunasegaran, Dharmani Devi Murugan and Zahurin Mohamed. Effect of Noni (Morinda citrifolia Linn.) fruit and its bioactive principles scopoletin and rutin on rat vas deferens contractility: An ex vivo study. The Scientific World Journal (2014). Impact Factor 1.730 (Tier 1)http://dx.doi.org/10.1155/2014/909586 (ISI-Indexed)
  • Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Omer Abdalla Ahmed Hamdi, Mehran Fadaeinasab, Maryam Hajrezaie, Khalijah Binti Awang, Chung Yeng Looi, Mahmood Ameen Abdulla and Zahurin Mohamed.Evaluation of acute toxicity and gastroprotective activity of curcuma purpurascens BI. rhizome against ethanol- induced gastric mucosal injury in rats (2014). BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 14(1):378 · OCTOBER 2014, Impact Factor: 1.88 · DOI: 10.1186/1472-6882-14-378 (ISI-Indexed)
  • Hidayati Mohd Shaari, Batoul Sadat Haerian, Larry Baum, Junji Saruwatari, Hui Jan Tan, Mohd Hanip Rafia, Azman Ali Raymond, Patrick Kwan, Takateru Ishitsu, Kazuko Nakagawa,Kheng Seang Lim, Zahurin Mohamed. ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to anti- epileptic drugs in Asia Pacific epilepsy cohorts. PHARMACOGENOMICS 15(4):459-66 · MARCH 2014 Impact Factor: 3.43 · DOI: 10.2217/pgs.13.239 (ISI-Indexed)
  • Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan and Zahurin Mohamed. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. PHARMACOGENOMICS 15(11):1479-1494 OCTOBER 2014 Impact Factor: 3.43 DOI: 10.2217/pgs.14.97 (Tier 1) (ISI-Indexed)
  • Shamsul Mohd Zain, Rosmawati Mohamed, David N. Cooper, Rozaimi Razali, Sanjay Rampal, Sanjiv Mahadeva, Wah- Kheong Chan, Arif Anwar, Nurul Shielawati Mohamed Rosli, Anis Shafina Mahfudz Phaik-Leng Cheah Roma Choudhury Basu,9 and Zahurin Mohamed1,2. Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease. PLOS ONE 9(4):E95604 · APRIL 2014 Northeast Ohio Medical University, United States of America. Impact Factor: 3.53 · DOI: 10.1371/journal.pone.0095604 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Moy Foong Ming, Agus Salim, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. Association of ADIPOQ gene with obesity and adiponectin levels in Malaysian Malays. Molecular Biology Reports (Impact Factor: 2.51). 01/2014; DOI:10.1007/s11033-014- 3147-0 (ISI-Indexed)
  • Shamsul Mohd Zain, Zahurin Mohamed, Rosmawati Mohamed. A common variant in the glucokinase regulatory gene rs780094 and risk of non-alcoholic fatty liver disease: A meta-analysis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30(1) AUGUST 2014 Impact Factor: 3.63 DOI: 10.1111/jgh.12714 (ISI-Indexed)
  • Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Choong Yi Fong, Hui Jan Tan, Sau Wei Wong, Ong Lai Choong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of TIMP4 rs3755724 polymorphism to susceptibility to focal epilepsy in Malaysian Chinese. Journal of Neuroimmunology 12/2014; 278. 2.79 Impact Factor (ISI-Indexed)

2013
  • Loke Ai Chin, Nor Zuraida Zainal, Lian AH, Zahurin Mohamed. 2013. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. Asian Biomedicine Journal 7(1): 105-112 (ISI-Indexed)
  • Nazree, Nur Elia; Loke, Ai Chin; Zainal, Nor Zuraida; Mohamed, Zahurin. Lack of Association between TPH2 gene polymorphisms with Major Depressive Disorder (MDD) in multiethnic Malaysian population. (ISI-Indexed)
  • Baum, L., Haerian, BS ; Ng, HK ; Wong, V; Ng, PW ; Lui, CHT ; Sin, NC ; Zhang, C ; Tomlinson, B ; Wong, WKG ; Wong, KS ; Tan, HJ ; Raymond, AA ; Zahurin, M ; Kwan, P.VOLTAGE GATED SODIUM CHANNEL GENE POLYMORPHISMS ARE ASSOCIATED WITH EPILEPSY. Epilepsia 2013; 54(3);344-344 (Tier 1; Impact Factor = 3.909) (ISI-Indexed)
  • Nazree, Nur Elia; Loke, Ai Chin; Zainal, Nor Zuraida; Mohamed, Zahurin. Lack of Association between TPH2 gene polymorphisms with Major Depressive Disorder (MDD) in multiethnic Malaysian population. Asia Pacific Psychiatry 2013. (Tier 4; Impact Factor = 0.47) (ISI-Indexed)
  • Hwa Li Tan, Shamsul Mohd Zain, Rosmawati Mohamed, Sanjay Rampal, Kin-Fah Chin, Roma Choudhury Basu, Phaik Leng Cheah, Sanjiv Mahadeva, Zahurin Mohamed. Association of glucokinase regulatory gene polymorphisms with risk and severity of non- alcoholic fatty liver disease: an interaction study with adiponutrin gene. JOURNAL OF GASTROENTEROLOGY 49(6) · JUNE 2013. Impact Factor: 4.02 · DOI: 10.1007/s00535-013-0850-x (ISI-Indexed)
  • Larry Baum, Batoul Sadat Haerian, Ho-Keung Ng, Virginia CN Wong, Ping Wing Ng, Colin H.T.Lui, Ngai Chuen Sin, Chunbo Zhang, Brian Tomlinson, Gary Wing-Kin Wong, Hui Jan Tan, Azman Ali Raymond, Zahurin Mohamed and Patrick Kwan. Case– control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. HUMAN GENETICS 133(5):651-659 · MAY 2014. Impact Factor: 4.52 · DOI: 10.1007/s00439-013-1405-1 (ISI-Indexed)
  • Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Suriati Mohamed Saini,Nik Ruzyanei NikJaafar. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women. ASIA- PACIFIC PSYCHIATRY 5 · AUGUST 2013 Impact Factor: 0.42 · DOI: 10.1111/appy.12043 (ISI-Indexed)
  • M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional polymorphism in the FAAH gene with methamphetamine dependence and methamphetamine-induced symptoms in a Malaysian population. Pharmacogenomics (2013); 14(5):505-514 (Tier 1; Impact Factor = 3.97)04/2013; 14(5):505-14. DOI: 10.2217/pgs.13.25 (ISI-Indexed)
  • Kavita S Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Mat Adenan Noor Azmi, Ivy Chung. Cancer- associated fibroblasts promote proliferation of endometrial cancer cells. Plos One (2013). July 2013. 8(7); e68923(Tier 1; Impact Factor = 3.53) (ISI-Indexed)
  • Ghasemi R, Dargahi L, Haeri A, Moosami L, Mohamed Z, Ahmadiani, A. Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders. MOLECULAR NEUROBIOLOGY 47(3) JANUARY 2013. Impact Factor: 5.29 DOI: 10.1007/s12035- 013- 8404-z (ISI-Indexed)
  • MOHD AIZAT ZAIN, Siti Norsyuhada Roffeei, Nor Zuraida Zainal, Sharmilla Kanagasundram, Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) SEPTEMBER 2013. Impact Factor: 2.27 DOI: 10.1097/YPG.0000000000000015 (ISI-Indexed)
  • Debbie Ann Loh, Foong Ming Moy, Nur Lisa Zaharan, Zahurin Mohamed. Eating Behaviour among Multi- Ethnic Adolescents in a Middle-Income Country as Measured by the Self-Reported Children s Eating Behaviour Questionnaire. PLOS ONE 8(12):E82885 DECEMBER 2013 Impact Factor: 3.53 DOI: 10.1371/journal.pone.0082885 (ISI-Indexed)
  • Zain SM, Mohamed Z, Mahadeva S, Rampal S, Basu RC, Cheah PL, Salim A, Mohamed R. Susceptibility and Gene Interaction Study of the Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphisms with Non- Alcoholic Fatty Liver Disease in a Multi-Ethnic Population. PLOS ONE 8(3):E58538 MARCH 2013. Impact Factor: 3.53 DOI: 10.1371/journal.pone.0058538 (ISI-Indexed)
  • Mohd Aizat Zain, Siti Norsyuhada Roffeei, Nor Zuraida Zainal, Sharmilla Kanagasundram, Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) · SEPTEMBER 2013. Impact Factor: 2.27 · DOI: 10.1097/YPG.0000000000000015 (ISI-Indexed)
  • Apalasamy YD, Ming MF, Rampal S, Bulgiba A, Mohamed Z (2013).Association of Melanocortin-4 Receptor Gene Polymorphisms with Obesity-related Parameters in Malaysian Malays. Ann Hum Biol. Jan;40(1):102-6. (Tier 2; Impact Factor = 1.98) (ISI-Indexed)
  • M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.PHARMACOGENOMICS 14(5):505-14 · APRIL 2013. Impact Factor: 3.43 · DOI: 10.2217/pgs.13.25 (ISI-Indexed)
  • Lay-Hoong Lian, Ai-Chin Loke, Nor Z Zainal, Zahurin Mohamed. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. Asian Biomedicine Vol. 7 No. 1 February 2013 (2013)DOI: 10.5372/1905- 7415.0701.xxx (ISI-Indexed)
  • YD Apalasamy, A Bulgiba, YF Moy, Z Mohamed. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays. Genetics and Molecular Research (2013). (ISI-Indexed)
  • Soobitha Subenthiran, Noor Rain Abdullah, Joyce Pauline Joseph, Prem Kumar Muniandy, Mok Boon Teck, Kee Chee Cheong, Zakiah Ismail and Zahurin Mohamed (2013). Linkage Disequilibrium between Polymorphisms of ABCB1 and ABCC2 to Predict the Treatment Outcome of Malaysians with Complex Partial Seizures on Treatment with Carbamazepine Mono- Therapy at the Kuala Lumpur Hospital. PLOS ONE 8(5):E64827 · MAY 2013 Kaohsiung Chang Gung Memorial Hospital, Taiwan Impact Factor: 3.53 · DOI: 10.1371/journal.pone.0064827 (ISI-Indexed)
  • Shamsul Mohd Zain, Zahurin Mohamed, Sanjiv Mahadeva, Sanjay Rampal, Roma Choudhury Basu, Phaik Leng Cheah, Agus Salim, Rosmawati Mohamed. Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. Plos One 2013; 8(3); 1-8. March 2013 | Volume 8 | Issue 3 | e58538(Tier 1; Impact Factor = 5.07) (ISI-Indexed)
  • Fatemeh Hemmati, Leila Dargahi, Sanaz Nasoohi, Rana Omidbakhsh, Zahurin Mohamed, Zamrichik, Murali Naidu, Abolhassan Ahmadiani. Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine. BEHAVIOURAL BRAIN RESEARCH · JUNE 2013 Impact Factor: 3.39 · DOI: 10.1016/j.bbr.2013.06.016 (ISI-Indexed)
  • Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Hui Jun Tan, Azman Ali Paymond, Zahurin Mohamed. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. PHARMACOGENOMICS 14(10):1153-66 · JULY 2013. Impact Factor: 3.43 · DOI: 10.2217/pgs.13.104 (ISI-Indexed)
  • Shamsul Mohd Zain,*, Zahurin Mohamed,*, Sanjiv Mahadeva, Phaik-Leng Cheah, Sanjay Rampal, Kin-Fah Chin, Roma Choudhury Basu,** Hwa-Li Tan*, and Rosmawati Mohamed (2013). Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with PNPLA3 variant. Journal of Gastroenterology and Hepatology 2013;28(5):873-9. doi: 10.1111/jgh.12104. (Tier 2; Impact Factor = 2.87) (ISI-Indexed)
  • Soobitha Subenthiran, Noor Rain Abdullah, Prem Kumar Muniandy, Joyce Pauline Joseph, Kee Chee Cheong, Zakiah Ismail and Zahurin Mohamed. G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine. GENETICS AND MOLECULAR RESEARCH: GMR 12(4):5937-5944 · NOVEMBER 2013 Impact Factor: 0.85 · DOI: 10.4238/2013.November.26.3 · (ISI-Indexed)
  • Zain SM, Mohamed Z, Mahadeva S, Rampal S, Basu RC, Cheah PL, Agus S, Rosmawati Mohamed. Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non- alcoholic fatty liver disease in a multi- ethnic population. PLOS ONE 2013 Apr 8;8(4):e60729 (Tier 1 ISI-Cited Publication) (ISI-Indexed)
  • Lay-Hoong Lian, Ai-Chin Loke, Nor Z Zainal, Zahurin Mohamed. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. ASIAN BIOMEDICINE 7(1) · FEBRUARY 2013 Impact Factor: 0.28 · DOI: 10.5372/1905- 7415.0701.xxx (ISI-Indexed)
  • Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan, Ivy Chung. Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLOS ONE 8(7):E68923 JULY 2013 . Impact Factor 3.534 DOI: 10.1371/journal.pone.0068923 (ISI-Indexed)
  • Zain SM, Mohamed Z, Mahadeva S, Cheah PL, Rampal S, Chin KF, Basu RC, Tan HL, Mohamed R. The impact of LEPR variants on risk of non-alcoholic fatty liver disease and its interaction with PNPLA3 variant. J Gastroenterol Hepatol ;28(5):873-9. (ISI-Indexed)
  • Megala Narasingam, Kamini Vijeepallam, Yasmin Khan, Zahurin Mohamed, Vijayapandi Pandy. Anxiolytic and antidepressant-like effects of Noni (Morinda Citrofilia L) fruits in mice. Indian Journal of Pharmacology 2013.Vol 45 (1). Neu/PP 83. (ISI-Indexed)

2012
  • Batoul Sadat Haerian, Larry Baum, Hui Jan Tan, Patrick Kwan, Azman Ali Raymond, Junji Saruwatari, Kazuko Nakagawa, Zahurin Mohamed. 2012. SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.PHARMACOGENOMICS 13(13):1477-85 · OCTOBER 2012. Impact Factor: 3.43 · DOI: 10.2217/pgs.12.127 (ISI-Indexed)
  • Y.D. Apalasamy, M.F. Ming, S. Rampal, A. Bulgiba and Z. Mohamed. 2012. Genetic association of SNPs in the FTO gene and predisposition to obesity in Malaysian Malays. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH. 45(12) AUGUST 2012. Impact Factor: 1.08 DOI: 10.1590/S0100-879X2012007500134 (ISI-Indexed)
  • Vijayapandi Pandy, Megala Narasingam and Zahurin Mohamed. Antipsychotic-like activity of Noni (Morinda citrifolia Linn.) in mice. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 12(1):186 · OCTOBER 2012 Impact Factor: 1.88 · DOI: 10.1186/1472-6882-12-186 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal,Awang Bulgiba, Zahurin Mohamed. 2012. Genetic association of SNPs in the FTO gene and predisposition to obesity in Malaysian Malays. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 45(12) AUGUST 2012, Impact Factor: 1.08 DOI: 10.1590/S0100-879X2012007500134 (ISI-Indexed)
  • Shamsul Mohd Zain, Rosmawati Mohamed, Sanjiv Mahadeva,Cheah Phaik Leng,Sanjay Rampal,Roma Choudhury Basu, Zahurin Mohamed. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. HUMAN GENETICS 131(7):1145-52 · JANUARY 2012. Impact Factor: 4.52 · DOI: 10.1007/s00439-012- 1141-y (ISI-Indexed)
  • Ghasemi R, Haeri A, Dargahi L, Mohamed Z, Ahmadiani A. 2012. Insulin in the Brain: Sources, Localization and Functions. MOLECULAR NEUROBIOLOGY 47(1) · SEPTEMBER 2012. Impact Factor: 5.29 · DOI: 10.1007/s12035-012- 8339-9 (ISI-Indexed)
  • Apalasamy, Y.D., Ming, M.F., Rampal, S., Bulgiba, A., Mohamed, Z., 2012. Association of melanocortin-4 receptor gene polymorphisms with obesity-related parameters in Malaysian Malays. ANNALS OF HUMAN BIOLOGY 40(1) · SEPTEMBER 2012. Impact Factor: 1.15 · DOI: 10.3109/03014460.2012.720709 (ISI-Indexed)
  • Mohd Aizat Zain, Suffee Nusrat Jahan, Gavin P Reynolds, Nor Zuraida Zainal, Sharmilla Kanagasundram and Zahurin Mohamed 2012. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration. BMC MEDICAL GENETICS 13(1):91 · OCTOBER 2012 Impact Factor: 2.45 · DOI: 10.1186/1471-2350-13-91 (ISI-Indexed)

2011
  • Zain, SM; Mohamed, Z; Mahadeva, S; ; Cheah, PL ; Rampal, S ; Basu, RC ; Mohamed, R. Does polymorphism in patatin-like phospholipase 3 gene (PNPLA3) confer risk of nonalcoholic fatty liver disease (NAFLD) in multiethnic Malaysian population? Drug Metabolism Reviews Volume: 43 Pages: 56-57 Published: MAY 2011 (ISI-Indexed)
  • Zain, MAM; Zainal, NZ; Kanagasundram, S; Mohamed, Z Association between PDLIM5 gene and bipolar disorder in Malaysian population. Drug Metabolism Reviews 2011 May. 43:57-57 (ISI-Indexed)
  • Sim, MS; Sulaiman, AH; Jaafar, ANFA; Mohamed, Z. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews 2011 May. 43:69-70 (ISI-Indexed)
  • Zahurin Mohamed, Zuraida Zainal, Lay Hoong Lian and Ai Chin Loke. Association Study of Tryptophan Hydroxylase 2 and Serotonin Transporter Genes with Major Depressive Disorder in Malaysian Ethnic Subgroups. Clinical Psychopharmacology and Neuroscience 2011;9 (1):40-40. (SCOPUS-Indexed)
  • BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: A systematic review and meta-analysis. PHARMACOGENOMICS 12(5):713-25 · MARCH 2011. Impact Factor: 3.43 · DOI: 10.2217/pgs.10.212 (ISI-Indexed)
  • BS Haerian, KS Lim, EHM Mohamed, HJ Tan, CT Tan, AA Raymond, CP Wong, SW Wong, and Z Mohamed. Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. SEIZURE 20(7):546-53 · APRIL 2011. Impact Factor: 2.06 · DOI: 10.1016/j.seizure.2011.04.003 (ISI-Indexed)
  • BS Haerian, KS Lim, EHM Mohamed, HJ Tan, CT Tan, AA Raymond, CP Wong, SW Wong, and Z Mohamed. Lack of association between synapsin II (SYN2) gene polymorphism and susceptibility epilepsy: A case- control study and meta-analysis. SYNAPSE 65(10):1073-9 · OCTOBER 2011 Impact Factor: 2.43 · DOI: 10.1002/syn.20939 (ISI-Indexed)
  • Mohamed EHM, Tan KS,Mohd Ali J, Mohamed Z.TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients.ANNALS OF THE ACADEMY OF MEDICINE, SINGAPORE 40(4):186-91 APRIL 2011 Department of Pharmacology, University of Malaya, Kuala Lumpur, Malaysia. Impact Factor: 1.22 (ISI-Indexed)
  • Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba and Zahurin Mohamed. Gender- Dependent Association of a 2-Adrenergic Gene Variant With Obesity Parameters in Malaysian Malays. ASIA- PACIFIC JOURNAL OF PUBLIC HEALTH 27(2) · DECEMBER 2011. Impact Factor: 1.11 · DOI: 10.1177/1010539511430250 (ISI-Indexed)
  • Kong WM, Chik Z, Ramachandra M, Subramaniam U, Aziddin RER and Mohamed Z. Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput Assay. MOLECULES 16(9):7344-56 · DECEMBER 2011 Impact Factor: 2.42 · DOI: 10.3390/molecules16097344 (ISI-Indexed)
  • BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. SEIZURE 20(5):387-94 · FEBRUARY 2011. Impact Factor: 2.06 · DOI: 10.1016/j.seizure.2011.01.008 (ISI-Indexed)
  • BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. EPILEPTIC DISORDERS: INTERNATIONAL EPILEPSY JOURNAL WITH VIDEOTAPE 13(1):65-75 · MARCH 2011.Impact Factor: 0.90 · DOI: 10.1684/epd.2011.0419 (ISI-Indexed)
  • Ching-Lee Wan, Nor Zuraida Zainal, Lay-Hoong Lian, Zahurin Mohamed. Association of the functional polymorphism in the catechol-O-methyltransferase gene with schizophrenia in the three ethnic groups of the Malaysian population. PSYCHIATRY RESEARCH 189(1):67-71 · MARCH 2011. Impact Factor: 2.68 · DOI: 10.1016/j.psychres.2011.02.008 (ISI-Indexed)
  • Mohamed, Z; Haerian, BS; Lim, KS; Tan, CT. Association of ABCB1 polymorphisms with response to sodium valproate in Malaysian epilepsy patients.Drug Metabolism Reviews 2011 May. 43:80-81 (ISI-Indexed)
  • EHM Mohamed, KS Tan, JM Ali, Z Mohamed. TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients. Annals Academy of Medicine. 2011. 40(4);186-191(Impact Factor = 1.01) (ISI-Indexed)

2010
  • Z Chik, AM Mustafa, TC Lee and Z Mohamed. Analysis of Captopril in Human Plasma Using Gas Chromatography- Mass Spectrometry (GCMS) with Solid-Phase Extraction (SPE). CURRENT ANALYTICAL CHEMISTRY 6(4):329-333 · OCTOBER 2010. Impact Factor: 1.19 (ISI-Indexed)
  • Chik Z, Basu RC, Pendek R, Lee TC and Mohamed Z. 2010. A Bioequivalence Comparison of Two Formulations of Rifampicin (300-vs 150-mg Capsules): An Open-Label, Randomized, Two-Treatment, Two-Way Crossover Study in Healthy Volunteers. CLINICAL THERAPEUTICS 32(10):1822-31 · SEPTEMBER 2010 Impact Factor: 2.59 · DOI: 10.1016/j.clinthera.2010.09.006 (ISI-Indexed)
  • M.S. SIM, A. HATIM, V.L. RAJ, M.H. HABIL AND Z. MOHAMED. 2010. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. BRAIN RESEARCH 1357:91-6 · OCTOBER 2010 Impact Factor: 2.83 · DOI: 10.1016/j.brainres.2010.08.053 (ISI-Indexed)
  • BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. 2010. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: A systematic review and meta-analysis. SEIZURE 19(6):339-46 · JULY 2010 , Impact Factor: 2.06 · DOI: 10.1016/j.seizure.2010.05.004 (ISI-Indexed)

2009
  • Z.Chik, R.C. Basu, R. Pendek, T.C. Lee, Z. Mohamed. Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 47(6):413-8 · JULY 2009. Impact Factor: 1.04 · DOI: 10.5414/CPP47413 (ISI-Indexed)
  • Haerian, BS, Mohamed Z, Mohamed EHM, Lim KS, Tan HJ, Tan CT, Raymond AA. Role of ABCB1 C3435T variant in response to antiepileptic drugs in epilepsy: A review. Med & Health 2009; 4(2): 64-74 (ISI-Indexed)
  • Zamri Chik, Z.Mohamed and TC Lee. Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers. Int J Clin Pharmacol Ther (2009) 47(6):413-418 (Tier 4; Impact Factor = 1.38) (ISI-Indexed)

2007
  • A.M. Mustafa, N.T. Malintan, S.Seelan, Z.Zhan, Z.Mohamed, J.Hassan, R.Pendek, R.Hussain, N.Ito, Phytestrogens levels determination in the cord blood from Malaysia rural and urban populations. TOXICOLOGY AND APPLIED PHARMACOLOGY 222(1):25-32 · AUGUST 2007 Impact Factor: 3.63 · DOI: 10.1016/j.taap.2007.03.014 (ISI-Indexed)

2006
  • Mohamed, EHM; Tan, KS; Mohamed, Z, et al 2006. Angiotensin-converting enzyme deletion (ACE D) polymorphism and ischaemic stroke in multi-ethnic Malaysian population. ACTA PHARMACOLOGICA SINICA 27:232-232 JULY 2006. Impact Factor: 2.50 (ISI-Indexed)
  • Eng HS, Mohamed Z, Calne R, Lang CC, Mustafa AM, Seet WT and Tan SY, The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients. KIDNEY INTERNATIONAL 69(10):1858-64 · MAY 2006. Impact Factor: 8.52 · DOI: 10.1038/sj.ki.5000325 · (ISI-Indexed)

2005
  • Antiinflammatory Properties of Mitragyna Speciosa Extract. R.E.R. Aziddin, MR Mustafa, Z.Mohamed and MA Mohd. Malaysian Journal of Science 2005;24:191-194, (Non-ISI/Non-SCOPUS)

2004
  • Pang, YS, Wong LP, Lee TC, Mustafa AM, Mohamed, Z & Lang CC. 2004. Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 58(3):332-5 · SEPTEMBER 2004. Impact Factor: 3.69 · DOI: 10.1111/j.1365-2125.2004.02144.x (ISI-Indexed)
  • YS Pang, Wong LP TC Lee, Z Mohamed, Chim C Lang , Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 58(6):680-680 DECEMBER 2004 Impact Factor: 3.69 DOI: 10.1111/j1365- 2125.2004.02271 (ISI-Indexed)

2003
  • CC Lang, SK Jamal, Z.Mohamed, MR Mustafa, AM Mustafa, and TC Lee , Evidence of an interaction between nifedipine and nafcillin in humans.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 55(6):588-90 JUNE 2003 Impact Factor: 3.69 DOI: 10.1046/j.1365- 2125.2003.01789.x (ISI-Indexed)

2001
  • H.A. El-Sheikh, B.H. Ali, M Zahurin, A.M. Mustafa, G. Alhadrami and A.K. Bashir , Comparative Pharmacokinetics of Theophylline in Camels (Camelus dromedarius) and Goats (Caprus hircus). JOURNAL OF VETERINARY MEDICINE SERIES A 48(10):581-6 JANUARY 2002. Impact Factor: 0.93 DOI: 10.1046/j.1439- 0442.2001.00401.x (ISI-Indexed)
  • Lucy Chan, SM Sim, O Farizaturradiah, Z.Mohamed , "Clinical pharmacokinetics of low dose sufentanil in surgical patients", Asean Journal of Anasethesiology 2001, Vol. 22, pg. 99-102, (ISI-Indexed)

1998
  • Lang, C.C., Mustafa A.M., Jamal, S.K., Mohamed, Z. et al 1998. Nafcillin is a potent inducer of cytochrome P4503A activity in humans. Naunyn-Scmiedebergs Archives of Pharmacology. 358 (1): R458-R458 (ISI-Indexed)

1997
  • Effect of gestational age on gentamicin pharmacokinetic parameters in the newborn. O.Farizaturradiah, Z.Mohamed, S.M.Sim and C.T.Lim , Journal of the University of Malaya Medical Centre 1997;2 (1):35-38 (Non-ISI/Non-SCOPUS)
  • High performance liquid chromatography of dextromethorphan and its main metabolite in human urine. Y.H.Noraliza, Z.Mohamed, A.Zaini, C.C.Lang, , Journal Of the University of Malaya Medical Centre 1997;2 (1):23-26, (Non-ISI/Non-SCOPUS)

1995
  • Yong. BH, Sim, Ong.G and Mohamed, Z., "Plasma bupivacaine concentrations following axillary block - A study in Malaysian patients", Asia Pacific Journal of Pharmacology.1995, Vol. 10, pg. 45-48, (Non-ISI/Non-SCOPUS)

1992
  • W. Tassaneeyakul, Z.Mohamed, D.J. Birkett, M.E.McManus, M.E. Veronese, R.H. Tukey, L.C.Quattrochi, F.J.Gonzalez and J.O.Miners , "Caffeine as a probe for human cytochrome P450: Validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.", 1992, Pharmacogenetics and Genomics, Vol. 2, pg. 173 - 183) (Impact Factor = 3.991) (Number of citations = 95). Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. PHARMACOGENETICS AND GENOMICS 2(4) AUGUST 1992 Impact Factor: 3.45 (ISI-Indexed)

1991
  • Z.Mohamed. In vitro metabolism of caffeine by rabbit and rat liver microsomes. Proceedings of the Malaysian Biochemical Society Conference (1991). Vol 16, pg 93-99 (Non-ISI/Non-SCOPUS)

1990
  • Birkett, DJ, Mohamed Z and Miners, JO. Urine caffeine concentrations to control caffeine intake during competitive sports events. EUROPEAN JOURNAL OF PHARMACOLOGY 183(2):633-633 · JULY 1990 Impact Factor: 2.68 · DOI: 10.1016/0014- 2999(90)93558-8 (ISI-Indexed)

1986
  • Z.Mohamed, I.H. Stevenson. Studies on the disposition and metabolism of 8-methoxypsoralen in experimental animals. Proceedings ofthe Malaysian Biochemical Society Conference. Vol 12, pg 87-92 (Non-ISI/Non-SCOPUS)
  • Mustafa Ali Mohd, Z.Mohamed and Muhamad Zakaria. Studies on the phytochemical and pharmacological properties of the Dioscorea species. Proceedings of the Malysian Biochemical Society Conference (1986), Vol 12, pg 165-169 (Non-ISI/Non-SCOPUS)
Proceeding

1997
  • High performance liquid chromatography of dextromethorphan and its main metabolite in human urine.Y.H.Noraliza, Z.Mohamed, A.Zaini, C.C.Lang. Journal Of the University of Malaya Medical Centre 1997;2(1):23-26, (Non-ISI/Non-SCOPUS)

1991
  • In vitro metabolism of caffeine by rabbit and rat liver microsomes. Z.Mohamed. Proceeding of the Malaysian Biochemical Society Conference 1991; 16: 93- 99. (Non-ISI/Non-SCOPUS)

1986
  • Studies on the phytochemical and pharmacological properties of the Dioscorea species. Mustafa Ali Mohd, Z. Mohamed and Muhamad Zakaria. Proceedings of the Malaysian Biochemical Society Conference 1986; 12: 165 - 169 (Non-ISI/Non-SCOPUS)
  • Studies on the disposition and metabolism of 8- methoxypsoralen in experimental animals. Z Mohamed and IHStevenson. Proceedings of the Malaysian Biochemical Society Conference 1986; 12:87-92, (Non-ISI/Non-SCOPUS)
  • Studies on the disposition and metabolism of 8- methoxypsoralen in experimental animals. Proceedings of the Malaysian Biochemical Society Conference 1986;12:87-92, 
Mass Media(Newspaper,Radio,Tv,Popular Magazine)

2011
  • Berita Minggu. Column Sihat. Ahad , 5 Jun 2011. Muka Surat 6. "Kaitan gen dan ubat. Projek Variasi Manusia kenal pasti rawatan, bersesuaian DNA pilih penyakit". 

2010
  • Zahurin Mohamed. 2010. Ubat Generik vs Ubat Berjenama. iSihat. Ogos 2010. 48-49. 
  • Zahurin Mohamed. 2010. Ubat Generik: Apa yang anda perlu tahu. iSihat. Julai 2010. 48-49 
  • Pil Perangsang IQ. Berita Harian. Interview with Zahurin Mohamed. Tuesday 30th November 2010 
  • Making Drugs affordable. Interview with Zahurin Mohamed. Malaysian Business. A Special Focus on Academic Value Creation. August 2010. Page 7. 
  • Zahurin Mohamed. Ubat Generik: Cara Menguji Keberkesanan dan Tahap Keselamatan. iSihat. September 2010; 46-47 
Article in Non-Refereed Journals

2006
  • Z.Mohamed. Understanding Bioequivalence: Study Concept and Design. Bulletin of Clinical Research. 2006;2(1):6- 9. 
Others

2005
  • Eng HS, Tan SY, Lang CC, Phipps ME, Mustafa AM, Seet WT, Mohamed Z. Multidrug Resistance-1 (MDR-1) gene polymorphisms: prevalence in different ethnic groups and correlation with cyclosporine concentration-to dose ratio in renal transplant recipients. Nephrology 2005; 10(Suppl.1): A13. 

2001
  • WL Lee, Ashok Kumar and Z.Mohamed. Influence of Mobile Phase additives and pH on retention time and enantioselectivity of cationic drugs using a1-acid glycoprotein column. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 2. Presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • HA Abouazra, Z.Mohamed & AM Mustafa. Structure-related inhibition of both rat and human hepatic dextromethorphan O-demethylylation by naturally- occuring flavonoids. Asia Pacific Journal of Pharmacology (2001) Vol 15, Suppl 2. presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology, 
  • O.Farizaturradiah, L.Chan, Z.Mohamed, SM Sim & G.Ong. Pharmacokinetics of sufentanil in patients undergoing ENT surgery. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 1, Presented at the 15th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • Zamri Chik, TC Lee, Z.Mohamed, AM Mustafa & CC Lang. Bioequivalence study of 2 tablet formulations of captopril in healthy volunteers. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 1, Presented at the 15th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 8-9th May 2000 
  • Z.Chik, T.C.Lee, Z.Mohamed and A.M.Mustafa. Pharmacokinetics of Two Doses of Oral Captopril in healthy subjects. Asia Pacific Journal of Pharmacology (2001)Vol. 15, no. 2. Presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • Y.K. Pang, T.C. Lee, CC Lang, A.M. Mustafa and Z.Mohamed. Genetic polymorphism of CYP2C19 in selected healthy Malaysian subjects. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 2. Presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • Z.Mohamed. Bioequivalence studies: The process and its current status in Malaysia(Plenary Lecture). Asia Pacific Journal of Pharmacology (2001), Vol. 15, No. 2. presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • SL Tan, TC Lee and Z.Mohamed. Inhibition of ACE activity in healthy Malaysian subjects after administration of enalapril. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 2. Presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • AM Mustafa, S Sathya, Z.Mohamed, P.Rokiah, SP Chan and FL Hew. Analysis of glibenclamide in plasma and adulterated traditional medicine preparation using HPLC and SPE. Asia Pacific Journal of Pharmacology (2001) Vol. 15, no. 2. Presented at the 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 
  • ZMohamed, O.Farizaturradiah, CT Lim & SM Sim. The influence of gestational age and birth weight on gentamicin pharmacokinetic parameters in the newborn. , Asia Pacific Journal of Pharmacology (2001), Vol. 15, no. 1, Presented at the 15th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 

1991
  • Zahurin Mohamed, Rahimah Abdul Kadir and Lynne Norazit (Editors). Women and Health Seminar. Compilation of Papers from Women and Health Seminar 8-9th June 1991. Organised by UNiversity Women Association (Z.Mohamed was the President of UWA then). 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • Pharmacogenomics Study Of Drug Abuse And Dependence On Amphetamine-type Stimulants (ATS) And Heroin In A Malaysian Population, Consultant, 2019 - 2021, Bantuan Kecil Penyelidikan (BKP), (National)
  • Psychopharmacogenomics Study Of Drug Abuse And Dependance On Amphetamine-Type Stimulants (ATS) And Heroin In A Malaysian Population, Consultant, 2018 - 2020, RU Geran - Fakulti Program, (National)
  • Genetic Determinants Of Susceptibility And Severity In Non-alcoholic Fatty Liver Disease, Consultant, 2016 - 2019, Bantuan Kecil Penyelidikan (BKP), (National)
  • Antiproliferative and Chemopreventive Effects of Selected Polyphenols on Colorectal Cancer: in vitro and in vivo Studies, Consultant, 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science), (University)
  • GENOMIC MEDICINE IMPLEMENTATION : THE PERSONALIZED MEDICINE, Principal Investigator(PI), 2015 - 2016, National Institute of Health, USA, (International)
  • Association of HLA gene polymorphism with risk of allosensitization in Malaysian dialysis patients, Consultant, 2015 - 2018, Bantuan Kecil Penyelidikan (BKP), (National)
  • Pharmacogenomics Studies (2013), Principal Investigator(PI), 2014 - 2014, High Impact Research (HIR), (National)
  • Setting up of the University of Malaya Bioequivalence and Testing Centre (UBAT), Principal Investigator(PI), 2014 - 2014, University of Malaya, (National)
  • Obesity in Malaysian adolescent population: Prevalence, risk factors, complications and intervention, Co-Investigator, 2014 - 2014, High Impact Research (HIR), (National)
  • PARTNER for a low income urban community. Principal Investigator. 2012 -2014 (HTMC flagship project). FL 009 -2011, RM 971,000, Co-Investigator, 2014 - 2017, HTMC Flagship project, (National)
  • The role of various Genetic Polymorphisms in Childhood Obesity, Co-Investigator, 2014 - 2014, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Genetic Contributions To Adverse Drug Reactions (adr) In The Malaysian Population: Focus On Calcineurin Inhibitor Nephrotoxicity (cnit), Consultant, 2013 - 2018, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Association Between Gene Variants With Clinical And Cardiometabolic Complications In Malaysian Paediatrics Populations, Principal Investigator(PI), 2013 - 2015, Postgraduate Research Grant (PPP) - Research, (National)
  • Neuropsychopharmacological Evaluation Of Some Medicinal Plants For The Treatment Of Alcohol Addiction And Withdrawal In Experimental Animal Models, Consultant, 2013 - 2016, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Pharmacogenomics Study Of Possible Anti-obesity Agent From Catha Edulis Plant Extract And Its Main Alkaloid Cathinone On Obese Animal Model, Principal Investigator(PI), 2013 - 2018, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Association Of Genetic Variation With Susceptibility To Epilepsy In The Malaysian Population, Consultant, 2013 - 2016, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Expression Patterns of Non-Alcoholic Fatty Liver Disease genes and Efficacy of Green Tea on Hyperlipidemic Animal Model, Consultant, 2013 - 2016, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Pharmacogenomics Studies, Principal Investigator(PI), 2012 - 2012, High Impact Research (HIR), (University)
  • Molecular study of methamphetamine dependence and memory loss in animal models, Principal Investigator(PI), 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Pharmacogenomic Studies, Principal Investigator(PI), 2011 - 2011, High Impact Research (HIR), (University)
  • Beijing Genomic Institute: Project on Obesity, Principal Investigator(PI), 2011 - 2016, High Impact Research (HIR), (University)
  • Association of Genetic Polymorphisms in selected candidate genes with response to atorvastatin therapy. Imran Zainal Abidin.RM70,000., Coordinator, 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Pharmacogenomics of Metabolic Syndrome in Schizophrenia, Co-Investigator, 2010 - 2013, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • SITUATIONAL ANALYSIS OF BIOETHICS AWARENESS AND EDUCATION in the face of the biosciences revolution: Towards resource building and policy frameworks in support of ethical practice in Science, Technology and Healthcare in Malaysia., Co-Investigator, 2009 - 2010, UNESCO Biennial Partcipation Programme, (International)
  • Variation Across candidate genes and its role in the development of non-alcoholic fatty liver disease (NAFLD) and its complications in patients with metabolic syndrome, Co-Investigator, 2009 - 2010, Fundamental Research Grant Scheme (FRGS), (National)
  • Association of Selected Candidate Genes With Response To Antiepileptic Drugs, Principal Investigator(PI), 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Case-control Study in determining the risk factors for the occurrence of pre-term birth in the Malaysian Population, Co-Investigator, 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Pharmacogenomic Study on Bipolar Disorders: A Case-Control Study. Gene Analysis Study of Selected Candidate Genes and Regulation of Gene Expression in Bipolar Disorder Patient on Response to Quetiapine Medication. Sharmilla A/P Kanagasundram. RM60,000, Co-Investigator, 2009, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • ASSOCIATION OF SELECTED CANDIDATE GENES WITH RESPONSE TO ANTIEPILEPTIC DRUGS, Principal Investigator(PI), 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • BIOEQUIVALENCE STUDIES AND ANALYTICAL RESEARCH, Principal Investigator(PI), 2008 - 2009, Centre of Research , (National)
  • Salivary compared to systemic measurement in the pharmacokinetic assessment of testosterone transdermal delivery system for the hormone replacement therapy., Co-Investigator, 2008 - 2010, Short Term Research Fund (Vote F)(PJP), (National)
  • Pharmacogenomics of Major Depressive Disorder, Principal Investigator(PI), 2008 - 2009, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • PHARMACOGENOMICS OF MAJOR DEPRESSIVE DISORDER, Principal Investigator(PI), 2008 - 2009, RU Geran, (National)
  • Polymorphism of various genes in schizophrenia, Principal Investigator(PI), 2007 - 2008, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • PHARMACOGENOMICS OF DEPRESSION, Principal Investigator(PI), 2007 - 2009, RU Geran, (National)
  • PHARMACOGENOMICS OF DEPRESSION, Principal Investigator(PI), 2006 - 2007, Fundamental Research Grant Scheme (FRGS), (National)
  • Comparison of the pharmacokinetics of subcutaneous tramadol between elderly and young patients following surgery, Co-Investigator, 1998 - 2000, MOSTI, (University)
  • Pharmacokinetics of subcutaneously admiminstered morphine - a comparative study between elderly and young patients, Co-Investigator, 1998 - 2000, MOSTI, (University)
  • Pharmacogenomics
  • Genetic Polymorphism of the drug-metabolizing enzymes
  • Clinical Pharmacokinetics
  • Endocrine Disrupting Compounds (EDCs) in the Environment

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCES, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF CAPTOPRIL, NAMELY, (APO CAPTO) [REFERENCE COMPOUND] 25mg TABLET VS. CAPORIL 25mg TABLET [TEST COMPOUNDS] IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2013-2013, IMEKS Pharma Sdn Bhd
  • An open labelled study of Clopidogrel, 2013-2013, Pharmaniaga/Infokinetics
  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF DIAZEPAM 5mg TABLETS IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS.Protocol no:UM-003-11, 2012-2012, Idaman Pharma Sdn Bhd
  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF ACYCLOVIR 200mg DISPERSIBLE TABLETS IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2012-2012, Idaman Pharma Sdn Bhd
  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF TETRACYCLINE TABLETS IN HEALTHY ADULT HUMAN SUBJECTS UNDER NON FASTING CONDITIONS, 2011-2011, Idaman Pharma Sdn Bhd
  • THE COMPARATIVE BIOEQUIVALENCE STUDY OF TWO FORMULATIONS OF AMOXYCILLIN (SYNAMOX 250 mg AND AMOXICILLIN 250 mg CAPSULES) IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2011-2011, Idaman Pharma Sdn Bhd
  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF AMPICILLIN TABLETS IN HEALTHY ADULT HUMAN SUBJECTS UNDER NON FASTING CONDITIONS, 2011-2011, Idaman Pharma Sdn Bhd
  • THE COMPARATIVE BIOEQUIVALENCE STUDY OF THREE FORMULATIONS OF CLOXACILLIN (ISOXACILLA 250 mg (TEST), ISOXACILLA 250 mg (TEST) AND MONOCLOX 250 mg (REFERENCE) CAPSULES) IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2011-2011, Idaman Pharma Sdn Bhd
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Ketoconazole 200mg Tablets in Healthy Adult Human Subjects Under Fasting Conditions, 2010, Sm Pharmaceuticals Sdn Bhd
  • AN OPEN LABEL, RANDOMIZED, THREE PERIOD, SIX SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF THREE FORMULATIONS OF PENICILLIN V 250mg TABLET IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2010-2010, Idaman Pharma Manufacturing Sdn Bhd
  • AN OPEN LABEL, RANDOMIZED, TWO PERIOD, TWO SEQUENCE, CROSSOVER, COMPARATIVE EVALUATION OF RELATIVE BIOAVAILABILITIES OF TWO FORMULATIONS OF NAPROXEN 550mg TABLETS IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS, 2010-2010, Dynapharm (M) Sdn. Bhd.
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation Of Relative Bioavailabilities of Two Formulations Of Penicillin V 250mg Tablets in Healthy Adult Human Subjects Under Fasting Condition, 2010-2010, Idaman Pharma Manufacturing Sdn. Bhd
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Cetirizine 10mg Tablets in Healthy Adult Human Subjects Under Fasting Conditions, 2010, Sm Pharmaceuticals Sdn Bhd
  • Clinical Trial (Bio-Equivalence) Agreement : Study Drugs, 2010-2010, Idaman Pharma Manufacturing Sdn. Bhd
  • Bioequivalence Studies for 6 different products of Idaman Pharma Manufacturing Sdn Bhd (amounting to >RM1,000,000 over a period of two years., 2010-2010, Idaman Pharma Manufacturing Sdn Bhd
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of naproxen in healthy adult human subjects under fasting conditions, 2009-2009, Dynapharm
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of cetrizine in healthy adult human subjects under fasting conditions, 2008-2008, SM Pharmaceutical Sdn Bhd
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of ketoconazole 200mg in healthy adult human subjects under fasting conditions, 2008-2008, SM Pharmaceuticals Sdn Bhd
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of ibuprofen in healthy adult human subjects under fasting conditions, 2008-2008, SM Pharmaceuticals Sdn Bhd
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of glibenclamide 5 mg in healthy adult human subjects under fasting conditions, 2007-2007, Idaman Pharma Manufacturing Sdn Bhd
  • An open-Label, randomised, two-period, two sequence, crossover, comparative evaluation of relative bioavailabilities of two formulations of doxycycline in healthy adult male subjects under fasting conditions, 2007-2007, Innovax
  • An open-Label, randomised, two-period, two sequence, crossover, comparative evaluation of relative bioavailabilities of two formulations of doxycycline in healthy adult male subjects under fasting conditions, 2007-2007, Innovax Sdn Bhd
  • An open-label, randomised, Two-periods, two sequences, cross-over, comparative evaluation of relative bioavailabilities of two formulations of salbutmol in healthy adult human subjects under fasting conditions, 2007-2007, Idaman Pharma manufacturing Sdn Bhd
  • The comparative Bioequivalence study of a generic (Raza Enalapril from Raza Manufacturing) and the proprietary Renitec from MSD) 20 mg enalapril in healthy human volunteers., 2001-2001, RAZA Manufacturing Sdn Bhd
  • The comparative Bioequivalence study of a generic (Vascor from Upha) and the proprietary (Zocor from MSD) 40 mg simvastatin in healthy human volunteers., 2001-2001, Upha
  • The comparative Bioequivalence study of a generic (Covastin from Xepa Soul Pattinson) and the proprietary (Zocor from MSD) 40 mg simvastatin in healthy human volunteers., 2001-2001, Xepa Soul Pattinson
  • The comparative bioequivalence study of generic (Kimafen from Duopharma) and the proprietary (Capoten from BMS) 25 mg captopril tablet in healthy human volunteers, 2000-2000, Duopharma
  • Bioequivalence Study: The comparative bioequivalence study of generic (Capriten from Xepa-soul Pattinson) and the proprietary (Capoten from BMS) 25 mg captopril tablet in healthy human volunteers., 2000-2000, Xepa-Soul Pattinson
  • Bioequivalence Study: The comparative bioequivalence study of generic omeprazole(Romesec from Ranbaxy) and the proprietary (Losec from Astra) 25 mg omeprazole capsule in healthy human volunteers., 1999-1999, Ranbaxy
  • Bioequivalence Study: The comparative bioequivalence study of generic (Captopril Denk from Luen Wah Medical Company) and the proprietary (Capoten from BMS) 25 mg captopril tablet in healthy human volunteers, 1999-1999, Luen Wah Medical Company
  • The bioequivalence of generic methyldopa (produced by RAZA) and the proprietary methyldopa (Aldomet, produced by Merck , Sharp & Dohme) in healthy volunteers. RAZA MANUFACTURING SDN BHD 02/06/1997-31/12/1998, 1998-1998, RAZA Manufacturing Sdn Bhd
  • Phase III trial of RSD921 as a local anaesthetic. The studies were a series of 3 studies: (a) The local anaesthetic effect of RSD921 on healthy volunteers (b) The dermal reactions against RSD921 in healthy volunteers (c) Clinical evaluation of RSD921 as a local anesthetic in patients, 1998-1998, CCM Pharma
  • Analysis of contents in a Chinese cough medication for the possible presence of opioids., 1998-1998, Veloo, Guna & Ramani Advocates and Solicirors, Singapore
  • Bioequivalence Study:The bioequivalence of generic isosorbide-5-mononitrate controlled-release form (Isotain 60 mg CR tablet from CCM PHARMA SDN. BHD) and the proprietary isosorbide-5-mononitrate (Imdur 60 mg from ASTRA) in healthy volunteers, 1998-1998, CCM PHARMA
  • Bioequivalence Study:The bioequivalence of generic methyldopa (produced by RAZA) and the proprietary methyldopa (Aldomet, produced by Merck , Sharp & Dohme) in healthy volunteers., 1997-1997, RAZA MANUFACTURING SDN BHD
  • Bioequivalence study of generic atenolol to the proprietary atenolol. My role was to develop and validate the assay method, recruit the subjects and produced a report., 1997-1997, Norse Crown Pharmaceuticals
  • Acute Toxicity Test on Rubber Gloves. My role is to Monitor the effects on animals, 1995-1995, Baxter Health Care SA

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Keynote Speaker At Postgraduate Seminar At University of Nottingham, University of Nottingham Malaysia, 2016, (National)
  • Keynote Speaker At The International Symposium On Allied Health Sciences. 5-6th Sept 2015. Kelantan, Malaysia. Title of Talk: Integration of Helath & Technology for Human Well-Being & Ecosystem, Universiti Sains Malaysia, 2015, (International)
  • Represents Malaysia At The Sjs/Ten Standardizing Case Definitions Working Group, Which is Coordinated by The United States National Institute of Health (Nih) and The National Health Genomics Research Institute (Nhgri), United States National Institute of Health (Nih) and The National Health Genomics Research Institute (Nhgri), 2015, (International)
  • Represents Malaysia At The Global Genomic Medicine Cooperative, Which is Coordinated by The United States' National Institute of Health (Nih) and by The National Health Genomics Research Institute (Nhgri), National Institute of Health (Nih) and by The National Health Genomics Research Institute (Nhgri), 2015, (International)
  • Organising Chairman of The Golden Helix Symposia 2015: Next Generation Pharmacogenomics. Kuala Lumpur. 11-13th March 2015. Jointly Organised by Golden Helix Foundation and University of Malaya, Golden Helix Foundation, a Foundation Based in London, 2015, (International)
  • Invited Facilitator for The Workshop for The Development of a National Code of Conduct for Biosecurity, Organised by Science and Technology Research Institute for Defence (Stride, Ministry of Defence) and The Us Dept of Defence. 3-4th June 2015, Stride, Ministry of Defence, 2015, (International)
  • Invited Speaker for The National Symposium On Ethical Issue in Research Ii. Title of Lecture is"National Bioethics Council Role in Promoting Ethics in Research Excellence". Also a Panel Member of Forum At Same Symposium, Entitled "Ethical Scope: Roles and Responsibilities". 19th May 2015, Universiti Teknologi Mara, 2015, (National)
  • Invited Discussant At Round Table Discussion "Islam and Neuroscience", Institut Kefahaman Islam Malaysia, 2014, (International)
  • Invited Speaker for The Monash Health Economics Forum 2014 "Value of Medicines: Patient'S and Healthcare Professiona;'S Perspectives, The School of Pharmacy, Monash University of Malaysia, 2014, (International)
  • Pelantikan Semula Sebagai Ahli Majlis Bioetika Negara 2014, Menteri Sains, Teknologi Dan Inovasi Malysia, 2014, (International)
  • Keynote Speaker of The Pharmacology and Physiology Scientific Congress 14: Title of Talk "Pharmacogenomics Studies in Multiethnic Population". 22-24th Aug 2014.Kuala Lumpur., Malaysian Society of Pharmacology and Physiology, 2014, (International)
  • Pharmacology Department, in 2013, Heads The List of Departments At The Faculty of Medicine, University of Malaya, Kuala Lumpur, With The Most Number of Publications Per Staff, and Impact Factor Per Staff, and Impact Factor Per Publication, No Formal Award, But a Recognition, 2013, (International)
  • Best Pre-Clinical MBBS Lecturer 2013, MBBS Final Year Students, 2013, (International)
  • 2012/2013 Qs World University Ranking by Subject 2012 Top 51-100 - Pharmacy and Pharmacology, Qs Intelligence Unit, 2013, (International)
  • Invited Speaker for The Symposium On Genetics and and Genome-Guided Personalised Medicine, Thailand Centre of Excellence and Riken, Japan, 2013, (International)
  • Council Member of The Malaysian National Bioethics Council: Re-Appointment, Ministry of Science, Technology and Innovations, 2013, (National)
  • Accreditation for Bioequivalence Centre from Ministry of Health,for The University of Malaya Bioequivalence and Testing Centre (Ubat), of Which I Am The Director. One of Only 3 Centres in Malaysia Which Were Awarded The Accreditation., National Pharmaceutical Control Bureau, Ministry of Health, 2013, (International)
  • Re-Accreditation Iso/Iec 17025:2005 of The University of Malaya Bioequivalence and Testing Centre (Ubat), of Which I Am The Director, Department of Standards Malaysia, Ministry of Science, Technology and Innovations, 2013, (International)
  • Keynote Speaker At Launching of The National Bioethics Council by The Minister of Science, Technology and Innovation, Ministry of Science, Technology and Innovation, 2012, (International)
  • 2011/2012 Qs World Ranking by Subject. UM Pharmacy and Pharmacology Top 51-100, Qs Intelligence Unit, 2012, (International)
  • Expert Panel for Pre-Investigational New Drug Applications, National Pharmaceutical Control Bureau, Ministry of Health, 2012, (National)
  • Invited Speaker for The 10th Asia Pacific Conference On Human Genetics, Asia Pacific Society for Human Genetics, 2012, (International)
  • Invited Speaker for 1st Meeting South East Asian Pharmacogenomics Research Network (Seapharm);Symposium for Genetic and Genome-Guided Personalized Medicine in South East Asia:Overview and Applications Siam City Hotel, Bangkok. February 2-3, 2012, South East Asian Pharmacogenomics Research Network (Seapharm), 2012, (International)
  • Excellence Service Award, University Malaya, 2011, (University)
  • Invited Speaker At 1st Malaysia Conference On Rare Disorders and Medical Genetics Conference. Title of Talk " The Pharmacogenomics Approach to Personalised Medicine. 9-10 June 2011, Malaysian Rare Disorders Society and Malaysian Genetics Society, 2011, (National)
  • Invited Speaker for 8th Asia-Pacific Medical Education Conference, National University of Singapore. 28th-30th Jan 2012, Nus, 2011, (International)
  • Keynote Speaker for 2nd Congress of Asian College of Neuropsychopharmacology, Korea. 23-24th Sept 2011, Korean College of Neuropsychopharmacology, 2011, (International)
  • Invited to Be Moderator for Seminar On Perspective On Islam and The West" Organised by Institute of Diplomacy and Foreigh Relations Malaysia (Idrf) and Centre of Civilisational Dialogue, UM. 16-17th June 2011, Idrf and Centre of Civilisational Dialogue, 2011, (National)
  • Keynote Speaker At Malaysian Genome Centre'S Eminent Speakers Series, Malaysian Genome Centre, 2011, (National)
  • Invited Speaker and Facilitator for Good Clinical Practice, Clinical Investigation Centre, University of Malaya Medical Centre, 2011, (National)
  • Keynote Speaker for 4th Asia Pacific Regional International Society for The Study of Xenobiotics Meeting. 22-25th April 2011 in Tainan, Taiwan., International Society for The Study of Xenobiotics (Issx), 2011, (International)
  • Best Poster Award for The 4th National Conference for Clinical Research 2010 and The 13th National Institutes of Health (Nih) Scientific Meeting. Pharmacogenomic Study of Carbamazepine in Epilepsy in Hospital Kuala Lumpur. S Subenthiran, Nr Abdullah, Z Mohamed, Jp Joseph, Am Mustaffa and Z Ismail., National Institutes of Health, 2010, (International)
  • Excellent Scientist Award 2005 (Saintis Cemerlang 2005). for \"Mitra Kit: The First Mitragynine Test Kit\", Ministry of Higher Learning. At The Invention Exhibition of New Invention, Techniques and Products 2005, Geneva., 2010, (International)
  • Awarded Second Price for Best Translated Science Book for 1996. Review of Medical Physiology by W.F.Ganong. (Kajian Semula Fisiologi Perubatan). Translated by Mustafa Ali Mohd, Zurina Ismail & Zahurin Mohamed. 1994. Translation Published by Dewan Bahasa Dan Pustaka., Dewan Bahasa Dan Pustaka, 2010, (National)
  • Best Poster for 4th National Conference for Clinical Research 2010 and The 13th National Institute of Health (Nih) Scientific Meeting. June 2010. S Subenthiran, Nr Abdullah, Z Mohamed, National Institute of Health (Nih), 2010, (National)
  • Award of Bionexus Partners (Bnp) Programme from Malaysian Biotechnology Corporation for Both 2009 and 2010, Malaysian Biotechnology Corporation, 2010, (National)
  • Khidmat Setia 30 Award, 2009
  • Certificate of Excellent Service, University Malaya, 2007, (University)
  • Excellence Service Award, University Malaya, 2006, (University)
  • Ehm Mohamed, Tan Ks, Z. Mohamed, Jm Ali, Ct Tan. C677t Polymorphism of Methylenetetrahydrofolate Reductase Gene and Increased Plasma Homocysteine Concentration in Ischaemic Stroke. First North-South Workshops On Pharmacogenetics, Kuala Lumpur 12-13 December 2005. Awarded Best Presenter, Usm, 2005, (International)
  • Gold Medal for Invention of Mitra Kit - Test Pour Reveler La Presence De La Mitragynine, Geneva Salon International Des Inventions Geneve, 2005, (International)
  • Certificate of Excellent Service, University Malaya, 2004, (University)
  • Bronze Medal Award for "Bitter Gourd - a Potential Hypoglycaemic Agent" Science and Technology Expo, Malaysia. Aug 2004, Ministry of Science, Technology and Innovation,, 2004, (National)
  • Awarded Best Scientific Paper. Prevalence of Genetic Polymorphism for 5,10-Methylenetetrahydrofolate Reductase (Mthfr) in Multi Ethnic Malaysian Ischaemic Stroke Population. Ehm Mohamed, Tan Ks, Z.Mohamed, Jm Ali, Ct Tan Presented At The Malaysian Society of Neurosciences Annual Scientific Meeting 18th-20th June 2004, Kucing, Sarawak, Malaysia., Malaysian Society of Neurosciences, 2004, (National)
  • Certificate of Excellent Service, University Malaya, 2003, (University)
  • Certificate of Excellent Service for 2003, 2004 and 2007 (Sijil Anugerah Cemerlang Bagi 2002, 2003, 2004 Dan 2007), University of Malaya, 2003, (International)
  • Best Lecturer Award for The MBBS Ii Year Ii 1996/97 Session, Medical Society (Medsoc) University of Malaya, 1997, (University)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


PLEANARY/KEYNOTE SPEAKER
  • Bioequivalence studies: The process and its current status in Malaysia. Z.Mohamed. , 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. 25th-26th June 2001, 2001-06-25 to 2001-06-26, Malaysian Society of Pharmacology and Physiology, (National)
  • Pharmacogenomics and the Promise of Personalised Medicine, 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, 2008-08-27 to 2008-08-28, Malaysian Society for Biochemistry and Molecular Biology, (National)
  • The Pharmacogenomics Approach to Personalised Medicine, Clinical Research and Trials Excellence Congress, 2008-10-21 to 2008-10-23, Clinical Research Centre, Ministry of Health, Malaysia, (National)
  • Bioethics and Society, Launching of the National Bioethics Council and Presentaion of the Letter of Appointment by the Minister of Science, Technology and Innovation, YB Datuk Seri Panglima Dr Maximus Johnity Ongkili, 2012-05-22 to 2012-05-23, Ministry of Science, Technology and Innovation, (National)
  • Pharmacogenomics Studies in a Multiethnic Population, Pharmacology and Physiology Scientific Congress, 2014-08-22 to 2014-08-24, Malaysian Society of Pharmacology and Physiology, (International)
  • Integration of Health & Technology for Human Well-Being & Ecosystem, International Symposium on Allied Health Sciences, 2015-09-05 to 2015-09-06, Universiti Sains Malaysia, (International)
INVITED SEMINAR
  • Pharmacogenomics, International Medical University Celebration of Research , 2008-05-01 to 2008-05-02, International Medical University, (University)
INVITED SPEAKER
  • Applications of Good Laboratory Practice in Biomedical Assay. Z Mohamed. , Good Laboratory Practice Seminar organised by the Ministry of Health. 2-3 Nov 2000, 2000-11-02 to 2000-11-03, Ministry of Health, Malaysia., (National)
  • Factors Influencing Absorption and Its Relationship with Bioequivalence Studies. Z.Mohamed. , Bioequivalence Study Workshop. 12th April 2002. Organised by the Ministry of Health., 2002-04-12 to 2002-04-13, Ministry of Health, Malaysia, (National)
  • Informed Consent., Good Clinical Practice Workshop. Kota Kinabalu, Sabah. 22-24 April 2008., 2008-04-22 to 2008-04-24, Clinical Research Centre, Sabah., (National)
  • Informed Consent, Good Clinical Practice Workshop. Sarawak. 26-28 May 2008., 2008-05-26 to 2008-05-28, Clinical Research Centre, Sarawak., (National)
  • Informed Consent, Good Clinical Practice Workshop, 2008-07-17 to 2008-07-17, Biotech Corp and Clinical Research Centre, Johor., (National)
  • Informed Consent, Good Clinical Practice Workshop, 2008-07-19 to 2008-07-21, Clinical Research Centre, Kelantan., (National)
  • Concept of Bioequivalence and the Malaysian Guidelines and requirements for bioequivalence studies., National Bioequivalence and Advanced Pharmacokinetics Workshop 2008, 2008-10-29 to 2008-10-30, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, (National)
  • Concept of Bioequivalence and the Malaysian Guidelines and Requirements for Bioequivalence Studies", National Workshop for Bioequivalence and Advanced Pharmacokinetics, , 2008-11-11 to 2008-11-12, Universiti Kebangsaan Malaysia, (National)
  • Overview of Research process, Research Methods Introductory Course 12-14 January. , 2010-01-12 to 2010-01-14, Medical Education Research Development Unit (MERDU), Faculty of Medicine, University of Malaya, (University)
  • Association of ABCB1 polymorphisms with risk of resistance to sodium valproate in Malaysian epilepsy patients , Australia-Malaysia Colloquium on Medical Science, 2010-05-28 to 2010-05-29, Australian Embassy with MOSTI, (National)
  • Informed Consent, 12th Good Clinical Practice Workshop. UKM, 2010-06-14 to 2010-07-16, Sekretariat Penyelidikan Perubatan dan Industri
  • Integration of Pharmacology Knowledge into Clinical Practice, 8th Asia Pacific Medical Education Conference, 2011-01-28 to 2011-01-29, Medical Education Unit of the National University of Singapore, (International)
  • (1) Informed Consent Process (2) Exercise on Ethics, Good Clinical Practice Workshop. , 2011-06-07 to 2011-06-07, Clinical Investigation Centre, UMMC. , (National)
  • The Pharmacogenomics Approach to Personalised Medicine., 1st Malaysia Conference on Rare Disorders and Medical Genetics. , 2011-06-09 to 2011-06-10, Human Variome Project Consortium, (National)
  • Pharmacogenomincs: Paving the Way to Personalised Medicine. , MGRC s 12th Eminent Speaker Series. 23rd June 2011. Zahurin Mohamed (Invited Speaker)., 2011-06-23 to 2011-06-23, Malaysian Genome Research Centre, (National)
  • Association study of tryptophan hydroxylase 2 and serotonin transporter genes with major depressive disorder in Malaysian ethnic subgroups, 2nd Congress of the Asian College of Neuropsychopharmacology, 2011-09-23 to 2011-09-24, Korean College of Neuropsychopharmacology and Neuroscience, (International)
  • Pharmacogenomics Studies in Multiethnic Malaysians, Symposium for Genetic and Genome Guided Personalized Medicine in Asia: Overview and Applications , 2012-02-02 to 2012-02-03, Thailand Center of Excellence for Life Sciences (Public Organization) together with Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Department of Medical Sciences, Ministry of public Health,and RIKEN, Japan, (International)
  • A Journey through a clinical trial review (Interactive Session): Scope on "Informed Consent Form , Workshop on Clinical Trial Enabler Project, 2012-05-10 to 2012-05-10, Clinical Research Centre, Ministry of Health, (National)
  • Pharmacogenomics of Antiepileptics, International Neuroscience Symposium 2012, 2012-07-23 to 2012-07-24, School of Medicine, University Malaysia Sabah, (International)
  • Peripheral PDLIM5 Expression in bipolar disorder and the effect of olanzapine administration, 10th Asia Pacific Conference on Human Genetics, 2012-12-05 to 2012-12-08, Asia Pacific Society of Human Genetics, (International)
  • Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration, Symposium for Genetic and Genome Guided Personalized Medicine in Asia: Overview and Applications, 2013-01-15 to 2013-01-16, Thailand Center of Excellence for Life Sciences (Public Organization) together with Faculty of Medicine, Ramathibodi Hospital, Faculty of Pharmacy Mahidol University, Department of Medical Sciences, Ministry of Public Health, and RIKEN, Genome Research Institute, Japan, (International)
  • The role of a biomedical scientist in fulfilling the promise of personalised medicine, 4th Malaysian Conference on Biomedical Sciences, 2013-05-10 to 2013-05-11, Universiti Sains Malaysia, (National)
  • THE ASSOCIATION BETWEEN α-2A ADRENERGIC RECEPTOR GENE VARIANT AND WEIGHT LOSS FOLLOWING SWITCHING OF ANTIPSYCHOTICS TO ARIPIPRAZOLE OR ZIPRASIDONE, INTERNATTONAL CONFERENCE ON MEDTCAL AND HEALTH SCIENCES (ICMHS), 2013-05-22 to 2013-05-24, Malaysian Society of Human Genetics, College of Pathologists, Academy of Medicine, Malaysia., (National)
  • Etika Penggunaan Haiwan Dalam Kajian & Penyelidikan, Kolokium Kebajikan dan Kesejahteraan Haiwan mengikut Perspektif Islam. , 2013-07-02 to 2013-07-02, Kementerian Pertanian dan Industri Asas Tani, (National)
  • (1) Institutional Review Board (2) Informed Consent Process (3) Exercises on Informed Consent, Good Clinical Practice Workshop, 2013-11-12 to 2013-11-14, Clinical Investigation Centre, UMMC, (National)
  • (1) Informed Consent Process (2) Exercises on Informed Consent, Workshop on Good Clinical Practice Dec 2013, 2013-12-10 to 2013-12-12, Clinical Investigation Centre, (National)
  • (1) Informed Consent Process (2) Scenarios of Issues in Informed Consent, Good Clinical Practice Workshop 8-10 April 2014, 2014-04-08 to 2014-04-10, Clinical Investigation Centre, (National)
  • Association of candidate gene polymorphisms with reduction in body mass index following antipsychotic switching to aripiprazole or ziprasidone, 3rd SEAPHARM Meeting and International Seminar and Workshop on Molecular Medicine: From Basic Science to Clinical Care, 2014-04-15 to 2014-04-16, University of Yarsai, RIKEN, The University of Tokyo and Thailand Centre of Excellence in Life Sciences, (International)
  • (1) Ethical Review (2) Informed Consent Process (3) Scenarios of Issues in Informed Consent, Good Clinical Practice Workshop 12-14 August 2014, 2014-08-12 to 2014-08-14, Clinical Investigation Centre, (National)
  • Use of Health Economics in Personalised Medicine, Monash Health Economics Forum 2014 "Value of Medicines: Patient's and Healthcare Professional's Perpectives", 2014-10-29 to 2014-10-30, The School of Pharmacy, Monash University Malaysia, (National)
  • The Role of Genetic Polymorphisms of Drug Targets and Transporter Genes in Responsiveness to Antiepileptic Drugs, Golden Helix Symposia 2015: Next Generation Pharmacogenomics, 2015-03-11 to 2015-03-12, Golden Helix Foundation and University of Malaya, (International)
  • Informed Consent. Exercises on Informed Consent., Good Clinical Practice Workshop. 17-19 March 2015, 2015-03-17 to 2015-03-19, Clinical Investigation Centre, University of Malaya, (National)
  • National Bioethics Council Role in Promoting Ethics in Research Excellence , National Symposium on Ethical Issues in Research II. , 2015-05-19 to 2015-05-19, Universiti Teknologi Mara, (National)
  • Challenges of Postgraduate Studies, 29th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology (MSPP), 2015-08-24 to 2015-08-25, Malaysian Society of Pharmacology and Physiology, (National)
ORAL
  • Caffeine metabolic pathways. Are they valid as in vivo and in vitro probe for human cytochrome P450 ? D.J.Birkett. W. Tassaneeyakul, M.E.Veronese, M.E. McManus, Z.Mohamed and J.O. miners., Proceedings of the 9th International Symposium on microsomes and drug oxidations. 1992, Sydney, , 1992-11-23 to 1992-11-25, (International)
  • The blood pressure-lowering effect of two saponins isolated from Dioscorea piscatorum. Zahurin Mohamed and A.M.Mustafa. , 7th South-East Asian - Western Pacific Meeting of Pharmacologists. Manila. P-C-12. Pg 105 (1995). , 1995-01-09 to 1995-01-11, (International)
  • Preliminary phenotyping of dextromethorphan oxidation in a Malaysian population. Y.H.Noraliza, C.C.Lang, A.Z.Mohd. Zain, Z.Mohamed., VIIIth Southeast Asian Drug Metabolism Workshop. JogJakarta 1996, 1996-07-15 to 1996-07-17, (International)
  • Nafcillin is a potent inducer of CYP3A4 activity in humans. (1997) . Z.Mohamed, A.M.Mustafa, S.K.Jamal, M.R.Mustafa, K.Jeyalingam, C.C.Lang., 22nd Annual Conference for Malaysian Society for Biochemistry and Molecular Biology. October 1997, 1997-10-13 to 1997-10-15, Malaysian Society for Biochemistry and Molecular Biology, (National)
  • High performance liquid chromatography of dextromethorphan and its main metabolite in human urine, 16th Congress of Pharmaceutical Sciences . 17-21 November 1997. Kuala Lumpur , 1997-11-17 to 1997-11-21, Malaysian Pharmacy Society, (National)
  • Studies of CYP3A4 activity in humans. Z.Mohamed, AM Mustafa, SK Jamal, MR Mustafa, K Jeyalingam & CC Lang.Abstract OW-2, IXth Southeast Asian Drug Metabolism Workshop. April 1998. , 1998-02-02 to 1998-02-04, Department of Pharmacology, University of Malaya, (International)
  • A pharmacokinetic and pharmacodynamic study of generic and brand name atenolol in hypertensive subjects. CC Lang, AM Mustafa, SL Chan, AM Choy, MR Mustafa & Z.Mohamed, IXth Southeast Asian Drug Metabolism Workshop. April 1998. Abstract P-25, 1998-02-09 to 1998-02-11, (International)
  • Pharmacokinetic profile of 50 mg of subcutaneous tramadol -a preliminary report. R.Vijayan, Z.Mohamed, Lucy Chan, Am Mustafa, G Ong & A.Delilkan., 9th World Congress on Pain in Vienna, Austria , 22 - 27 Aug 1999 , 1999-08-22 to 1999-08-27, (International)
  • Pharmacokinetic profile of 50 mg of subcutaneous tramadol a preliminary report. R.Vijayan, Z.Mohamed, Lucy Chan, Am Mustafa, G Ong & A.Delilkan. , 9th World Congress on Pain. Vienna, Austria. 22 - 27 Aug 1999, 1999-08-22 to 1999-08-27, (International)
  • Effects of Selected Local Plant Extracts on Cytochrome P450 Enzymes. A.M. Mustafa, Z.Mohamed L.Z. Tan & Y.N. Razliyana , Malaysian Science and Technology Congress 2001 (MSTC 2001) 24-26 September 2001. Kota Kinabalu, Sabah., , 2001-09-24 to 2001-09-26, UMS, (National)
  • R.E.R. Aziddin, MA Mohd, MR Mustafa and ZmOhamed "Antiinflammatory properties of the leaf extract of Mitragyna speciosa. ", 2003, Presented at the International Seminar on Natural Products: 19th Annual Seminar & Workshop of the Malaysian Natural Products Society, University Malaya, KL, Malaysia., , International Seminar on Natural Products: 19th Annual Seminar & Workshop of the Malaysian Natural Products Society, University Malaya, KL, Malaysia., , 2003-08-04 to 2003-08-05, Malaysian Natural Products Society, (International)
  • PCR-RFLP: A tool for indirectly tailored drug therapy. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed, 7th Asian Conference on Analytical Science, Hong Kong, July, 2004. , 2004-06-07 to 2004-06-10, (International)
  • Prevalence of Genetic Polymorphism for 5,10-Methylenetetrahydrofolate Reductase (MTHFR) in Multi Ethnic Malaysian Ischaemic Stroke Population. EHM Mohamed, Tan KS, Z.Mohamed, JM Ali, CT Tan. Awarded Best Scientific Paper, Malaysian Society of Neurosciences Annual Scientific Meeting 18th to 20th June 2004, Kucing, Sarawak, Malaysia. , 2004-06-18 to 2004-06-20, Malaysian Society of Neurosciences, (National)
  • Application of Ligand-Receptor Binding Assays. Raja Elina Raja Aziddin, MR Mustafa, AM Mustafa, Z.Mohamed. , Malaysian Association of Clinical Biochemists 14th Annual Scientific Meeting 23- 24th July, 2004. , 2004-07-23 to 2004-07-24, Malaysian Association of Clinical Biochemists, (National)
  • Chinese has higher CYP3A5*3 allele frequency compared to the Malays and Indians in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 5th HUGO Pacific Meeting & 6th Asia-Pasific Conference on Human Genetics. 17-20 November 2004, Biopolis, Singapore., , 2004-11-17 to 2004-11-20, (International)
  • Multidrug Resistance 1 MDR-1) Exon26 C3435T polymorphism is not associated with cyclosporine dose requirements in renal transplant recipients. HS Eng, SY Tan, CC Lang, AM Mustafa, WT Seet, Z Mohamed , International Conference on Health Sciences. 6th-8th May 2005. KL., , 2005-05-06 to 2005-05-08, (National)
  • C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene and Increased Plasma Homocysteine Concentration In Ischaemic Stroke. EHM Mohamed, Tan KS, Z. Mohamed, JM Ali, CT Tan. Awarded Best Presenter , First North-South Workshops on Pharmacogenetics, Kuala Lumpur 12-13 December 2005. Awarded Best Presenter , 2005-12-12 to 2005-12-13, USM, (National)
  • VL Raj, N.Mahali, NZ Zainal and Z.Mohamed; T102C Polymorphism of Serotonin 2A (5HT2A) Receptor and Schizophrenia: A Preliminary Report, 2nd National Colloquium & Workshop in Pharmacogenetics. , 2008-04-26 to 2008-04-29, Institute of Research in Molecular Medicine, Universiti Sains Malaysia, (National)
  • T102C Polymorphism of Serotonin 2A (5HT2A) Receptor and Schizophrenia: A Preliminary Report.2008, Zahurin Bt Mohamed, 2nd National Colloquium & Workshop in Pharmacogenetics. Kota Bharu, Kelantan, 2008-08-18 to  , (National)
  • The G-1438A polymorphism of the 5HT2A receptor gene and its association with schizophrenia in the Malaysian Population. Shamsul Mohd Zain, Tiong Chea Ping, Nor Zuraida Zainal, Zahurin Mohamed and Vijaya Letchimi Raj, 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, , 2008-08-27 to 2008-08-28, Malaysian Society for Biochemistry and Molecular Biology, (National)
  • ABCB1/MDR1 C3435T polymorphism in epilepsy patients receiving carbamazepine. BS Haerian, Z Mohamed, CT Tan, AA Raymond, KS Lim, HJ Tan, EHM Mohamed and VL Raj., 8th Biennial Convention of the ASEAN Neurological Association (ASNA) & Neurosciences 2009, 20th Annual Scientific Meeting of the Malaysian Society of Neurosciences 2009. 1st 4th April 2009. Berjaya Times Square Hotel & Convention Centre, Kuala Lumpur (oral), 2009-04-01 to 2009-04-04, (International)
  • SCN1A polymorphism in epilepsy patients receiving carbamazepine. BS Haerian1, EHM Mohamed, KS Lim, HJ Tan, VL Raj, CT Tan, AA Raymond, Z Mohamed., 16th International Congress of Neurology & Clinical Electrophysiology of Iran. 19-22 May 2009. Iranian Journal of Neurology. Vol 8 Supplement 1, Spring 2009, 2009-05-19 to 2009-05-22, Iranian Journal of Neurology, (International)
  • Association of TCF7L2 gene polymorphisms with Type 2 diabetes mellitus in Malaysia: A preliminary report.Muhammad Huzaimi Haron, Rokiah Pendek, Zahurin Mohamed, Nor Azizan Abdullah., 15th Congress of the Asean Federation of Endocrine Societies. 28-1 Dec 2009. Bangkok. , 2009-11-28 to 2009-12-01, Journal of the Asean Federation of Endocrine Societies., (International)
  • Association of ABCB C1236T and C3435T polymorphisms with the risk of resistance to sodium valproate in Malaysian epilepsy patients. Z Mohamed, BS Haerian, EM Mohamed, KS Lim, HJ Tan, H Omar, S Mohammad, AA Raymond, CP Wong, SW Wong and CT Tan. Oral Presentation., 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. , 2010-04-05 to  , Malaysian Society of Pharmacology and Physiology, (National)
  • Bioethics education for a globalised world: Educate, inform and empower. An analysis to examine the need for bioethics education, training and awareness. , 10th World Congress of Bioethics. Singapore July 2010. Oral Presentation, 2010-07-08 to 2010-07-10, International Association of Bioethics, (International)
  • The impact of TCF7L2 variants on antidiabetic treatment regime selection: a Malaysian perspective. Muhammad H Haron, R Pendek, Z Mohamed, VL Raj, NA Abdullah. , 16th World Congress on Basic and Clinical Pharmacology, 2010-07-17 to 2010-07-23, International Union of Basic and Clinical Pharmacology, (International)
  • Association of ABCB1 polymorphisms with response to sodium valproate in Malaysian epilepsy patients., Asian Pacific International Society for Study of Xenobiotics (APISSX) 2011. 22-25th April 2011. Z Mohamed, BS Haerian, KS Lim, CT Tan (Oral Presentation)., 2011-04-22 to 2011-04-25, International Society for Study of Xenobiotics , (International)
  • Susceptibility and gene interaction study of the angiotensin II type I receptor gene with non-alcoholic fatty liver disease in a multi-ethnic population, 26th Scientific Meeting of the Malaysian Society of Pharmacology & Physiology, 2012-05-18 to 2012-05-20, Malaysian Society of Pharmacology & Physiology, (National)
POSTER
  • Some aspects of the disposition and metabolism 8-methoxypsoralen in experimental animals. Z.Mohamed, J.D. Baty, S.F. Fan & I.H. Stevenson. , British Journal of Pharmacology Scientific Meeting. 80, 167P, (1983), 1983-11-07 to  , (International)
  • The in vitro metabolism of psoralens used in photochemotheraphy. N.C.IIes,Z.Mohamed, D.C.Old, B.E. Johnson & I.H.Stevenson. , British Journal of Pharmacology Scientific Meeting. 81 - 83. 443P. (1984), 1984-11-20 to  , (International)
  • The effects of 8-methoxypsoralen on the drug metabolising enzymes. Z. Mohamed.C.12.4 (1985). , Fourth South-East Asian Western Pacific Regional Meeting of Pharmacologists. Penang. , 1985-06-16 to 1985-06-18, Malaysian Society of Pharmacology and Physiology, (National)
  • The identification of a major metabolite of 8-methoxypsoralen in rat bile and its photosensitising property. Z.Mohamed , Fourth South-East Asian Western Pacific Regional Meeting of Pharmacologists. Penang, 1985-06-16 to 1985-06-18, Malaysian Society of Pharmacology and Physiology, (National)
  • Some studies on the metabolism of 8-methoxypsoralen in both the in vivo and in vitro systems. Z. Mohamed and I.H.Stevenson., First South East Asian Drug Metabolism Workshop, Singapore, 1986-06-15 to 1986-06-17, NUS, (International)
  • Some aspects of the disposition and metabolism of 8-methoxypsoralen in experimental animals. Z.Mohamed, South East Drug Metabolism Workshop. Singapore. Abstract 18. , 1987-06-14 to 1987-06-16, NUS, (International)
  • An in vitro screening technique for the detection of photosensitising compounds. Z.Mohamed, Noraini Mahyuddin and Muhamad Zakaria, 8th National Seminar and UNESCO Regional Workshop on the Bioassay of Natural Products. (1991), 1991-05-06 to 1991-05-07, (International)
  • Caffeine metabolism by rabbit liver microsomes. Z.Mohamed, J.O. Miners and D.J. Birkett.P-204., Sixth South East Asian Western Pacific Regional Meeting of Pharmacologists. Hong Kong. (1991) , 1991-05-12 to 1991-05-14, (National)
  • Characterisation of caffeine metabolism in human liver microsomes. Z. Mohamed., 9th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. (1991) , 1991-06-03 to 1991-06-04, Malaysian Society of Pharmacology and Physiology., (National)
  • Caffeine metabolism by rabbit liver microsomes. Z.Mohamed, J.O. Miners and D.J. Birkett. , Sixth South East Asian Western Pacific Regional Meeting of Pharmacologists. Hong Kong. P-204. (1991)., 1991-06-10 to  , University of Hong Kong, (International)
  • Major differences in bioavailability of two generic products of nifedipine when compared to the proprietary nifedipine. Z.Mohamed, A.M. Mustafa, S.K. Jamal, C.T.Chua, K.Jeyalingam, M.R.Mustafa. Abstract A6., , Research Colloquim of the University of Malaya , 1997-08-04 to 1997-08-05, University of Malaya , (University)
  • Does gestational age affect gentamicin pharmacokinetic parameters in the newborn? Z.Mohamed. O.Farizaturradiah, S.M.Sim, C.T.Lim. , 16th Congress of Pharmaceutical Sciences . 17-21 November 1997. Kuala Lumpur., 1997-11-17 to 1997-11-21, Malaysian Society of Pharmaceutical Sciences, (International)
  • Occurrence of the CYP2D6 gene duplication and deletion, and the CYP2D*610A,10B Chinese allelle in an Asian population. JY Wong, S.Wise, Z.Mohamed, Noraliza Yusof & EJD Lee. , IXth Southeast Asian Drug Metabolism Workshop. April 1998. Abstract OW-7., 1998-11-10 to 1998-12-18, University of Malaya, (International)
  • The effects of fluoxetine on the in vitro CYP2D6-dependent metabolism of dextromethorphan in Sprague-Dawley rat. Z.Adam, CE Ong, A.M Mustafa & Z.Mohamed. , 14th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology . 7-9 Mei 1999, 1999-05-07 to 1999-05-09, Malaysian Society of Pharmacology and Physiology , (National)
  • Single oral omeprazole pharmacokinetics and CYP2C19 activity in Malaysian subjects. A.Doci, YS Pang TC Lee, Z.Mohamed, AM Mustafa & CC Lang., Joint Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and The British Pharmacological Society. 25-28 April 2000. Melbourne, Australia., , 2000-04-25 to 2000-04-28, (International)
  • Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies, Z.Chik, A.M. Mustafa, Z.Mohamed & T.C.Lee. "Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies. ", 2001, ASIANALYSIS VI, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30, , 2001-02-05 to 2001-02-08, (International)
  • Determination of enalapril and its active metabolite enalaprilat in plasma by Gas Chromatography Mass Spectrometry. Tan Shiau Leng, T.C.Lee, Z.Mohamed & A.M. Mustafa., ASIANALYSIS VI, The Sixth Asian Conference on Analytical Science. Tokyo 2001. IPA-29, , 2001-02-05 to 2001-02-09, (International)
  • Inhibition of cytochrome P450 2D6 activity in rat liver microsomes by quercetin.HA Abouazra, CE Ong, AM Mustafa & Z.Mohamed. , 15th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology , 2001-05-07 to 2001-05-08, Malaysian Society of Pharmacology and Physiology , (National)
  • Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies. Z.Chik, A.M. Mustafa, Z.Mohamed & T.C.Lee. ASIANALYSIS VI, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30, 2001-08-06 to  , (International)
  • CYP2C19 genotype and Phenotype in a Malaysian population using omeprazole as the probe drug. Z.Mohamed, YS Pang, TC Lee, AM Mustafa, CC Lang, XIVth World Congress of Pharmacology. 7th 12th July 2002. San Francisco, California, USA., 2002-07-07 to 2002-07-12, International Union of Pharmacology, (International)
  • Assessment of the Bioequivalence of Enalapril Pharmacokinetic or Pharmacodynamic Approach? Shiau-Leng Tan, Toong-Chow Lee and Z.Mohamed. , 5th FAOPS Congress. Federation of Asian and Oceanian Physiology Society, 23-26 September 2002. Kuala Lumpur., 2002-09-23 to 2002-09-26, FAOPS and Malaysian Society of Pharmacology and Physiology, (International)
  • Effects of selected bioactive compounds from grapefruit (citrus paradis) and pomelo (citrus grandis) on the cytochrome P450 3A4 system. , 5th FAOPS Congress. Federation of Asian and Oceanian Physiology Society, 23-26 September 2002. Kuala Lumpur., 2002-09-23 to 2002-09-26, Malaysian Society of Pharmacology and Physiology, (International)
  • HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed. PCR-RFLP: A tool for indirectly tailored drug therapy. , The 7th Asian Conference on Analytical Science, Hong Kong, July, 2004. (Poster Presentation), 2004-07-20 to 2004-07-24, (International)
  • Cytochrome P450 3A5 Polymorphisms in Malaysian Populations. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed, 36th Asia-Pacific Academic Consortium for Public Health (APACPH) Conference 2004, Brisbane, Australia. (Poster Presentation) , , 2004-09-20 to 2004-09-24, Asia-Pacific Academic Consortium for Public Health (APACPH), (International)
  • The MDR Variant Allele Frequencies in the two major ethnic Populations in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 36th Asia-Pacific Academic Consortium for Public Health (APACPH) Conference 2004, Brisbane, Australia. (Poster Presentation), , 2004-09-20 to 2004-09-24, (International)
  • Allelic distribution of C3435T in different ethnic groups in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 5th HUGO Pacific Meeting & 6th Asia-Pasific Conference on Human Genetics. 17-20 November 2004, Biopolis, Singapore., , 2004-11-17 to 2004-11-20, Biopolis, (International)
  • "Multidrug Resistance-1 (MDR-1) gene polymorphisms: Prevalence in different ethnic groups and correlation with cyclosporine concentration-to-dose ratio in renal transplant recipients. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z.Mohamed , 3rd World Congress of Nephrology, 26-30 June 2005, Singapore , 2005-06-26 to 2005-06-30, (International)
  • The impact of cytochrome P450 3A5 genetic polymorphism on cyclosporine concentration-to-dose ratio in renal transplant recipients. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z.Mohamed, 3rd World Congress of Nephrology. 26-30 June 2005, Singapore , 2005-06-26 to 2005-06-30, (International)
  • Angiotensin-converting enzyme deletion (ACE D)polymorphism and ischaemic stroke in multi ethnic Malaysian population. EHM Mohamed, Tan KS, Z. Mohamed, JM Ali, CT Tan and Azman W, International Union of Pharmacology (IUPHAR), Beijing, China 2-7 July 2006 , 2006-07-02 to 2006-07-07, (International)
  • Association Analysis of the serotonin 5HT2C receptor and dopamine D3 receptor gene polymorphisms with schizophrenia in three ethnic groupsZ.Mohamed, VL Raj, NF Mahali, SZ Suki, EHM Mohamed & NZ Zainal. pg. 3-72, 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists and 41st Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists , 2007-12-03 to 2007-12-06, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, (International)
  • Zahurin Bt Mohamed, Siti Zaleha Suki, Elsa Haniffah Mejia Mohamed, Vijaya L Raj and Nor Zuraida Zainal. Polymorphism of the Dopamine D3 Receptor Gene in Multi-Ethnic Patients with Schizophrenia. , International Conference on Pharmacogenomics, Korea, 2008 , 2008-04-10 to 2008-04-13, Inje University College of Medicine, (International)
  • Association analysis of the serotonin 5HT2C receptor and dopamine D3 receptor gene polymorphisms with schizophrenia in three ethnic groups. Zahurin Mohamed, Vijaya L Raj, Noor Fadzlin Mahalai, Siti Zaleha Suki, EHM Mohamed and Nor Zuraida Zainal , 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, , 2008-05-12 to  , Malaysian Society for Biochemistry and Molecular Biology, , (National)
  • Bioequivalence Study of Two Tablet Formulations of Salbutamol in Healthy Adult Subjects. Z Chik, RC Basu, D.Murugan, SM Khor, Z,Mohamed, R.Pendek and TC Lee, , 22nd Malaysian Society of Pharmacology & Physiology Scientific Meeting 2008, , 2008-08-27 to 2008-08-28, Malaysian Society of Pharmacology & Physiology , (National)
  • Association of ABCB1 (MDR1) and SCN1A polymorphism with resistance to carbamazepine in Malaysian epileptic patients. Batoul Sadat Haerian, EHM Mohamed, Z.Mohamed, VL Raj, KS Lim and CT Tan. , Fifth Epilepsy Congress, Tehran 4-6 Nov 2008, 2008-11-04 to 2008-11-06, (International)
  • Association between the serotonin transporter gene and major depressive disorder in three major ethnic groups in Malaysia. Nor Zainal, Zahurin M, Lian L Hoong, Vijaya L Raj, Elsa M Mohamed, Loke Ai Chin. , American Psychiatric Association Annual Meeting. May 16-21, 2009. San Francisco, USA (Poster), 2009-05-16 to 2009-05-21, American Psychiatric Association, (International)
  • G-2458A Lep gene polymorphism is associated with body mass index (BMI) in the Malaysian Population. YD Apalasamy, FM Moy, S Rampal, AM Bulgiba and Z Mohamed. , International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. 19-20 September 2009. Hong Kong., 2009-09-19 to 2009-09-22, University of Hong Kong, (International)
  • Association between single nucleotide polymorphisms of FAAH gene and GSTP1 gene with addiction to stimulants in the Malaysian population. MS Sim, VL Raj, A Hatim and Z Mohamed. , International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. 19-20 September 2009. Hong Kong., 2009-09-19 to 2009-09-22, (International)
  • Association between neuregulin1 gene polymorphism with schizophrenia in three ethnic groups in the Malaysian population. Z Mohamed, CL Wan, LH Lian and NZ Zainal. Poster Presentation. , 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. , 2010-04-05 to  , (National)
  • Association of FABP2 A54T polymorphism with sodium valproate responsiveness in Malaysian epilepsy patients. Mohamed EHM, Haerian BS, Mohammad Noor N, Lim KS, Tan HJ, Tan CT, Raymond AA, Wong CP and Mohamed Z. , 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 2010. Poster Presentation., 2010-04-05 to  , Malaysian Society of Pharmacology and Physiology, (National)
  • Association of ABCB1 and NR112 polymorphisms with response to carbamazepine in Malaysian epilepsy patients. BS Haerian, EHM Mohamed, KS Lim, HJ Tan, AA Raymond, CT Tan, CP Wong, SM Zain, SNM Roffeei and Z Mohamed. , American Society for Pharmacology and Experimental Therapeutics (ASPET). April 2010. Anaheim, California. Poster presentation, 2010-04-05 to  , American Society for Pharmacology and Experimental Therapeutics (ASPET)., (International)
  • Tryptophan hydroxylase 2 (TPH2) gene is associated with major depressive disorder in the three main ethnic groups of the Malaysian population, 16th World Congress on Basic and Clinical Pharmacology, 2010-07-17 to 2010-07-23, International Union of Basic and Clinical Pharmacology, (International)
  • Angiotensin II Type I polymorphisms and the risk of non-alcoholic fatty liver disease (NAFLD), JSH Single Topic Conference on Non-Alcoholic Fatty Liver Disease. 17-20th November 2010. Tokyo, Japan, 2010-11-17 to 2010-11-20, JSH Japan, (International)
  • Association of INSIG2 RS7566605 Polymorphism with obesity-related parameters in Malaysian Malays, Human Genome Meeting 2011, 2011-03-14 to 2011-03-17, HUGO and UAE, (International)
  • Central adiposity and body composition as indicators of dyslipidaemia among adolescents in Kuala Lumpur: A case-control study, 26th Scientific Meeting of Malaysian Society of Pharmacology & Physiology, 2012-05-18 to 2012-05-20, Malaysian Society of Pharmacology and Physiology, (National)
  • Non-alcoholic Fatty Liver Disease: A complex disease involving multiple gene interactions, 5th Pan Arab Human Genetics Conference , 2013-11-17 to 2013-11-19, Golden Helix Institute of Biomedical Research, Dubai., (International)
  • Polymorphism of the resistin gene and their association with obesity and resistin levels in Malaysians , Human Genome Meeting 2014, 2014-04-27 to 2014-07-30, Human Genome Organisation, (International)
PRESENTER
  • Preliminary phenotyping of dextromethorphan oxidation in a Malaysian population. Y.H.Noraliza, C.C.Lang, A.Z.Mohd. Zain, Z.Mohamed. , Eighth Southeast Asian Drug Metabolism Workshop. JogJakarta (1996)., 1996-09-09 to  , University of Jogjakarta, (International)
  • Single oral omeprazole pharmacokinetics and CYP2C19 activity in Malaysian subjects. A.Doci, YS Pang TC Lee, Z.Mohamed, AM Mustafa & CC Lang. , Joint Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and The British Pharmacological Society. 25-28 April 2000. Melbourne, Australia., 2000-04-25 to 2000-04-28, (International)
  • Effects of some endocrine chemicals on male rats . Normadiah K, Massaoud AD, Mustafa AM, Ruby H and Mohamed Z., European Journal of Anatomy, Vol 6, Suppl 1 pp 45-46, July 2002, 2002-07-18 to  , (International)
  • Validated Assay for Assessing CYP2C19 and CYP3A4 activities simultaneously using rat liver microsome. GY Christina, Z Mohamed and Ruby Husain , International Conference on Health Sciences. 6th-8th May 2005. KL., 2005-05-06 to 2005-05-08, (International)
OTHERS
  • Convention for Biological Weapons and Toxins, Workshop on Law on Convention for Biological Weapons and Toxins, 2012-07-19 to 2012-06-19, Science and Technology Research Institute for Defence, (National)
  • Did not present. Invited participant (Discussant), Persidangan Meja Bulat Sehari " Umat Islam dan Neurosains: Antara Tuntutan dan Kewaspadaan", 2014-06-12 to 2014-06-12, IKIM, (National)
  • Participant, Faculty of Medicine Research Week, 2015-05-11 to 2015-05-15, Department of Pharmacology and Department of Pharmacy, Faculty of Medicine, University of Malaya, (University)
  • Scenario for Development of a Draft of the Code of Conduct for Biosecurity, Workshop for the Development of a National Code of Conduct for Biosecurity, 2015-06-03 to 2015-06-04, Science and Technology Research Institute for Defence (STRIDE, Ministry of Defence), (National)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).


  • Pelantikan Sebagai Felo Penyelidik Bersatu, Pusat Kajian Kecemerlangan Melayu (PKKM), 2017, 2, (University)
  • Member of the International Union for Basic and Clinical Pharmacology, Pharmacogenomics Section since March 2016 (Asian Region), the most prestigious organisation for pharmacologists in the world. (http://www.iuphar.org/index.php/sections-subcoms/genetics-genomics/governance ), International Union for Basic and Clinical Pharmacology, Pharmacogenomics Section, 2017, 2, (International)
  • Appointment to the National Advisory Committee for the Malaysian Society for Pharmacology and Physiology, Malaysian Society of Pharmacology and Physiology, 2017, 2, (National)
  • Pharmacogenomics Working Group under the Global Genomics Medicine Collaboration (representing Malaysia), Global Genomics Medicine Collaboration, 2017, 24, (International)
  • Global Genomics Medicine Collaboration, Global Genomics Medicine Collaboration is based in University of Florida, 2015, 24, (International)
  • Panel member of the Development of the National Code of Conduct for Biosecurity, Science & Technology Research Institute for Defence (STRIDE), Ministry of Defence, Malaysia, 2015, 12, (National)
  • Chairman of the Conference, Golden Helix Symposium 2015, 2015, 12, (International)
  • Asian Network for Pharmacogenomics Research, Asian Network for Pharmacogenomics Research, 2013, 36, (International)
  • SouthEast Asian Consortium for Pharmacogenomics Research (SEAPHARM), Riken (Japan) and Thailand Centre of Excellence for Life Sciences, 2013, 60, (International)
  • Bioequivalence Studies Contract Research, Idaman Pharma Sdn Bhd, 2011, 36, (National)
  • UM-Aurigene Collaboration, Aurigene Discovery Technologies Limited, India , 2011, 24, (International)
  • Contract Research (Bioequivalence Studies), Idaman Pharma Sdn Bhd, 2010, 24, (National)
  • Research Collaboration, Chinese University of Hong Kong, 2010, 100, (International)
  • Contract Research (Bioequivalence Studies), Dynapharm Sdn Bhd, 2010, 6, (National)
  • Contract Research (Bioequivalence Studies), SM Pharmaceuticals, 2009, 12, (National)
  • Contract Research (Bioequivalence Studies), Idaman Pharma Sdn Bhd, 2009, 12, (National)
  • Country Representative for the Asian Network of Pharmacogenomics Research in which research data on Pharmacogenomics research are shared, Asian Network of Pharmacogenomics Research, 2008, 100, (International)
  • Contract Research (Bioequivalence Studies), PHARMANIAGA BERHAD, 2005, 12, (International)
  • Contract Research (Bioequivalence Studies), Upha, 2001, 12, (National)
  • Contract Research (Bioequivalence Studies), Duopharma, 2000, 12, (National)
  • Contract Research (Bioequivalence Studies), Luen Wah Medical Co., 2000, 12, (National)
  • Contract Research (Bioequivalence Studies), Ranbaxy, 1999, 12, (National)
  • Contract Research (Bioequivalence Studies), Xepa-soul Pattinson, 1999, 12, (National)
  • Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), Fischer General Scientific (M) Sdn Bhd, 1999, 300, (International)
  • Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), Shimadzu (Asia ) Pacific Pte Ltd, 1999, 300, (International)
  • Member of various committees under the Ministry of Health pertaining to Bioequivalence Studies, GLP, GCP and Traditional Medicine, Ministry of Health, 1999, 300, (National)
  • Contract Research (Bioequivalence Studies), PHARMANIAGA BHD, 1999, 60, (National)
  • Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), United Nations University, 1999, 300, (International)
  • Contract Research (Bioequivalence Studies), Norse Crown, 1998, 12, (National)
  • Contract Research (Bioequivalence Studies), CCM PHARMA SDN. BHD, 1998, 12, (National)
  • Contracted to carry out analysis of a medication, Veloo, Guna & Ramani Advocates and Solicirors, Singapore, 1997, 6, (Arrangement Between The Company And Our Laboratory)
  • Contract Research (Bioequivalence Studies), RAZA MANUFACTURING SDN BHD, 1997, 12, (National)
  • Contract study to test toxicity of rubber gloves, Baxter Health Care SA, 1995, 12, (International)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Panel/Committee Member of the Malaysian Phase 1 Clinical Trial Guideline. Published Nov 2017, Clinical Research Malaysia and Ministry of Health, Malaysia, Expert Advisor, 2017, (National)
  • Chairman of the Consensus Meeting for the Guidelines for the use of Human Biological Tissues for Research, Organised by Clinical Research Malaysia with the Ministry of Health, Malaysia, Chairman, 2015-2015, (National)
  • Panel member for the development of the National Code of Conduct for Biosecurity, Science & Technology Research Institute for Defence (STRIDE), Ministry of Defence, Malaysia jointly with the US Department of defence, Expert Advisor, 2015-2015, (National)
  • Panel bagi Pemilihan Naib Canselor IPTA bagi Universiti Penyelidikan (Universiti Malaya), Jabatan Pengajian Tinggi (Bahagian Governan IPTA), Ahli Panel, 2013-2013, (National)
  • Member of the National Bioethics Council - continuation of the term (Ahli Majlis bagi Majlis Bioetika Negara - sambungan), Ministry of Science, Technology and Innovation, Council Member, 2013-2014, (National)
  • Reviewer for Asia Pacific Journal of Public Health, Asia Pacific Journal of Public Health, Reviewer, 2013-2013, (International)
  • Member of the National Committee for Clinical Research, chaired by the Director General of the Ministry of Health, Malaysia, Ministry of Health, Member Of The National Committee, 2013-2014, (National)
  • Panel Member for the Committee for Assessment of Exploratory Research Grant Scheme (ERGS)., Ministry of Higher Education, Expert Advisor, 2012-Present, (National)
  • Invited for a Presentation in the Capacity as Council Member of the National Bioethics Committee. The meeting was an Expert Meeting on "Ethics of the Use of Animals in Experimentation" organised by the Institute of Islamic Understanding 7 June 2012. Title of presentation "Current Ethical Issues and in the use of animals in Medical and Biomedical Research"., Institute of Islamic Understanding, Expert Advisor, 2012-Present, (National)
  • Panel Assessor for Committee on Pre-investigational New Drug Applications. Appointment under the Ministry of Health., Ministry of Health, Malaysia, Expert Advisor, 2012-Present, (National)
  • Appointed a Council Member of the National Bioethics Committee. The Council was launched on 22 May 2012 by the Minister of MOSTI, YB Datuk Seri Panglima Dr Maximus Johnity Ongkili. I presented the Keynote Address at the Launch, entitled "Bioethics and Society".The Council plays an advisory role in all matters pertaining to bioethics in Malaysia., Appointment by the Ministry of Science, Technology and Innovation from Oct 2011., Expert Advisor, 2011-Present, (National)
  • Member of the National Committee for the revision of the Malaysian Guidelines on Good Clinical Practice (GCP). This Guidelines is used for all GCP workshops that are carried out throughout the Clinical Research Centres under MOH, at the Universities and at Research Institutes. The numbers of GCP workshops throughout Malaysia are about 30-50 yearly. These are three-day workshops with an examination at the end. The same committee are involved in preparation of the examination module., Ministry of Health, Malaysia, Expert Advisor, 2010-Present, (National)
  • Member of the National Pro-Tem Committee on National Bioethics Council (NBC). The NBC was only recently passed by Cabinet (September 2010). This committee recommends policies pertaining to issues on bioethics, an issue which would cut across numerous Ministries including Ministry of Health, Ministry of Science, Technology and Innovation, Ministry of Agriculture, Minstry of Education., Cabinet had recently approved the formation of the Council., Committee Member, 2009-2010, (National)
  • Expert on Bioequivalence (BE) Studies and have been carrying out such studies for the manufacturers of generic drugs throughout Malaysia for the past 12 years since 1999. It is mandatory that BE studies be done for generic drugs before the drugs can be registered for sale in the country. There are only 3 or 4 such centres in the country. Companies that have used our services include Idaman Pharma Sdn Bhd, Pharmaniaga, CCM Pharma, Xepa Soul Pattinson., Various generic drug manufacturers, Consultant, 2009-Present, (National)
  • Have been an invited speaker and facilitator for many Good Clinical Practice Workshops that have been organised throughout the country either by Clinical Research Centres under the Ministry of Health or others like HUKM. Have been a facilitator for GCP Workshops held in Kota Kinabalu (2008), Kucing (2008), Kuantan (2008), HUKM (2008, 2009, 2010) and UMMC (2006, 2007, 2008, 2009, 2010)., Clinical Research Centre, Ministry of Health., Expert Advisor, 2006-Present, (National)
  • Member of the National Committee on Good Laboratory Practice. This committee recommends policies pertaining to the mutual acceptance of data among international bodies in relation to GLP., Ministry of Health, Malaysia., Committee Member, 2004-Present, (National)
  • Member of the National Bioequivalence Committee. This is a powerful committee which is chaired by the Director of tyhe National Pharmaceutical Control Bureau, decides on the national policies governing the quality of generic drugs including the regulations governing bioequivalence studies. Only generic drugs that have passed Bioequivalence Data can be marketed in Malaysia. This can make or break a generic drug manufacturer. This committee is involved in such decisions., Ministry of Health, Malaysia., Committee Member, 2002-Present, (National)
  • Member of the National Committee for Clinical Research. This committee which is chaired by the Director General of Health, makes policies that have much impact on clinical research for the whole country and has been responsible for decisions such as the requirement for training for Good Clinical Practice (GCP) for doctors and research staff which is now strictly implemented., Ministry of Health, Malaysia., Committee Member, 1999-Present, (National)
  • Have been involved in Continuing Medical Education talks to medical doctors and other health providers throughout the country on the subject of Bioequivalence Studies. These talks are commisioned by Pharmaniaga. The venues for these talks include [1] Hospital Besar Kuantan (9 Oktober 1999)[2] Hospital Besar Kota Bharu (19 Nov 1999) [3] Hospital Besar Kuala Trengganu (29 June 2000) [4]USM (27 Sept 2000)[5] Hospital Kuala Krai (2001) [6] Klang GH 10th August 2004 [7] HUKM 9th September 2004 [8] Hospital Fatimah, Ipoh (23 March 2005) [9] Cancer Support Group, Putrajaya Hospital (26th March 2005) [10] Faculty of Medicine UiTM (18th April 2005) [11] Private Medical Practitioners Association of Selangor and KL (1st May 2005) [12] Damansara Specialist Hospital (11th May 2005) [13] UMMC Hari Jururawat Bioequivalence Studies: Ensuring Confidence in the Use of Generic Drugs (25th June 2005) [14] Hospital Kulim (14th July 2005) [15] Tawakal Specialist Hospital (17th August 2005) [16] Subang Jaya Medical Centre (19th August 2005) [17] Lourdes Medical Centre (27th September 2005) [18] Hospital Taiping (28th October 2005), Pharmaniaga Sdn Bhd in conjunction with various hospitals, Consultant, 1999-Present, (National)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).


  • External Examiner for the Professional Examination of the Medical Course at Lincoln University, Professional Examination For The Mbbs Course ,  (2017 - 2017)
  • PhD Thesis for IIUM, Thesis ,  (2017 - 2017)
  • June 2015. Evaluation of the standard of the examination and examination scheme carried out by the Faculty of Dentistry, UKM. Observes the practicals and academic matters relating to the students. Studies the programmes that are being offered., Assessor For The Degree Of Doctor Of Dentistry ,  (2015 - 2015)
  • PhD (USM): 2015. Munavar Miya Shaik; Thesis entitled "The Association of MTHFR 677C>T, ESR 325C>G, 594G>A and TNF-a-308G>A Gene Polymorphisms with Migraine, Thesis ,  (2015 - 2015)
  • Assessment of the Curriculum, the Examination, Standards, of this course for this newly set-up Faculty, Professional Examination For The Doctor Of Dental ,  (2014 - 2014)
  • Reviewer for sceintific journal called "Pharmaceutical Biology" for a manuscript entitled "Comparison of Inhibitory Potentials of Mitragynine, 7-Hydroxymitragynine,Buprenorphine and Ketamine on 4-Methylumbelliferone Glucuronidation by Human Liver". Sept 2014. Microsomes and Recombinant Human UGT Isoforms, Article In Journal ,  (2014 - 2014)
  • This evaluation involves the entire Pharmacy Course that is offered by the International Medical University for the entire session 2013/2014. I am required to look through examination papers and observation of the examination procedure, and also evaluation of the assessments that have been made by the IMU academic staff, Bachelor Of Pharmacy (hons) Course For Imu ,  (2014 - 2015)
  • Member of Assessor for Audit and Accreditation of Clinical Masters Programme at UKM, Masters Programme ,  (2014 - 2014)
  • USM: Masters. Nanthini A/P Jayabalan "Cannabinoid (CB) 1 Receptors in the Cerebellum as molecular targets of Mitragyna Speciosa (ketum) addiction in mitragynine-sensitised albino Swiss Mice", Thesis ,  (2014 - 2014)
  • Reviewer for Journal of Pharmaceutical Biology. Entitled " Comparison of Inhibition Potentials of Mitragynine, 7-hydroxymitragynine and several commonly abused drugs ----", Article In Journal ,  (2014 - 2014)
  • Article in Human Genetics (Impact Factor = 4.8) TITLE: Deep targeted resequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PPARVB with the severity of nonalcoholic fatty liver disease AUTHORS: Kitamoto, Takuya; Kitamoto, Aya; Yoneda, Masato; Hyogo, Hideyuki; Ochi, Hidenori; Mizusawa, Seiho; Ueno, Takato; Nakao, Kazuwa; Sekine, Akihiro; Chayama, Kazuaki; Nakajima, Atsushi; Hotta, Kikuko, Article In Journal ,  (2014 - 2014)
  • Reviewer for article for Human Genetics (Impact Factor = 4.7.Deep targeted resequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PPARVB with the severity of nonalcoholic fatty liver disease., Article In Journal ,  (2013 - 2013)
  • Masters USM: Shafra Binti Zainal Abidin. Inhibitory Effects of Active Constituents and Extracts of Andropgraphis Paniculata on the Activities of UDP-Glucuronosyl Transferases (UGTs)., Thesis ,  (2013 - 2013)
  • Promotion to Professor for Taylor's University, Promotion To Professor ,  (2013 - 2013)
  • PhD (USM): Noordalilati Muhd Noor. Teratogenicity study of Hempedu Bumi (Andrographis paniculata) in rats., Thesis ,  (2013 - 2013)
  • BMedScience IMU: Lau Pui Shen. Functional characterisation of cytochrome P450 2C19 allelic variants CYP2C19*23 and CYP2C19*24., Thesis ,  (2013 - 2013)
  • Masters thesis (USM): Seah Tiong Chai " Development of a cell-based green fluorescence protein assay for the screening of CYP3A4 inducers and inhibitors., Thesis ,  (2013 - 2013)
  • Evaluation of the entire Medical Curriculum MBBS for the Second Year of UKM's Medical Programme, from the suitability and standard of the the examination, the conduct of the examination, research activities carried out within the department etc., Mbbs Course For Second Year For Ukm ,  (2013 - 2013)
  • BMedSci (IMU): Hsu Chia Jie. Identification of inhibitory effects on cytochrome P450 (CYP) 3A4 by edible bird nest (EBN) extracts in vitro, Thesis ,  (2013 - 2013)
  • Assessor for promotion to a professor position, Thesis ,  (2013 - 2013)
  • BMedSc (IMU): Lau Pui Shen. Functional characterisation of cytochrome P450 2C19 allelic variants CYP2C19*23 and CYP2C19*24., Thesis ,  (2013 - 2013)
  • PhD USM : Teratogenicity study olf Hempedu umi (Andrographis paniculata) in rats. July 2012. Noordalilati Muhd Noor., Thesis ,  (2012 - 2012)
  • BMedSc (IMU): Identification of inhibitory effects on cytochrome P450 (CYP) 3A4 by edible birds nest (EBN) extracts in vitro. Hsu Chia Jie (ME090226613). June 2012., Thesis ,  (2012 - 2012)
  • External Examiner for the IMU Medical Programme. Involves review of examination papers, examine the students, observe the examination processes and submit a written report., External Examiner For The Imu Medical Programme ,  (2012 - 2012)
  • PhD Thesis (USM): Genotoxicity and Prenatal Development Toxicity Studies of Orthosiphon stamineus Aqueous Extract. Hussin Bin Muhammad. Jan 2012., Thesis ,  (2012 - 2012)
  • UKM Promotion to an Associate Professor position. Dr Kamisah Yusof. Feb 2012, Promotion To An Associate Professor Position ,  (2012 - 2012)
  • Review Editor of Frontiers of Pharmacogenetics and Pharmacogenomics, Review Editor Of A Journal ,  (2011)
  • External Member of Staff Selection Committee for Academic Appointments at Monash University. From Sept 2011., Committee For Academic Appointments For Monash Uni ,  (2011 - 2011)
  • Evaluation of the above course at the Kuliyyah of Dentistry, International Islamic University of Malaysia. 2-8 May 2011., Second Professional Dental Examination Session 201 ,  (2011)
  • PhD Thesis USM: Genotoxicity and Teratogenicity Evaluation of Orthosiphon Stamineus Aqueous Extract. Hussin Bin Muhammad., Thesis ,  (2011 - 2011)
  • Manipal-Melaka MBBS Course for the Pharmacology component. 22-27 Feb 2011., Thesis ,  (2011 - 2011)
  • Tier 1 Journal (Impact Factor 4.398) "Pharmacogenomics". Functional Variant from SCN1A: Influence on dose, serum levels and therapeutic outcome of monotherapy with first-line antiepileptic drugs. Reviewer of article in an academic journal. Nov 2011., Article In Journal ,  (2011 - 2011)
  • External Assesor for selection of potential members of academic staff for Monash University, Member Of Panel For Academic Staff Selection ,  (2011 - 2012)
  • Identification of human ABCC3 variants and functional analysis of the promoter variants: in vitro and human studies. Sasaki et al. Drug Metabolism and Pharmacokinetics. Reviewer of an article in an academic journal., Article In Journal ,  (2011 - 2011)
  • No association of peptide tyrosine-tyrosine (PYY) gene R72T variant with obesity among the Kampar Health Clinic Cohort, Malaysia. Malaysian Journal of Nutrition. Reviewer of a full paper in a journal., Article In Journal ,  (2011 - 2011)
  • Masters Thesis (USM): Effects of Mitragyna speciosa extracts on drug metabolising enzymes. Juzaili Azizi., Thesis ,  (2011 - 2011)
  • Tier 1 Journal with Impact Factor 4.398 "Pharmacogenomics". Association of genetic variants in six candidate genes with valproic acid therapy optimisation. Reviewer of article in academic journal. Feb 2011., Article In Journal ,  (2011 - 2011)
  • PhD Thesis (Internal Examiner): Metamphetamine Dependence in Malaysia: Psychiatric Co-Morbidity and Suicidality, metamphetamine induced psychosis, genetic polymorphisms and treatment of metamphetamine-dependence using aripiprazole. Ahmad Hatim Sulaiman., Thesis ,  (2011 - 2011)
  • Panel Penilai Pakar untuk Penilaian Pembiayaan Dana Kementeian Sains, Teknologi dan Inovasi, Project ,  (2010)
  • Master Thesis: Effect of Phyllanthus niruri (Linn) on Phase i and II drug metabolism and its molecular mechanism elucidation in rat liver. Moath Kahtan Bashir. July 2010 (USM), Thesis ,  (2010 - 2010)
  • PhD Thesis (Manipal University): Effects of Tualang Honey on Reproductive System of Male Rats exposed to Cigarette Smoke. Mahaneem Binti Mohamed. USM. September 2010., Thesis ,  (2010 - 2011)
  • PhD Thesis (Manipal University): Morphological changes in the testis and spermatozoa of mice treated with imatinib. Submitted to the Manipal University, India. June 2010., Thesis ,  (2010 - 2010)
  • New applications for Research University Grants for USM., Project ,  (2010 - 2010)
  • Gene-wide tagging study revealed no association between ABCC2, ABCC5 and ABCG2 genetic polymorphism and multidrug resistance in epilepsy. Pharmacogenomics (ISI journal with Impact Factor = 4.398). Reviewer of an article in an academic journal. Reviewer of an article in an academic journal. August 2010., Article In Journal ,  (2010 - 2010)
  • Pharmacokinetic consideration for prescribing in children. Medical & Health Review Journal. Reviewer of an article in an academic journal. 11 March 2010, Article In Journal ,  (2010 - 2010)
  • Ethical Perception of Modern Biotechnology among Muslims in Malaysia. Asia Pacific Journal of Molecular Biology and Technology. Reviewer of an article in an academic journal. Jan 2010., Article In Journal ,  (2010 - 2010)
  • PhD Thesis: The Predictive Value of Single Nucleotide Polymorphism of the Human Tumour Necrosis Factor-Alpha and Interleukin 10 in Human Gestational Diabetes Mellitus. Thesis by Shabnam Montazeri for Doctor of Philosophy (Community Health), conferred by the International Medical University. July 2009., Thesis ,  (2009 - 2009)
  • PhD Thesis: Teratogenicity Study of Hempedu Bumi (Angrographis Paniculata) in Rats. External Examiner. USM. Thesis by Noordalilati Binti Muhd Noor. PhD. July 2009, Thesis ,  (2009 - 2009)
  • 2nd Part of the Second Professional Examination, Pharmacology Subject, Kulliyah of Dentistry, International Islamic University Malaysia. June 2009, Evaluation Of The Dental (bds) Programme ,  (2009 - 2009)
  • PhD Thesis: Effects of the Extracts and Active Constituents of Hempedu Bumi, Pegaga, and Misai Kucing on Cytochrome P450 Enzymes in Human Liver. Pan Yan. International Medical University. July 2009., Thesis ,  (2009 - 2009)
  • BBiomedSc Thesis: Identification of BCR-ABL kinase domain mutations among patients with chronic myeloid leukemia. Liang Kai Ling. 2009. UM., Thesis ,  (2009 - 2009)
  • Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Current Pharmacogenomics and Personalised Medicine. Reviewer of an article in an academic journal. Nov 2009., Article In Journal ,  (2009 - 2009)
  • Master in Medical Science Thesis: Multiresidue determination of quinolone and chloramphenicol in poultry muscles from Malaysian processing plants by high performance liquid chromatography tandem mass spectrometry. Marni Sapar. July 2009. Conferred by University of Malaya., Thesis ,  (2009 - 2009)
  • PhD Thesis (Ineternational Medical University). Effects of the Extracts and Active Constituents of Hempedu Bumi, Pegaga, and Misai Kucing on Cytochrome P450 Enzymes in Human Liver. PhD. Pan Yan. July 2009., Thesis ,  (2009 - 2009)
  • BMedSc Thesis: Drug-Drug Interaction Between Sunitinib and Paracetamol in a Mouse Model: Biochemical and Histopathological Assessment . Adeline Lim Yi Ling. International Medical University, Thesis ,  (2009 - 2009)
  • PhD Thesis (USM). Drug interactions between imatinib and acetaminophen - Pharmacokinetic and histopathological studies in a mouse model. Mohamed Inthisham Mohamed Nassar. 2008., Thesis ,  (2008 - 2008)
  • A pharmacokinetic interaction between propranolol and Eurycoma longifolia (Tongkat Ali). Shima'a Ahmed Benslman. MSc. 2008. USM., Thesis ,  (2008)
  • BMedSc Thesis: In vitro evaluation of interaction between Eurycomalia longifolia active constituents and human cytochrome P450. Ching Siau Ying. IMU. Nov 2008., Thesis ,  (2008 - 2008)
  • Palm kernel oil blends as suppository bases in the delivery of aspirin. For Journal of the University of Malaya Medical Centre. Reviewer of an article in an academic journal., Article In Journal ,  (2007 - 2007)
  • BMedSc Thesis: The use of chimeragenesis to study structure-function properties of cytochrome P4502C isoenzymes in human liver. Jonathan Cheah Gin Guan. IMU. Nov 2007, Thesis ,  (2007 - 2007)
  • PhD Thesis: Pharmacokinetic interaction study between ciprofloxacin and theophylline in healthy volunteers. Saeed Obeid Abdulla Alfadly. USM. 2007., Thesis ,  (2007 - 2007)
  • BBiomedSc: Relationship between IL-5 levels and eosinophil count in Malaysian asthmatics. Affidah Binti Sabran. UM. 2007., Thesis ,  (2007 - 2007)
  • BBiomedSc: Screening of antioxidant activity of plant extracts: A comparison of different methods of assessment. Ahmad Bazli bin Abu Shuib. UM. 2007., Thesis ,  (2007 - 2007)
  • BMedSc Thesis: Catalytic activity and protein stability of cytochrome P450 2C8 (CYP2C8) allelic variants carrying mutation at amino acid Ile264. Rajinder Singh a/l Harjit Singh. IMU. 2006., Thesis ,  (2006 - 2006)
  • PhD Thesis: Drug metabolism and toxicity studies of Misai Kucing (Orthosiphon stamineus, Benth) in rats. Chin Jin Han. USM. 2006., Thesis ,  (2006 - 2006)
  • External Examiner MBBS UiTM Medical Professional 2 Examination 2005(Pharmacology), Evaluator Of The Mbbs Programme For Pharmacology ,  (2005 - 2005)
  • Masters Thesis: Kesan jangka panjang ekstrak etanol Andrographis paniculata (Burm. F) Nees ke atas tikus betina diabetik aruhan-streptozotocin. Ahmad Syahrin Bin Mohd Saifuddin. USM. MSc. 2005., Thesis ,  (2005 - 2005)
  • PhD Thesis: Effect of pyramid environment on anti-wound healing properties of corticosteroids, nonsteroidal antiinflammatory drugs and anticancer agents in albino rats. Surekha R Kamath. Manipal University, India. April 2005., Thesis ,  (2005 - 2005)
  • BMedSc Thesis: Construction and characterisation of mutations at isoleucine 264 in cytochrome P450 (CYP) 2C* enzyme. Jonathan Ting Ee. IMU., Thesis ,  (2005 - 2005)
  • PhD Thesis. Siti Amrah Bt Sulaiman. Kajian mengenai profail kontraseptif sediaan herba tradisional orang asli kaum temuan. PhD, Universiti Sains Malaysia. Disember 2004, Thesis ,  (2004 - 2004)
  • External Examiner for Semester 3 Examination of the MBBS Course for International Medical University. December 2004., Evaluation Of The Medical (mbbs) Programme ,  (2004 - 2004)
  • MMedSc Thesis: Phytooestrogens (Genistein and Diadzein): Distribution in tempeh and their endocrine-modulating effects in mice. Jegathambigai R. 2004., Thesis ,  (2004 - 2004)
  • BMedSc Thesis: Characterisation of in vitro modulatory effects of flavonoids on human cytochrome P450 (CYP) 2C8 isoenzyme. Pang Chia Yong. IMU. 2004., Thesis ,  (2004 - 2004)
  • PhD Thesis: Ethnic differences in drug responses and disposition. Wong Li Ping. UM. Jan 2004., Thesis ,  (2004 - 2004)
  • PhD Thesis: Kepentingan peranan gen enzim detoksifikasi dalam penyakit karsinoma hepatoselular: Kaitan polimorphisme gen, aras protein, aduk dan kerosakan oksidatif DNA serta kajian kultur sel HEPG2 tertransfeksi. Zalinah Ahmad. UKM. 2003., Thesis ,  (2003 - 2003)
  • PhD thesis UKM. Dr Azian Abdul Latif.Kesan Suplimentasi Vitamin E Kelapa Sawit (Palmvitee) Terhadap Respons Imun Dan Status Antioksidan: Kajian Pada Pembawa Hepatitis Dan Mencit Diperlaku Karsinogen. November 2002., Thesis ,  (2002 - 2002)
  • PhD thesis : Abdul Rasyid (USM) for the thesis entitled Kajian Ultrasonografi Kesan Kurkumin Terhadap Pundi Hempedu Manusia. October 2001, Thesis ,  (2001 - 2001)
  • MSc Thesis: The role of Cytochrome P-450 Monooxygenase in Braedybaenia similaris Tolerance Towards Metaldehyde. Sakinah Harith (UKM). August 2001, Thesis ,  (2001 - 2001)
  • Masters Thesis: Kajian peranan sitokrom P-450 monoksigenase dalam kerintangan Bradybaena similaris terhadap metaldehida. Sakinah Binti Harith. MSc. UKM. 2001., Thesis ,  (2001 - 2001)
  • MSc Thesis: Kajian Ketoksikan Akut dan Subkronik Pironaridina dan Artesunata. A'edah bte Abu Bakar (USM)January 2001., Thesis ,  (2001 - 2001)
  • External Examiner for the BDS Examination (for Pharmacology) at UKM. March 2000 and again in March 2002, Evaluation Of The Dental (bds) Programme ,  (2000 - 2002)
  • PhD: Kajian ketoksikan akut dan subkronik pironaridina dan artesunat. A'edah Hj Abu Bakar. USM. 2000., Thesis ,  (2000 - 2000)
  • External Examiner for the MBBS Manipal-Melaka Programme (for Pharmacology) August 1999, for March 2000, for August 2002, Feb 2003, August 2008 and many more times --- latest being February 2011, Evaluation Of The Medical (mbbs) Programme ,  (1999)
  • Masters of Science (UKM). Kajian perencatan pertumbuhan tumor, aruhan apoptosis dan pengekspresan protein penindas tumor P53 oleh goniotalamin pada model tumor mamari tikus teraruh 7,12-dimetilbenz(A) antrasen. Shamsul bin Muhamad. August 1998., Thesis ,  (1998 - 1998)
  • Masters of Science (USM) Genetic Polymorphism of Debrisoquine Metabolism : A Preliminary Study in Malays with a View of Developing Clinical Applications. Ahmad Hussein. MSc. May 1998, Thesis ,  (1998 - 1998)
  • Masters of Biomedical Science (UKM). Thesis entitled The Study of Adenosine Deaminase Activity and of Adenosine, Inosine and Hypoxanthine in Cerobrospinal Fluid and Serum of Rabbits induced with Meningitis. Haslida bt Hussin. M.Sc. March 1997., Thesis ,  (1997 - 1997)
  • Masters Thesis: Pengkajian aktiviti adenosin deaminase serta adenosin, inosin dan hipoxantin di dalam cecair serebrospina dan serum arnab teraruh meningitis. Haslida Binti Husin. UKM. Masters in Biomedical Science. 1996., Thesis ,  (1996 - 1996)
  • Masters of Science (USM). Thesis entitled Cardiovascular Studies in an Animal Model of Diabetes. Mahgub A.Abugama. M.Sc. January 1995., Thesis ,  (1995 - 1995)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Board of Trustee for the Fund for the Renovation of Mosques in Kelantan Post-Flood (Ahli Lembaga Pemegang Amanah Tabung Ihsan Pemulihan Masjid Banjir Kelantan). Appointment by Senator Dato' Dr Asyraf Wajdi Dusuki, Chairman of the Fund. Patron is YB Dato' Sri Mustapa Mohamed, Minister of Trade and Industry. , (Country), 22/01/2015 until 22/01/2017
  • Invited to a talk show on slot on "Sains dan Islam" by IKIM on Friday 5th Sept 2014 at 12.30pm. The talk show was on the aggression on Gaza by the Israel army and hosted by the Deputy Director of IKIM Prof Datin Azizan Baharuddin., (National), 05/09/2014 until 05/09/2014
  • Member of Council for Steering Committee of the Persatuan Orang Kota Bharu , (Community), 04/08/2014 until 04/08/2017
  • Member of the Council of Advisors of Persatuan Orang Kota Bharu (POKB)for Special Funds for Kidney Patients at Hospital Raja Perempuan Zainab II, (Community), 04/08/2014 until 04/08/2017
  • Advisor for Society for Muslim Medical Students (Persatuan Siswa-Siswi Perubatan Islam Universiti Malaya (PSIPUM) since 1994 till present. The last AGM was held at the Faculty of Medicine, UM, on Tuesday 8th July 2014, for election of the ExCo , (University), 08/07/2014 until  
  • Council Member of the Villa Flora Condominium, Taman Tun Dr Ismail, (Community), 28/06/2014 until 01/07/2015
  • Coordinator for the 5th Annual Ramadhan Project 2014 for sponsorship drive for food hampers to 110 families at the DBKL Flats, Kampung Kerinci, 200 residents of Lembah Subang and 17 girl orphans at Baitul Izzah at Pinggir Taman Tun Dr Ismail., (Community), 02/06/2014 until 28/06/2014
  • Ahli Persatuan Kemajuan Wanita Kelantan Di Kuala Lumpur dan Selangor (PUSPA). Hadiri Majlis Pelancaran Buku "Biografi Tokoh Wanita Kelantan" oleh YBM Tengku Razaleigh Hamzah., (Community), 22/03/2014 until 22/03/2014
  • Coordinated the Yearly Contribution of "Qurban in Cambodia", for donation of Meat to the Needy Muslims in Cambodia, (Community), 01/10/2013 until 01/11/2013
  • Organiser of a Talk by Miko Peled, Jewish American, Pro-Palestinian Activist, at the University of Malaya; on behalf of Viva Palestinia Malaysia., (National), 16/06/2013 until 16/06/2013
  • Organiser of the Yearly Contribution to the Needy Families of the Kg Kerinci DBKL Flats, (Community), 01/06/2013 until 07/07/2013
  • Advisor to the yearly Charity Ride projects of the Universiti Teknologi Malaysia (UTM) students. Students ride from KL to Johor to collect funds along the way for the reconstruction of GAZA., (Country), 04/10/2010 until 25/12/2010
  • Advisor for the Baktisiswa Sarawak 2010 Programme, organised by MedSoc Medical Society, (University), 01/03/2010 until  
  • Committee Member of Viva Palestina Malaysia (formerly known as COMPLETE as above). Chairman of the Awareness Subcommittee. Jan 2010 till now, (National), 14/01/2010 until  
  • Advisor for Bengkel UPSR bagi Science. Organised by Taman Tun Dr Ismail Residents Association, (Community), 15/06/2009 until  
  • Committee Member of Badan Kebajikan Taman Tun Dr Ismail (BAKTI), a community group involved in charity and social activities, (Community), 02/06/2009 until  
  • Committee Member of Coalition of NGOs against the persecution of Palestinians (COMPLETE). Deputy Chairman of the Awareness Subcommittee. Jan 2009-Jan 2010, (National), 14/01/2009 until 14/04/2010
  • Coordinator for the monthly Contributions to orphans at a Tahfiz in Kelantan, (Community), 08/12/2008 until 04/01/2010
  • Coordinator for yearly contributions to the needy families of the DBKL apartments prior to Ramadhan, (Community), 05/03/2007 until  
  • Committee Member and Member of Kanwork (Cancer Network), a Breast Cancer Support Group, (National), 17/01/2006 until  
  • Honorary Secretary of the Health Awareness Network Initiatives, Old Girls Association of the Tunku Kurshiah College, March 2005 - 2007, (Community), 01/03/2005 until  
  • Member of the Organising Committee for the yearly Regional Conference on Medical Management from the Islamic Perspective. 2000-2008 , (International), 18/09/2000 until 08/09/2008
  • Member of the University of Malaya Medical Centre (UMMC) Academic Committee for the Welfare of Patients, (Community), 03/01/2000 until  
  • Member of the Masjid At-Taqwa and been a member of various subcommittees and involved in many activities organised by the mosques such as presenting talks on medications., (Community), 17/12/1991 until  
  • Member of the Residents Association (RA) of Taman Tun Dr Ismail and I have been involved in many community projects organised by RA such as their Family Day., (Community), 04/12/1990 until  

SUPERVISION


POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed
  • Doctoral Degree (phd), Sanaz Koosha, Flavonoids and Colorectal Cancer, 2019/2020
  • Doctoral Degree (phd), Tan Hwa Li, Molecular Studies of Non-Alcoholic Fatty Liver Disease, 2019/2020
  • Doctoral Degree (phd), Atefehalsadat Seyedan, Medicinal Plants and Pancreatic Lipas Activities, 2019/2020
  • Doctoral Degree (phd), Abdul Samad Ahmed Mokbel Al-salahi, Antidiabetic Properties of Khat, 2019/2020
  • Doctoral Degree (phd), Mohd Aizat Bin Mohd Zain, PDLIM knockout animals, 2018/2019
  • Doctoral Degree (phd), Megala A/p Narasingam, Noni fruit and Drug Addiction, 2018/2019
  • Doctoral Degree (phd), Immaculate Langmia, Pharmacogenomics of Adverse Drug Reactions, 2017/2018
  • Doctoral Degree (phd), Behnaz Riazalhosseini, Pharmacogenomics of Hepatitis B Infection, 2017/2018
  • Doctoral Degree (phd), Sim Maw Shin, Molecular Studies of Amphetamine Dependence, 2017/2018
  • Doctoral Degree (phd), Elham Rouhollahi, Natural Product, 2017/2018
  • Doctoral Degree (phd), Kong Wai Mun, Studies on Mitragyna, 2017/2018
  • Doctoral Degree (phd), Elham Amini, Molecular Approaches to Alzheimer's Diseases, 2017/2018
  • Doctoral Degree (phd), Prevathe Poniah, Pharmacogenomics of Prostate Cancer, 2017/2018
  • Doctoral Degree (phd), Mojtaba Golpich, Animal Model of Parkinson's Disease, 2017/2018
  • Doctoral Degree (phd), Sujatha Suthandiram, Pharmacogenomics of Lymphoproliferative Disorder, 2016/2017
  • Master Degree, Md Mirazul Islam, Blood Cancers, 2014/2015
  • Master Degree, Mohd Aizat Bin Mohd Zain, Pharmacogenomics of Bipolar Disorder, 2013/2014
  • Master Degree, Ng Mei Fong, Study of Olanzapine-Induced Obesity, 2011/2012
  • Master Degree, Diong Shiau Hui, The Use of Methadone Replacement Therapy for Heroin Addiction, 2011/2012
  • Master Degree, Hidayati Binti Mohd Sha'ari, Pharmacogenomics of Epilepsy, 2011/2012
  • Master Degree, Nur Elia Binti Mohd Nazree, Association between candidate genes and sexual dysfunction in patients with major depressive disorder, 2011/2012
  • Doctoral Degree (phd), Yamuna Devi A/p Apalasamy, Pharmacogenomics of Obesity, 2010/2011
  • Doctoral Degree (phd), Batoul Sadat Haerian, Pharmacogenomics of Epilepsy, 2010/2011
  • Doctoral Degree (phd), Raja Elina Raja Aziddin, Phytochemical screening and pharmacological studies of Mitragyna Species, 2010/2011
  • Master Degree, Afiqah Alyaa Binti Md Fuzi, Pharmacogenomics of Endometrial Cancer, 2009/2010
  • Master Degree, Siti Zaleha Suki, Pharmacogenomics of Pre-Term Birth, 2009/2010
  • Master Degree, Lee Ern Chi, Pharmacogenomics of Breast Cancer, 2009/2010
  • Doctoral Degree (phd), Shamsul Mohd Zain, Pharmacogenomics of Non-Alcoholic Fatty Liver Disease, 2009/2010
  • Master Degree, Soobitha A/p Subenthiran, Population Pharmacokinetics and Pharmacogenomics, 2009/2010
  • Master Degree, Dr Muhammad Huzaimi Bin Haron 02-06-2008, Pharmacogenomics of Diabetes Insipidus, 2008/2009
  • Master Degree, Didi Erwandi Bin Mohamad Haron, Pharmacokinetics of Testosterone, 2008/2009
  • Master Degree, Elsa Haniffah Mejia Mohamed, Genetic polymorphism study of the methylenetetrahydrofolate reductase (MTHFR) and renin angiotensin system (RAS) in Malaysian ischaemic stroke population, 2008/2009
  • Master Degree, Wan Ching Lee, Pharmacogenomics of Schizophrenia, 2007/2008
  • Master Degree, Loke Ai Chin, Pharmacogenomics of Major Depressive Disorder, 2007/2008
  • Master Degree, Gareth Sim Maw Shin, Pharmacogenomics of Drugs of Abuse, 2007/2008
  • Master Degree, Kaleswari Somasundaram, Studies on antidiabetic and related effects of Momordica charantia, Azadirachta indica and Murraya koenigh extracts on normal and STZ-induced diabetic rats. Kaleswari Somasundaram. 2007., 2006/2007
  • Master Degree, Hasni Misbah, Effects of selected bioactive compounds from grapefruit (Citrus paradisi) and pomelo (Citrus grandis) on the cytochrome P450 3A4 system, 2005/2006
  • Master Degree, Christina Gertrude Yap, The effects of Citrus Grandis (pummelo) juice and its extracts on cytochrome P4502C19 and P450 3A4, 2005/2006
  • Master Degree, Eng Hooi Sian, Multidrug resistance-1 (MDR-1) and cytochrome P450 3A (CYP3A) gene polymorphisms: Allelle frequencies in healthy subjects and correlations with cyclosporine dose requirement and trough concentration-to-dose ratio in renal allograft recipients, 2004/2005
  • Master Degree, Sathya Seelan S/o Natchimuthu, Monitoring of phytooestrogens in human cord blood and plant-based food and studies of some of their pharmacological properties., 2003/2004
  • Master Degree, Zamri Bin Chik, Gas chromatography-mass spectrometric analysis of captopril and its application in pharmacokinetic studies in healthy subjects, 2000/2001
  • Master Degree, Pang Yek Sze, Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects, 2000/2001
  • Master Degree, Tan Shiau Leng, Pharmacokinetics and bioequivalence syudies of enalapril and its correlation with angiotensin converting enzyme inhibition activity, 2000/2001
  • Master Degree, Farizaturradiah Bt Osman, Pharmacokinetic parameters of gentamicin, amikacin, theophylline and sufentanil - A study in the Malysian population, 1999/2000
  • Master Degree, Nor Ainy Bt Mahyudin, Compounds of Homalium longifolium Benth, with special emphasis on photosensitising activities, 1994/1995
  • Master Degree, Mustafa Ali Mohd, Pharmacology of the Dioscorea species, 1988/1989
  • Doctoral Degree (phd), Hanan Abdelkarim Salman Abouazra, Structure Activity Relationship of the inhibitory action of flavonoids on liver cytochrome P450 isozymes

Terminated
  • Doctoral Degree (phd), Yuka Nozaka, Genetics of Epilepsy, 2013/2014
  • Doctoral Degree (phd), Rana Ombakshah, Molecular Studies of Alzheimers Disease, 2012/2013
  • Doctoral Degree (phd), Fatemah Hemmati, Animal Model of Alzheimer's Disease, 2012/2013
  • Doctoral Degree (phd), Anahita Hamidi, Molecular Studies of Childhood Obesity, 2011/2012

Ongoing
  • Doctoral Degree (phd), Shahrzad Riahi, Methadone and Sexual Dysfunction, 2018/2019
  • Doctoral Degree (phd), Abdulmannan Hasan Saad, Natural Product, 2018/2019
  • Doctoral Degree (phd), Mustafa Ahmed Al-shagga, Obesity and Khat, 2018/2019
FIRST DEGREE/DIPLOMA/PRE-DEGREE
(Course Title), (Academic Session), (No. of Candidates)

Completed
  • Four-months Industrial Training of Suthasini A/P Poniah from Aimst University. Title "Association of polymorphism with obesity parameters in humans", 2013/2014, 1
  • Four-months Industrial Training of student Ling Wei Shyang from Aimst University. Project title "Antiobesity effect of Green Tea Extracts", 2013/2014, 1
  • MDEB 3401. Project Title: ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPs) IN ADIPOQ & FTO GENE WITH CHILDHOOD OBESITY. SANDEE TUN. Matric No. MEB 090702. 2011/12, 2011/2012, 2
  • MDEB3401. Project title: Angiotensin II type 1 receptor (AGTR1) GENE polymorphism PREDICTS RISK OF FIBROSIS IN nonalcoholic fatty liver disease. Ngoh Teck Keong. MEB090021. 2011/12, 2011/2012, 2
  • ASSOCIATION OF PNPLA3 RS738409 SINGLE NUCLEOTIDE POLYMORPHISM WITH DEVELOPMENT AND PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). Tan Hwa Li. Attachment from USM., 2011/2012, 1
  • Association of SOD2 gene polymorphisms with metamphetamine dependence and psychosis in Malaysian population. Ahmad Nur Fayyadh Bin Ahmad Jaafar. MEB070003. B Biomedical Science. 2010/11, 2010/2011, 1
  • Association study of the -866 G/A polymorphism of uncoupling protein 2 (UCP2) with certain obesity-related parameters in Malaysian Malay subjects. Amir Hakim Bin Mohd Yusof. B Biomedical Science. 2010/11, 2010/2011, 1
  • Relationship between T102C polymorphism of the 5HT2A receptor gene and occurrence of psychosis in patients with schizophrenia. Mohd Aizat Bin Mohd Zain. B Biomedical Science. 2008/09., 2008/2009, 1
  • Polymorphism of the T102C serotonin 2A receptor gene in multi-ethnic patients with major depressive disorder and its association with suicidal behaviour. Mohd Izwan Bin Zainol. B Biomedical Science. 2008/09., 2008/2009, 1
  • Association of G-1438A polymorphism of 5HT 2A receptor with schizophrenia and with response to risperidone treatment in Malaysian patients. Shamsul Bin Mohd Zain. B Biomedical Science. 2008.2009., 2008/2009, 1
  • Polymorphism of serotonin 5-HT 2C receptor in multiethnic patients with schizophrenia. Noor Fadzlin Bte Mahali. 2007/08., 2007/2008, 1
  • The polymorphism of dopamine D3 receptor in multiethnic patients with schizophrenia. Siti Zaleha Suki. B Biomedical Science. 2007/08., 2007/2008, 1

Ongoing
  • Industrial Training Placement Requisition for BSc (Biotechnology students) of Aimst University Faculty of Applied Sciences for 11 weeks. Jeremy Chew Zi Sheng and Lai Ying., 2014/2015, 2
  • Attachment from University of Naresuan, Thailand, for 3 months. Thanet Sornda and Narong Jaturas (Bachelor of Medical Science), 2011/2012, 2

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).


POST GRADUATE
  • Masters in Psychological Medicine, 2010/2011, 6, 6
  • Masters in Clinical Dentistry, 2010/2011, 15, 3
  • Masters in Clinical Dentistry, 2009/2010, 15, 3
  • Masters in Psychological Medicine, 2009/2010, 6, 6
  • Masters in Clinical Dentistry, 2008/2009, 16, 4
  • Masters in Psychological Medicine, 2008/2009, 10, 8
  • Masters in Clinical Dentistry, 2007/2008(2), 15, 0
  • Masters in Psychological Medicine, 2007/2008, 8, 8
  • Masters in Clinical Dentistry, 2006/2007, 20, 7
  • Masters in Psychological Medicine, 2006/2007(1), 8, 6
FIRST DEGREE
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2010/2011, 70, 5
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2010/2011, 55, 12
  • PRINCIPLES OF GENERAL PHARMACOLOGY AND TOXICOLOGY, 2010/2011(1,2,3), 50, 10
  • MBBS (Medical) Course, 2010/2011, 200, 35
  • FARMAKOLOGI, 2010/2011(1,2,3), 70, 47
  • PROFESSIONAL ETHICS IN BIOMEDICAL SCIENCE, 2010/2011, 32, 4
  • ADVANCED MEDICAL PHARMACOLOGY, 2010/2011(1), 10, 3
  • FARMAKOLOGI, 2009/2010, 70, 47
  • MBBS (Medical) Course, 2009/2010, 200, 35
  • PRINCIPLES OF GENERAL PHARMACOLOGY AND TOXICOLOGY, 2009/2010, 50, 10
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2009/2010, 55, 12
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2009/2010, 70, 5
  • PROFESSIONAL ETHICS IN BIOMEDICAL SCIENCE, 2009/2010, 32, 4
  • ADVANCED MEDICAL PHARMACOLOGY, 2009/2010, 10, 3
  • ADVANCED MEDICAL PHARMACOLOGY, 2008/2009, 3, 10
  • ANALYTICAL TECHNIQUES IN CLINICAL TOXICOLOGY AND XENOBIOTICS, 2008/2009(1), 4, 6
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2008/2009, 70, 12
  • Medical Degree, 2008/2009, 210, 82
  • PRINCIPLES OF GENERAL PHARMACOLOGY AND TOXICOLOGY, 2008/2009, 50, 10
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2008/2009, 55, 15
  • FARMAKOLOGI, 2008/2009, 70, 65
  • Basic Pharmacology to Medical students, 2007/2008, 210, 62
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2007/2008, 70, 10
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2007/2008, 55, 15
  • Professional Ethics, 2007/2008(2), 32, 4
  • Basic Pharmacology to the Dental Students, 2007/2008, 70, 62
  • FARMAKOLOGI, 2007/2008, 70, 11
  • Professional Ethics in Biomedical Research, 2006/2007(2), 32, 10
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2006/2007(1), 52, 13
  • Basic Pharmacology to Medical students, 2006/2007, 212, 58
  • Basic Pharmacology to the Dental Students, 2006/2007, 70, 46